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ZUSAMMENFASSUNG 
I 
Zusammenfassung 
Rezeptor-interagierendes Protein Kinase 1 (RIPK1) ist involviert in 
Signalkaskaden die Zelltod und Entzündungen regulieren. RIPK1 reguliert 
NF-κB Aktivierung, interagiert mit RIPK3 um Nekroptose zu steuern und 
vermittelt Apoptose in einer RIP1 Kinase Aktivität abhängigen Art und Weise. 
Das intestinale Epithel ist eine einzellige Schicht, die den luminalen Inhalt von 
sub-epithelien Immunzellen separiert. Um Gewebehomöostase und die 
intestinale Barriereintegrität zu gewährleisten, muss der Zelltod von 
intestinalen Epithelzellen streng reguliert sein. Die in vivo Funktion von RIPK1 
für die Regulierung von Zelltod und Homöostase in Epithelgewebe ist 
weitgehend unbekannt. Um die Funktion von RIPK1 im intestinalen Epithel zu 
studieren wurde das Cre-loxP System benutzt um Mäuse zu generieren, die 
defizitär für RIPK1 spezifisch in intestinalen Epithelzellen sind. Mäuse mit 
einer IEZ-spezifischen RIPK1 Deletion (RIPK1IEZ-KO) zeigten erhöhte IEZ 
Apoptose begleitet von Villus Atrophie, Krypt Hyperproliferation und eine 
milde Entzündung im Kolon und Ileum, was zu einem frühzeitigem Tod 
innerhalb des ersten Lebensmonat führte. Die intestinal Pathologie war 
teilweise abhängig von TNFR1-vermittelter Signalübertragung aber 
entwickelte sich unabhängig von der Microbiota und der MyD88-abhängigen 
Signalübertragung. Epithelzellpezifische Deletion von FADD verhinderte IEZ 
Apoptose, aber RIPK1IEZ-KO/FADDIEZ-KO Doppelknockout Mäuse zeigten IEZ 
Nekroptose und entwickelten Colitis ulcerosa. Zusätzliche Deletierung von 
RIPK3 verhinderte intestinale Entzündung und IEZ Nekroptose, was darauf 
hindeutet, dass IEZs in RIPK1IEZ-KO/FADDIEZ-KO Mäusen durch RIPK1-
unabhängige RIPK3-abhängige Nekroptose starben. Daher besitzt RIPK3-
vermittelte Nekroptose in IEZs eine höhere Immunogenizität als FADD-
vermittelte Apoptose. RIPK1-defizitäre IEZs zeigten den Abbau von den 
überlebensfördernden Proteinen TRAF2, cIAP1 und cFLIP, was direkt mit 
dem Tod von IEZs assoziiert sein könnte.  
 
Zusammenfassend, die Ergebnisse in dieser Arbeit offenbaren eine neue 
gerüstartige Funktion von RIPK1 für die Regulation von intestinaler 
Homöostase durch die Verhinderung von FADD-vermittelter Apoptose.  
 
ABSTRACT 
II 
Abstract 
Receptor-interacting protein kinase 1 (RIPK1) is involved in signalling 
pathways regulating cell death and inflammation. RIPK1 regulates NF-κB 
activation, interacts with RIPK3 to drive necroptosis and mediates apoptosis 
in a RIP1 kinase activity dependent manner. The intestinal epithelium is a 
single cell layer that separates luminal microbes from sub-epithelial immune 
cells. To maintain tissue homeostasis and sustain an intact intestinal barrier, 
cell death of intestinal epithelial cells must be tightly regulated. The in vivo 
role of RIPK1 in regulating epithelial tissue homeostasis and cell death 
remains largely unknown. To study the function of RIPK1 in the intestinal 
epithelium, the Cre-loxP system was employed to generate mice that were 
deficient for RIPK1 specifically in intestinal epithelial cells (IECs). Mice with 
IEC-specific RIPK1 ablation (RIPK1IEC-KO) exhibited increased IEC apoptosis 
accompanied by villus atrophy, crypt hyperplasia and very mild inflammation 
of the colon and the ileum, resulting in premature within the first month of life. 
Intestinal pathology was partially dependent on TNFR1 signalling but 
developed independently of the microbiota and MyD88-dependent signalling. 
Epithelial specific FADD ablation prevented premature death of RIPK1IEC-KO 
mice and inhibited IEC apoptosis, but RIPK1IEC-KO/FADDIEC-KO double 
knockout mice showed IEC necroptosis and developed ulcerating colitis. 
Additional ablation of RIPK3 prevented intestinal inflammation and IEC 
necroptosis, indicating that IECs in these mice died by RIPK1-independent 
RIPK3-dependent necroptosis. Thus in IECs, RIPK3-mediated necroptosis is 
more immunogenic then FADD-mediated apoptosis. RIPK1-deficient IECs 
showed degradation of pro-survival proteins TRAF2, cIAP1 and cFLIP, which 
could be directly associated with death of IECs.  
 
In summary, the results presented in this work reveal a novel scaffolding 
function of RIPK1 for maintaining intestinal homeostasis by inhibiting FADD-
dependent apoptosis of IECs.  
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INTRODUCTION 
 1 
1. Introduction  
1.1 Regulated cell death 
The survival of every multicellular organism is inextricably connected to cell 
death. Throughout life, for the maintenance of tissue homeostasis, cell death 
is necessary to eliminate damaged and infected cells and to control cell 
numbers.  
Cell death is classified into two gross categories, namely “accidental cell 
death” (ACD) and “regulated cell death” (RCD). ACD cannot be prevented or 
modulated, is resistant to pharmacologic interventions and caused by 
chemical, mechanical or physical insults (Galluzzi et al., 2012). On the other 
hand, RCD is dependent on an initiating stimulus and engages a molecular 
machinery to execute death. Therefore, it is amenable to modulation by 
genetic or pharmacologic means. In a physiological context, for instance 
during embryonic development, tissue homeostasis or infection and immune 
responses, RCD is referred to as “programmed cell death” (PCD) (Galluzzi et 
al., 2015).  
In 2012, the Nomenclature Committee on Cell Death (NCCD) proposed a 
classification of cell death subtypes according to measurable biochemical 
features such as apoptosis, necroptosis, pyroptosis, autophagic cell death to 
account for the different forms of cell death, which will be followed throughout 
this work (Galluzzi et al., 2012).  
 
1.1.1 Cell death in homeostasis and immunity 
It is estimated, that every second 106 cells die in an adult human body, to 
keep proliferation and differentiation in balance for organ shaping and 
homeostasis (Green, Ferguson, Zitvogel, & Kroemer, 2009). These cells die 
by caspase dependent apoptosis, classically considered as an 
immunotolerogenic mode of programmed cell death (Green et al., 2009; 
Poon, Lucas, Rossi, & Ravichandran, 2014). Morphological features of 
apoptosis are plasma membrane blebbing, cell body shrinkage (pyknosis), 
nuclear condensation culminating in fragmentation (karyorrhexis) and 
formation of membrane-bound cell fragments (apoptotic bodies) (Kerr, Wyllie, 
& Currie, 1972). Fragmented dying cells are rapidly removed by tissue-
INTRODUCTION 
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resident professional phagocytes (macrophages or dendritic cells) and/or non-
professional phagocytes in the neighborhood (Poon et al., 2014). Both, 
controlled disassembling and rapid removal of apoptotic cells, ensures that no 
cellular content is released into the extracellular space, thereby preventing the 
initiation of an inflammatory response (Lamkanfi & Dixit, 2010). Furthermore, 
apoptotic cells can actively induce the expression of anti-inflammatory 
cytokines in phagocytes, such as IL-10, transforming growth factor β (TGF-β) 
and Lactoferrin, which inhibit recruitment of additional macrophages and/or 
neutrophils (Nagata, Hanayama, & Kawane, 2010; Poon et al., 2014). 
Impaired clearance of apoptotic cells has been implicated in exacerbated 
inflammation, atherosclerosis, autoimmunity, cancer and other pathologies 
(Poon et al., 2014).  
Beyond its role during homeostasis, apoptosis is important in the immune 
response during infection. Upon sensing the presence of an invading 
pathogen, the immune system activates signaling pathways that promote pro-
inflammatory and anti-microbial gene expression to counteract the infection. 
In addition, proteins regulating cell survival and cell death are expressed. In 
various infection models, induction of apoptosis in infected cells was shown to 
reduce pathogen replication and dissemination (Lamkanfi & Dixit, 2010). 
Apoptosis can be induced by different means. Through binding of death 
receptor ligands (DRLs) to their widely expressed specific death receptors 
(DRs 1-6) on the cell surface, death receptor mediated or “extrinsic apoptosis” 
is induced. In contrast to this, the death-inducing stimulus can emanate from 
the cytoplasm by mitochondrial cytochrome c release, leading to “intrinsic 
apoptosis”, or by pattern recognition receptors (PRRs). One important protein 
involved in signal transduction and regulation of cell death in response to DR 
and PRR stimulation is receptor-interacting protein kinase 1 (RIPK1).  
 
For a long time, apoptosis was considered to be the only form of RCD, 
whereas necrosis was categorized as an ACD modality in response to 
physiochemical stress. Morphologically, necrotic cell death is characterized by 
organelle swelling and loss of plasma membrane integrity (Festjens, Vanden 
Berghe, & Vandenabeele, 2006; Krysko, Vanden Berghe, D'Herde, & 
Vandenabeele, 2008; Vanden Berghe et al., 2010). The rupture of the cell 
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membrane results in an uncontrolled release of intracellular “danger-
associated molecular patterns” (DAMPs) including heat-shock protein 70 
(HSP70), DNA-binding protein high mobility group box 1 (HMGB1) and DNA 
fragments, which have potent pro-inflammatory capabilities (Kono & Rock, 
2008; Krysko et al., 2008; Lamkanfi & Dixit, 2010). Therefore, in contrast to 
immunotolerogenic apoptotic cell death, necrosis is considered as an 
immunogenic mode of cell death.  
Recent findings implicated necrosis in various pathologic conditions like 
ischemia-reperfusion (I/R) and traumatic injury, Amyotrophic lateral sclerosis 
(ALS), Huntington’s disease, systemic inflammation, atherosclerosis, 
microbial as well as viral infections and others (W. Zhou & Yuan, 2014). In 
1988 it was discovered, that stimulation with tumor necrosis factor (TNF) 
could induce necrotic cell death in some cell lines (Laster, 1988). Further 
studies revealed necrosis not to be accidental, but rather a regulated form of 
cell death that engages a molecular machinery. After the discovery that the 
chemical compound necrostatin-1 can inhibit DR-induced necrosis, the new 
definition “necroptosis” was introduced to describe regulated necrosis 
(Degterev et al., 2005; Vandenabeele, Declercq, Van Herreweghe, & Vanden 
Berghe, 2010). In addition to DR signaling, necroptosis can be induced by 
stimulation of various PRRs and interferon alpha/beta receptor 1 (IFNAR1) 
(Kaiser et al., 2013; Robinson et al., 2012; Thapa et al., 2011). Downstream 
of DRs and PRRs, receptor-interacting protein kinase 3 (RIPK3) and RIPK1, 
the latter one constituting the molecular target of necrostatin-1, are essential 
for DR induced necroptosis (Cho et al., 2009; Degterev et al., 2008; He et al., 
2009; Holler, 2000; Holler et al., 2000; D. W. Zhang et al., 2009).  
 
1.2 Receptor-interacting protein kinase 1 (RIPK1) 
RIPK1 was discovered in 1995 as an interaction partner of the death receptor 
Fas (CD95) and is constitutively expressed in many tissues (Stanger, Leder, 
Lee, Kim, & Seed, 1995). Human RIPK1 is a 671 aa protein with a predicted 
molecular weight of 76 kDa encoded by the rip1 gene located on chromosome 
6 (Hsu, Huang, Shu, Baichwal, & Goeddel, 1996). Murine RIPK1 consists of 
656 aa and shares 68% homology with human RIPK1 with the highest 
similarity in the death domain (Hsu, Huang, et al., 1996; Stanger et al., 1995). 
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RIPK1 is one of seven known members of the RIP kinase family, classified as 
serine/threonine kinases due to a conserved kinase domain present in all 
identified RIP kinases (Festjens, Vanden Berghe, Cornelis, & Vandenabeele, 
2007; D. Zhang, Lin, & Han, 2010).  
RIPK1 consists of three domains; a N-terminal kinase domain, an 
intermediate domain (ID) and a C-terminal death domain (DD). The kinase 
domain enables RIPK1 to autophosphorylate, which is required for RIPK1 
mediated necroptosis but not for TNF induced NF-κB activation (Hsu, Huang, 
et al., 1996; Newton et al., 2014; Polykratis et al., 2014; Ting, Pimentel-
Muinos, & Seed, 1996). At residue aspartic acid 324 (Asp324) the ID domain 
harbors a caspase-8 cleavage site. Cleavage of RIPK1 at this site shuts off 
NF-κB activation, inhibits necroptosis and promotes apoptosis during DR 
induced casaspe-8 activation and RIG-I mediated antiviral responses (Lin, 
Devin, Rodriguez, & Liu, 1999; Rajput et al., 2011). Upon TNF signaling, 
Lysine 377 (K377) located in the ID of RIPK1 is ubiquitinated by Lys63-linked 
ubiquitin chains and this modification seems to be important for RIPK1 
mediated NF-κB activation (Ea, Deng, Xia, Pineda, & Chen, 2006; H. Li, 
Kobayashi, Blonska, You, & Lin, 2006). In addition, a receptor-interacting 
protein homotypic interaction motif (RHIM), that is responsible for the 
interaction of proteins containing this particular protein-protein binding motif, is 
present in the ID. The RHIM domain is required for the interaction of RIPK1 
with RIPK3, TIR-domain-containing adaptor-inducing IFNβ (TRIF) and DNA-
dependent activator of IRFs (DAI) (Kaiser & Offermann, 2005; X. Sun, Yin, 
Starovasnik, Fairbrother, & Dixit, 2002; Upton, Kaiser, & Mocarski, 2008). A 
DD enabling its interaction with death receptors, TNFR1-associated death 
domain protein (TRADD) and FAS-associated death domain (FADD) can be 
found at the C-terminus of RIPK1 (Park et al., 2007). Via its DD-mediated 
interactions RIPK1 is involved in the assembly of intracellular signaling 
complexes that initiate downstream signaling to induce pro-inflammatory and 
pro-survival gene expression or trigger apoptosis or necroptosis.  
Ever since its discovery, RIPK1 has been implicated in the regulation of cell 
death, as its overexpression caused spontaneous death in baby hamster 
kidney cells (Stanger et al., 1995). Mice with full body ablation of RIPK1 were 
born at the expected Mendelian ratios but died within 3 days after birth due to 
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massive cell death of adipose lineages and T-cells in lymphoid tissues 
(Kelliher et al., 1998).  
 
RIPK1 is involved in genotoxic stress induced NF-κB activation mediated by 
the NEMO PIDDosome, a complex that contains p53-induced protein with a 
death domain (PIDD), RIP1, NEMO and IKK2 (Janssens, Tinel, Lippens, & 
Tschopp, 2005). In a second pathway, RIPK1 and NEMO induce cytokine 
production and caspase-8 activation upon extensive DNA damage sensed by 
ataxia telangiectasia mutated (ATM) kinase (Biton & Ashkenazi, 2011).  
 
Furthermore, a direct role of RIPK1 as a repressor of gene transcription in the 
nucleus downstream of epidermal growth factor receptor (EGFR) has been 
reported (Ramnarain et al., 2008). However, most studies on RIPK1 focused 
on its cytoplasmic role in signal transduction and regulation of cell death. The 
mechanisms of RIPK1 mediated signaling pathways are described in the 
following chapters.  
 
1.3 Death receptor signaling 
The tumor necrosis factor (TNF) ligand superfamily and their cognate 
receptors are important regulators of inflammatory responses and cell death 
in response to infection and tissue injury. Members of the TNF receptor 
superfamily are expressed differentially in different cell types. The death 
receptors (DR), a subgroup of the TNF receptor superfamily, are 
characterized by a cytoplasmic DD motif. Upon ligand binding to its receptor, 
the DR’s DD recruits DD containing adapter proteins forming a receptor 
associated signaling complex to initiate downstream signaling cascades 
resulting in cell death or inflammatory gene expression.  
In humans, six different death receptors have been identified: Tumor necrosis 
factor superfamily member 1a, (Tnfrs1a) (TNFR1) is activated by TNF and 
lymphotoxin α (LTα), tumor necrosis factor receptor superfamily member 6 
(Tnfrsf6) (Fas or CD95) is activated by Fas ligand (FasL or CD95L), DR3 
(Tnfrsf25) is activated by TL1A, TNF-related apoptosis-inducing ligand 
receptor 1 and 2 (TRAILR1 and TRAILR2) are bound by TRAIL (Apo2) and 
finally, DR6 is activated by amyloid precursor protein (APP) (Silke & Hartland, 
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2013; Wilson, Dixit, & Ashkenazi, 2009). DR 3 and DR6 may not efficiently 
induce cell death (Wajant, 2003). Mice express homologs of all human DRs 
except TRAILRs. Instead, murine TRAILR is a single ortholog of human 
TRAILR1 and TRAILR2. 
 
1.3.1 TNF signaling 
1.3.1.1 NF-κB activation 
TNF exerts its pro-inflammatory and anti-apoptotic functions by activating 
canonical transcription factor NF-κB, c-Jun N-terminal kinase (JNK) and p38 
mitogen-activated protein kinases (MAPK). TNF ligation to TNFR1 initiates 
receptor trimerization and subsequent recruitment of adaptor proteins TRADD 
and RIPK1 to TNFR1 via DD interactions. However, the mechanisms 
coordinating DD interactions between TNFR1, TRADD and RIPK1 are not 
fully understood (Hayden & Ghosh, 2012; Hsu, Huang, et al., 1996). TRADD 
recruits the E3 ubiquitin ligases TNFR-associated factor 2 (TRAF2) and 
TRAF5 via TRAF binding domain interactions (Hsu, Huang, et al., 1996; Hsu, 
Shu, Pan, & Goeddel, 1996; Hsu, Xiong, & Goeddel, 1995). TRAF2 binds the 
E3 ligases cellular inhibitors of apoptosis (cIAP1 and cIAP2) and recruits them 
to the TNFR1 complex (Rothe, Pan, Henzel, Ayres, & Goeddel, 1995; Shu, 
Takeuchi, & Goeddel, 1996). The TRAF2-cIAP1/2 axis including E3 ligase 
activity of cIAP1are required for the efficient recruitment of the linear ubiquitin 
chain assembly complex (LUBAC), consisting of haem-oxidized IRP2 ubiquitin 
ligase-1 (HOIL-1L), HOIL-1 interacting protein (HOIP) and SHANK-associated 
RH domain-interacting protein (SHARPIN) (Haas et al., 2009). This complex, 
when associated to the receptor, is termed ‘complex I’ (Figure 1). To mediate 
downstream signaling, cIAPs modify Lys377 of RIPK1 by adding K63-linked 
poly-ubiquitin chains (Mahoney et al., 2008). This modification provides a 
scaffolding platform for the further recruited proteins transforming growth 
factor β activated kinase (TAK1), TAK1 binding protein 1 and 2 (TAB1/TAB2), 
IκB kinase 1 and 2 (IKK1/IKK2) and NF-κB essential modulator (NEMO) 
(Hayden & Ghosh, 2012). RIPK1 K63-ubiquitin chain mediated proximity of 
TAB1/TAB2/TAK1 and IKK1/IKK2/NEMO complexes induces trans-auto-
phosphorylation of TAK1. Activated TAK1 initiates MAPK kinase activation 
and phosphorylates IKK2. Nuclear factor of kappa light polypeptide gene 
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enhancer in B-cells (NF-κB) inhibitor alpha (IκBα) is phosphorylated by IKK2, 
and thereby targeted for ubiquitination and proteasomal degradation. The 
canonical NF-κB heterodimer p65:p50 is then released and translocates to the 
nucleus, where it induces target gene expression (Figure 1) (Hayden & 
Ghosh, 2012). 
 
Addition of K48-, K63-linked and linear ubiquitin chains to different members 
of receptor-associated ‘complex I’ are thought to be important for efficient 
signal transduction and modulation. Upon TNF stimulation, RIPK1 and NEMO 
are modified with linear ubiquitin chains added by LUBAC. These are believed 
to stabilize complex I as well as to support efficient recruitment of NEMO, due 
to its high binding affinity for linear ubiquitin chains (Mollah et al., 2007; 
Tokunaga et al., 2009). Accordingly, cells or mice deficient in HOIL-1 and 
HOIP or carrying mutations in Sharpin (chronic proliferative dermatitis 
mutation; cpdm) showed reduced IκBα phosphorylation after TNF stimulation 
(Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011).  
The importance RIPK1 and its modification with K63-linked ubiquitin chains 
for NF-κB activation remain controversial to date (Hayden & Ghosh, 2014; 
Ofengeim & Yuan, 2013). Initially, RIPK1 was reported to be essential for NF-
κB activation (Ea et al., 2006; Hsu, Huang, et al., 1996; Kelliher et al., 1998; 
H. Li et al., 2006). RIPK1 deficient B-cells failed to activate NF-κB in response 
to murine and human TNF as demonstrated by electrophoretic mobility shift 
assay (EMSA) (Kelliher et al., 1998). The importance of RIPK1 for NF-κB 
activation was attributed to TNF induced K63-linked polyubiquitination of 
K377, because mutating this residue abolished the recruitment of TAK- and 
IKK-complexes to complex I as well as IκBα phosphorylation after TNF 
stimulation (Ea et al., 2006; H. Li et al., 2006).  
In contrast, a different study reported ubiquitinated RIPK1 and no defects in 
IκBα phosphorylation upon TNF stimulation of cells expressing a mutated 
ubiquitin, which cannot be linked using residue K63 (Xu, Skaug, Zeng, & 
Chen, 2009). From these results, an ubiquitin-dependent but K63-
polyubiquitination independent mechanism for TNF-induced IKK activation 
was concluded (Xu et al., 2009). A more recent study reported normal NF-κB 
activation in multiple cell types isolated from RIPK1 deficient mice and 
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suggested a cell type specific function of RIPK1 for NF-κB activation (Wong et 
al., 2010).  
Although the exact role of RIPK1 for NF-κB activation remains elusive, 
TRADD is required for full TNF-induced NF-κB activation (Ermolaeva et al., 
2008; Pobezinskaya et al., 2008). TRADD deficient mouse embryonic 
fibroblasts (MEFs) and bone marrow-derived macrophages (BMDMs) showed 
reduced IκBα phosphorylation and no ubiquitination of RIPK1 after TNF 
stimulation (Ermolaeva et al., 2008; Pobezinskaya et al., 2008). Other 
proteins of complex I, such as cIAP1 and cIAP2 were shown to be likewise 
important for NF-κB activation (Mahoney et al., 2008). Traf2-/- cells show 
slightly reduced NF-κB activation in response to TNF, whereas TRAF2/5 
double knockout cells are completely defective in IKK activation, suggesting 
redundant functions of TRAF2 and TRAF5 in the context of NF-κB activation 
(Tada et al., 2001; Yeh et al., 1997).  
 
NF-κB target genes include pro-inflammatory genes, e.g. Tnf, Il6, anti-
apoptotic gene Cflar, encoding Cellular FLICE (FADD-like IL-1β-converting 
enzyme)-inhibitory protein (cFLIP), and negative regulators of canonical NF-
κB signaling, A20 and cylindromatosis (CYLD). Both, A20 and CYLD, are 
deubiquitylating enzymes that can interact with RIPK1. CYLD is capable of 
removing K63-ubiquitin chains from RIPK1, thereby promoting the 
dissociation of complex I and triggering the formation of a death inducing 
cytosolic complex (DISC) (Hitomi et al., 2008; Moquin, McQuade, & Chan, 
2013; O'Donnell, Legarda-Addison, Skountzos, Yeh, & Ting, 2007; Wright et 
al., 2007). On the other hand, A20 has dual ubiquitin editing properties on 
RIPK1. First, the N-terminal deubiquitylase domain of A20 removes K63-
polyubiquitin chains from RIPK1, and second, a C-terminal zinc finger domain 
catalyzes K48-linked polyubiquitination of RIPK1, thereby targeting RIPK1 for 
proteasomal degradation (Wertz & Dixit, 2008).  
 
Some proteins of the canonical NF-κB pathway downstream of TNFR1 
function as negative regulators in the non-canonical NF-κB pathway, which 
usually is activated by ligands of a subset of the TNF ligand superfamily 
including BAFF, TWEAK or CD40L (Darding & Meier, 2012). In unstimulated 
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cells, NF-κB inducing kinase (NIK) is modified with K48-linked ubiquitin chains 
and thus targeted for proteasomal degradation by a TRAF2-TRAF3-cIAP1/2 
complex. In order to induce ubiquitination of NIK, TRAF3 directly binds to NIK 
and recruits TRAF2. TRAF2 then recruits cIAP1/2, which in turn attaches K-48 
linked ubiquitin chains to NIK. Consequently, non-canonical NF-κB is not 
active at steady state (Vallabhapurapu et al., 2008; Zarnegar et al., 2008). 
Upon stimulation and subsequent receptor ligation, the TRAF2-TRAF3-
cIAP1/2 complex is recruited to the receptor. Depending on the activated 
receptor and the cellular context, either TRAF3 is ubiquitinated by cIAPs and 
subsequently degraded, or TRAF2 and cIAP1/2 are degraded. In both cases, 
NIK is stabilized and phosphorylates IKK1. Active IKK1 forms homodimers, 
which in turn phosphorylate p100, thereby inducing its partial degradation and 
the generation of a p52 cleavage fragment. p52 dimerizes with RelB, the 
dimer translocates to the nucleus and induces target gene expression. Beside 
receptor stimulation, deletion of cIAPs or TRAF2 can result in activation of 
non-canonical NF-κB signaling (Vallabhapurapu et al., 2008; Zarnegar et al., 
2008).  
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1.3.1.2 TNF induced apoptosis and necroptosis 
In addition to anti-apoptotic signaling mediated via complex I formation and 
NF-κB activation, TNF signaling can induce the formation of death inducing 
cytosolic complexes (DSIC) complex IIa, complex IIb and complex IIc (also 
called the necrosome) resulting in apoptotic (complex IIa and IIb) or 
necroptotic cell death (complex IIc/necrosome) (Figure 1) (Pasparakis & 
Vandenabeele, 2015).  
Destabilization of complex I results in the formation of complex IIa by 
association of TRADD with FADD via DD interaction and subsequent 
recruitment of caspase-8 by FADD through the death effector domain (DED) 
(Kelliher et al., 1998; Micheau & Tschopp, 2003; L. Wang, Du, & Wang, 
2008). An alternative apoptosis inducing complex, called complex IIb, 
consisting of RIPK1, RIPK3, FADD and caspase-8 can form as well (Figure 1) 
(Pasparakis & Vandenabeele, 2015; L. Wang et al., 2008; Wilson et al., 
2009). In both complexes FADD recruits two procaspase-8 molecules that 
dimerize. Procaspase-8 dimers undergo a conformational change resulting in 
autocatalytic cleavage and the generation of p43/p41, p30 and other caspase-
8 cleavage fragments. In a second cleavage step, p43/p41 and p30 fragments 
are processed to p10 and p18 fragments that form a fully catalytic active 
caspase-8 heterotetramer (Medema, Scaffidi, et al., 1997; Medema, Toes, et 
al., 1997). Active caspase-8 in turn cleaves and thereby activates effector 
caspases-3, -6 and -7 as well as BH3 interacting domain (Zheng et al.) death 
agonist. Bid mediates the release of mitochondrial proteins, thus inducing 
apoptosome formation and procaspase-9 activation in an indirect manner. 
Active caspase-9 in turn activates effector caspases, thereby providing an 
amplification loop for induction of apoptosis in cells with low levels of DISC 
components (Wilson et al., 2009). Effector caspases further activate 
cytoplasmic endonucleases, which degrade nuclear material, and proteases 
for the degradation of cytoskeletal proteins causing morphological features 
observed in apoptotic cells (Elmore, 2007).  
The third death-inducing complex downstream of TNF, complex IIc, is 
composed of RIPK1, RIPK3 and mixed lineage kinase domain like (MLKL) 
(Pasparakis & Vandenabeele, 2015). According to the current model, RIPK1 
autophosphorylation alters the conformation of RIPK1 and allows a RHIM 
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mediated interaction with RIPK3 (Chan, Luz, & Moriwaki, 2015). The RIPK1-
RIPK3 heterodimer recruits additional RIPK3 molecules to form a large 
RIPK3-RIPK3 amyloid complex leading to RIPK3 autophosphorylation (Cho et 
al., 2009; He et al., 2009; J. Li et al., 2012; D. W. Zhang et al., 2009). 
Dimerization or oligomerization as well as phosphorylation of at least one 
RIPK3 molecule within the complex at Ser232 (Ser227 in human RIPK3) is 
essential for the recruitment of MLKL to the necrosome complex (W. Chen et 
al., 2013; J. Li et al., 2012; McQuade, Cho, & Chan, 2013; Orozco et al., 
2014; Wu et al., 2014). RIPK3 phosphorylates MLKL at Ser345, Ser347, 
Ser352 and Thr349 (Thr357 and Ser358 in human MLKL). This leads to the 
exposure of the 4-helical bundle domain of MLKL, stimulating its 
oligomerization and subsequent translocation to the plasma membrane (Cai 
et al., 2014; X. Chen et al., 2014; Dondelinger et al., 2014; Murphy et al., 
2013; L. Sun et al., 2012; H. Wang et al., 2014; Xie et al., 2013). Although the 
precise mechanism of necroptosis through MLKL function is not entirely clear, 
two models have been proposed so far: first, disruption of cell membrane my 
MLKL results in influx of Ca2+ and Na+ and second, MLKL was shown to 
directly disrupt membrane integrity by binding to membrane phospholipids via 
its 4-helical bundle domain (Cai et al., 2014; X. Chen et al., 2014; Dondelinger 
et al., 2014; Su et al., 2014; H. Wang et al., 2014).  
 
The final cellular outcome of TNFR1 induced signaling is regulated through 
different ways. First, NF-κB activation induces the expression of anti-apoptotic 
proteins such as cFLIP, a catalytically inactive homolog of caspase-8. The two 
predominant isoforms of cFLIP, cFLIPL and cFLIPS both can form 
heterodimers with caspase-8. cFLPL has a similar domain architecture as 
caspase-8, but lacks a catalytic cysteine residue (Darding & Meier, 2012). 
Caspase-8-cFLIPL heterodimers allow partial caspase-8 enzymatic activity 
but not caspase-8 autocatalytic cleavage to inhibit the generation of the 
apoptosis inducing p18/p10 caspase-8 fragments (Pop et al., 2011; Scaffidi, 
Kirchhoff, Krammer, & Peter, 1999; Wachter et al., 2004). On the other hand, 
cFLIPS only contains the DED and dimerization with caspase-8 completely 
inhibits the enzymatic activity of caspase-8 (Kavuri et al., 2011).  
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cFLIPL is a negative regulator of complex IIa mediated apoptosis, which is 
induced by stimulating cells with TNF and protein synthesis inhibitor 
cyclohexamide (Chx) (L. Wang et al., 2008). TNF stimulation of Panc-1 cells 
in which FLIP is knocked down mimiced the combinatory stimulation of TNF 
and Chx (L. Wang et al., 2008). Furthermore, overexpression of cFLIP 
protected cells from TNF and Chx induced apoptosis (L. Wang et al., 2008). 
Apoptosis mediated by complex IIa occurs independent of RIPK1 or its kinase 
activity, since knockdown of RIPK1 or addition of Nec-1 did not protect cells 
from TNF and Chx induced apoptosis (Holler et al., 2000; L. Wang et al., 
2008). In fact, RIPK1 deficient fibroblasts and lymphocytes were highly 
sensitive to TNF induced apoptosis (Kelliher et al., 1998; H. Zhang et al., 
2011). Another study reported no difference in viability of primary and 
immortalized RIPK1 deficient MEFs in response to TNF compared to WT 
MEFs (Wong et al., 2010). Interestingly, Ripk1-/- MEFs were sensitized to 
TNF/Chx-induced apoptosis, arguing for a pro-survival role of RIPK1 in 
TNF/Chx-induced complex IIa mediated apoptosis (Wong et al., 2010).  
 
Figure 1 TNF induced signalling complexes. 
Upon binding to its cognate receptor, TNF is capable to induce distinct intracellular signalling pathways. 
TNF ligation results in assembly of a receptor-associated complex I, which mediates downstream NF-κB 
activation for pro-survival and pro-inflammatory gene transcription. Apoptosis can be induced by the 
formation of death inducing complex IIa composed of TRADD, FADD and caspase-8, which is negatively 
regulated by cFLIP. Destabilization of complex I by deubiquitination of RIPK1 leads to the assembly of a 
RIPK1, RIPK3, FADD and caspase-8 containing apoptosis inducing cytosolic complex IIb. In complex IIa and 
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IIb FADD recruits dimerizing pro-caspase-8 molecules, which are activated by autocatalytic cleavage to 
induce apoptosis. When caspase-8 activity is blocked, RIPK1 and RIPK3 are no longer cleaved by caspase-8 
within complex IIb, stabilize and auto-phosphorylate. Phosphorylated RIPK3 phosphorylates MLKL, which 
then executes necroptosis. For details see text. K63-linked ubiquitination chains are represented by red rings and linear ubiquitination chains by purple 
rings; Brown insets in TRADD and FADD represent DDs, orange insets in FADD and pro-capasase-8 depict 
DEDs. Yellow and black stripes in RIPK1 and RIPK3 represent RHIMs and caspase-8 cleavage sites 
respectively.  
Abbreviations: cIAP1/2, cellular inhibitors of apoptosis 1/2; CYLD, cylindromatosis; FADD, Fas-associated 
via death domain; IKK1/2, inhibitor of κB kinase 1/2; LUBAC, linear ubiquitin chain assembly complex, 
MLKL, mixed lineage kinase domain-like; NEMO, NF-κB essential modifier; P, phosphorylation; RIPK1/3, 
receptor interacting protein kinase 1/3; TAB2/3, TGF-beta activated kinase 1 binding protein 2/3; TAK1, TGF-beta activated kinase 1; TNF, tumor necrosis factor; TNFR1, TNF receptor 1; TRADD, TNF receptor 
associated death domain; TRAF2, TNF receptor-associated factor 2.  
 
On the other hand, complex IIb mediated apoptosis is induced upon 
stimulation of cells with TNF and Smac mimetics (SM), a synthetic IAPs 
antagonist that induces autoubiquitination and proteasomal degradation of 
cIAP1 and cIAP2 (Bertrand et al., 2008; Gaither et al., 2007; L. Li et al., 2004; 
Petersen, Peyton, Minna, & Wang, 2010; Petersen et al., 2007; E. 
Varfolomeev et al., 2007; Vince et al., 2007). A complex with similar 
components, called the “ripoptosome”, can form upon loss of cIAPs upon 
TLR3 stimulation or genotoxic stress independent of death receptor 
stimulation (Feoktistova et al., 2011; Tenev et al., 2011). TAK1, NEMO or 
Pellino deficient cells are also sensitized to TNF-induced complex IIb-
mediated apoptosis (Pasparakis & Vandenabeele, 2015). Apoptosis induced 
by complex IIb is dependent on RIPK1 and its kinase activity as it can 
efficiently be inhibited by RIPK1 deletion or addition of Nec1 (Arslan & 
Scheidereit, 2011; Bertrand et al., 2008; Dondelinger et al., 2013; Gaither et 
al., 2007; Geserick et al., 2009; Petersen et al., 2007; L. Wang et al., 2008; 
Wong et al., 2010). 
Destabilization of complex I by deubiquitination or impaired K63-linked or 
linear ubiquitination of RIPK1 is believed to favor the formation of death-
inducing complex IIb and/or complex IIc. For instance, disabled K63-linked 
ubiquitination of RIPK1 by cIAPs upon SM treatment favors complex IIb 
formation and apoptosis (Bertrand et al., 2008; L. Wang et al., 2008). The 
importance of IAPs for prevention of RIPK1-mediated inflammation and cell 
death is underscored by the finding, that deletion of RIPK3 or one allele of 
RIPK1 partially rescues the embryonic lethality of ciap1-/- xiap-/- or ciap1-/- 
ciap2-/- mice (Moulin et al., 2012). Furthermore, cells expressing mutated 
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RIPK1, where the addition of ubiquitin chains to K377 is prevented, were 
highly sensitive to TNF-induced apoptosis (O'Donnell et al., 2007).  
In addition, mutation of SHARPIN or HOIL-1 deficiency renders cells sensitive 
to TNF induced RIPK1 kinase activity dependent apoptosis and necroptosis 
(Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011). Chronic 
proliferative dermatitis mice (cpdm) carry a mutation in the Sharpin gene and 
develop spontaneous inflammation of the skin, primarily caused by TNFR1-
induced RIPK1 kinase activity and TRADD dependent apoptosis (Berger et 
al., 2014; Gijbels et al., 1996; Kumari et al., 2014; Seymour et al., 2007).  
In contrast to the findings described above, other studies reported 
ubiquitinated RIPK1 in complex II, suggesting that deubiquitination of RIPK1 
is not essential for the induction of cell death (Cho et al., 2009; Lamothe, Lai, 
Xie, Schneider, & Darnay, 2013; Moquin et al., 2013).  
 
In both, complex IIa and IIb, execution of extrinsic apoptosis depends on 
FADD and caspase-8. Full body ablation of either FADD or caspase-8 
resulted in early embryonic lethality due to extensive RIPK3-dependent 
necroptosis, demonstrating that FADD and caspase-8 suppress necroptosis in 
vivo (Kaiser et al., 2011; Oberst et al., 2011; E. E. Varfolomeev et al., 1998; 
Yeh et al., 1998; H. Zhang et al., 2011; J. Zhang, Cado, Chen, Kabra, & 
Winoto, 1998). Caspase-8 suppresses necroptosis by cleaving RIPK1 and 
RIPK3, while the C-terminal RIPK1 cleavage fragment inhibits TNF-induced 
NF-κB activation and promotes apoptosis (Feng, Ma, Yang, & Wu, 2006; 
Feng et al., 2007; J. W. Kim, Choi, & Joe, 2000; Lin et al., 1999; Martinon, 
Holler, Richard, & Tschopp, 2000). Apoptosis mediated by complex IIa or IIb 
can be blocked by addition of pan-caspase inhibitor zVAD-fmk, which 
sensitizes cells to necroptotic cell death. Since Nec1 efficiently blocks 
necroptosis downstream of TNFR1, TNF-induced necroptosis is RIPK1 kinase 
activity dependent (Cho et al., 2009; He et al., 2009; D. W. Zhang et al., 
2009).  
In addition to RIPK1 and RIPK3, CYLD is another substrate of caspase-8 
capable of promoting necroptosis. Mutation of the caspase-8 cleavage site of 
CYLD sensitized cells to TNF-induced necroptosis (O'Donnell et al., 2011). 
Furthermore, knockdown or deletion of CYLD protected against TNF/Smac 
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mimetics induced apoptosis as well as RIPK1-mediated necroptosis (Hitomi et 
al., 2008; Moquin et al., 2013; L. Wang et al., 2008). Since in Cyld-/- cells 
RIPK1 and RIPK3 ubiquitination was greatly enhanced, it was suggested that 
CYLD exerts its pro-necrotic function by deubiquitinating RIPK1 and RIPK3 
within the necrosome rather than acting in complex I (Moquin et al., 2013).  
 
1.3.2 Apoptosis and necroptosis induced by other death receptors 
Fas/CD95 (tumor necrosis factor receptor superfamily member 6; TNFRSF6) 
and TRAIL receptor (in humans TRAILR1 and TRAILR2) are members of the 
DR family that can induce apoptosis after stimulation with their specific 
ligands CD95L (or agonistic antibodies) or TRAIL/Apo2L respectively (Lavrik 
& Krammer, 2012; Wilson et al., 2009). Fas ligation induces receptor 
oligomerization and formation of a membrane associated DISC composed of 
FADD, procaspase-8 and cFLIPL (Muzio et al., 1996; Scaffidi et al., 1999; 
Sprick et al., 2002). Stimulation outcome is determined by the stoichiometry of 
forming procaspase-8 and cFLIP homo- or heterodimers and their processing. 
Induction of apoptosis is correlated to the amount of generated p43/p41 
caspase-8 cleavage fragments, whereas induction of non-apoptotic pathways, 
namely NF-κB activation, depends on the amount of p43-FLIP cleavage 
fragments (Neumann et al., 2010). Although apoptosis occurs independent of 
RIPK1, upon loss of IAPs and/or caspase inhibition Fas can induce RIPK1 
kinase dependent necroptosis (Geserick et al., 2009; Holler et al., 2000).  
RIPK1 has been implicated in Fas induced cytokine and chemokine 
production via activation of NF-κB (Cullen et al., 2013). Furthermore, in Fas 
stimulated Jurkat cells, RIPK1 is required for NF-κB activation but is 
dispensable for ERK and JNK activation (Kreuz et al., 2004).  
A DISC with a similar composition is formed upon TRAIL stimulation. In 
contrast to the membrane associated Fas DISC, the TRAIL DISC is 
internalized by the endosome (Sprick et al., 2002; X. D. Zhang, Franco, 
Nguyen, Gray, & Hersey, 2000). Beside apoptosis, TRAIL can also induce the 
formation a secondary cytosolic complex that is devoid of TRAILR but 
contains FADD, caspase-8, TRAF2 and NEMO (E. Varfolomeev et al., 2005). 
The formation of this secondary complex requires caspase-8 activity and 
results in NF-κB and MAPK activation. Within this complex, RIPK1 is required 
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for efficient IKK and p38 activation but is dispensable for JNK activation (E. 
Varfolomeev et al., 2005). 
 
1.4 Pattern Recogntion Receptor (PRR) signaling 
Recognition of invading pathogens and the initiation of a proper innate 
immune response are critical for host defense. Pattern recognition receptors 
(PRR) are part of the innate immune system and activated by molecular 
structures shared by many pathogens, called pathogen-associated molecular 
pattern (PAMPs), as well as in response to cellular stress and DAMPs. 
Signaling via PPR initiates an inflammatory response to fight the infection, 
alerts the adaptive immune system and can induce the death of infected cells 
to prevent pathogen dissemination. The PRR family includes Toll-like recptors 
(TLRs), C-type lectin receptors (CLRs), NOD-like receptors (NLRs), RIG-I like 
recptors (RLRs) and others (Kawai & Akira, 2011).  
 
1.4.1 RIPK1 in Toll-like receptor (TLR) signaling  
TLRs are transmembrane proteins consisting of a leucine-rich repeat (LRR) 
ectodomain for recognition of PAMPs; a transmembrane domain; and a 
intracellular Toll-interleukin 1 (IL-1) receptor (TIR) domain for signal 
transduction (Kawai & Akira, 2010). Until now, 12 and 10 TLRs have been 
identified in mice and humans, respectively.  
TLRs detect distinct PAMPs derived from bacteria, mycobacteria, viruses, 
fungi and parasites. TLR3 is activated by virus derived double-stranded RNA 
or its synthetic analog poly(I:C), internalized and translocated to the 
endosome (Alexopoulou, Holt, Medzhitov, & Flavell, 2001; Oshiumi, 
Matsumoto, Funami, Akazawa, & Seya, 2003; Yamamoto et al., 2003; 
Yamamoto, Sato, Hemmi, et al., 2002; Yamamoto, Sato, Mori, et al., 2002). 
TLR4 detects lipopolysaccharides, an outer membrane component of gram-
negative bacteria, as well as gram-positive bacterial derived cytolysins 
(Hoshino et al., 1999; Poltorak et al., 1998; Qureshi et al., 1999).  
Except TLR3, all TLRs use TIR-domain containing myeloid differentiation 
primary response 88 (MyD88) as an adaptor protein to initiate downstream 
signaling resulting in NF-κB- and MAPK-mediated pro-inflammatory gene 
expression. TLR3 exclusively, and TLR4 as an additional signaling arm, utilize 
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TIR-domain-containing adapter-inducing interferon-β (TRIF) to induce 
cytokine expression through interferon regulatory factor 3/7 (IRF) and NF-κB 
activation as well as cell death (Kawai & Akira, 2010).  
To activate NF-κB, TRIF interacts with RIPK1 via RHIM domain interaction 
and TRAF6 via a TRAF6 binding domain (Cusson-Hermance, Khurana, Lee, 
Fitzgerald, & Kelliher, 2005; Meylan et al., 2004). TRADD and the E3 ligase 
Pellino1 are recruited to RIPK1, and the latter one attaches K63-ubiquitin 
chains to RIPK1, thereby providing a platform for recruitment and activation of 
the TAK and canonical IKK complex to mediate MAPK and NF-κB activation 
(Cusson-Hermance et al., 2005).  
The TRIF-dependent signaling arm downstream of TLR3 and TLR4 is capable 
to induce apoptosis and necroptosis in order to eliminate infected host cells 
(Lamkanfi & Dixit, 2010). A preassembled complex called “Ripoptosome” 
containing TRIF, RIPK1, RIPK3, FADD, caspase-8, caspase-10 and cFLIP 
can induce apoptosis and necroptosis in some cell lines after TLR3 
stimulation upon loss of IAPs, although the necessity for a direct interaction 
with TLR3 remains elusive (Feoktistova et al., 2011; Tenev et al., 2011). 
RIPK1 is the core component of the Ripoptosome and its kinase activity is 
required for apoptosis and necroptosis, whereas the type of cell death 
induced depends on the ratio of cFLIP isoforms within the complex 
(Feoktistova et al., 2011; Tenev et al., 2011). More recently, the sequential 
assembly of a similar machinery, additionally containing TRADD and TRAF2, 
directly to TLR3 in the presence of cIAPs was demonstrated. This TLR3-
induced apoptosis is RIPK1 dependent and negatively regulated by the 
TRADD-TRAF2-cIAPs complex (Estornes et al., 2012). Likewise to TLR3, 
also TLR4 stimulation was reported to induce TRIF-dependent apoptosis 
through the downstream effectors RIPK1, FADD and caspase-8 (Ma, Temkin, 
Liu, & Pope, 2005; Ruckdeschel et al., 2004).  
When caspase-8 activity is inhibited, TLR3 or TLR4 stimulation can induce 
RIPK3 mediated, TRIF- and RIPK1 kinase activity dependent necroptosis (He, 
Liang, Shao, & Wang, 2011; Kaiser et al., 2013; Polykratis et al., 2014). 
However, also RIPK1-independent necroptosis downstream of TLR3 has 
been reported, presumably mediated via a direct RHIM-mediated interaction 
between TRIF and RIPK3 (He et al., 2011; Kaiser et al., 2013). In contrast to 
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RIPK1, TRIF does not contain a kinase domain suggesting different 
mechanisms of RIPK3 activation by RIPK1 and TRIF (Chan et al., 2015). 
RIPK3 was shown to compete with RIPK1 for binding to the RHIM domain in 
TRIF and therefore RIPK3 can prevent TRIF/RIPK1 dependent NF-κB 
activation (Meylan et al., 2004). In addition, TRIF was identified as a substrate 
for caspase-8 and its cleavage inhibited NF-κB activation. However if 
cleavage of TRIF suppresses necroptosis is not known (Rebsamen, Meylan, 
Curran, & Tschopp, 2008). In summary, similar to TNFR1 signaling, 
TLR3/TLR4 signaling can have three distinct cellular outcomes; NF-κB 
activation; apoptosis and necroptosis. However, the hierarchy of RHIM 
interactions between TRIF, RIPK1 and RIPK3 to determine cell fate are not 
known (Kaiser et al., 2013).  
 
 
Figure 2 TLR3 and TLR4 induced signalling pathways. LPS binding to TLR4 induces MyD88-dependent NF-κB activation. TLR3- and TLR4-induced TRIF dependent NF-κB activation requires RIPK1 TRADD, TRAF3 and Pellino1. Pellino1 modifies RIPK1 with K63-linked 
polyubiquitination chains (red rings) providing a scaffold for downstream NF-κB activation. RIPK3 can 
negatively regulate TRIF-dependent NF-κB activation. An apoptosis inducing complex containing TRIF, 
TRADD, RIPK1, RIPK3, FADD and caspase-8 can form after TLR3 and TLR4 stimulation. When caspase-8 
activity is inhibited, TLR3 stimulation can induce RIPK1-dependent as well as RIPK1-independent RIPK3 
and MLKL-mediated necroptosis. DAI can directly interact with RIPK3 via a RHIM interaction to induce 
necroptosis.. For details see text.  
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Yellow stripes in TRIF, RIPK1 and RIPK3 represent RHIMs. Brown insets in RIPK1 and TRADD depict DDs. 
Black stripes in RIPK1 and RIPk3 represent caspase-8 cleavage sites. Orange insets ins FADD and 
procaspase-8 illustrates DEDs.  
Abbreviations: DAI, DNA-dependent activator of IRFs; FADD, Fas-associated via death domain; IKK1/2, 
inhibitor of κB kinase 1/2; MLKL, mixed lineage kinase domain-like; MyD88, myeloid differentiation 
primary response gene 88; NEMO, NF-κB essential modifier; P, phosphorylation; RIPK1/3, receptor 
interacting protein kinase 1/3; TAB2/3, TGF-beta activated kinase 1 binding protein 2/3; TAK1, TGF-beta 
activated kinase 1; TIRAP, TIR-domain containing adaptor protein; TNF, tumor necrosis factor; TNFR1, TNF 
receptor 1; TRADD, TNF receptor associated death domain; TRAF3, TNF receptor-associated factor 3; 
TRAM, TRIF-related adaptor molecule.   
 
1.4.2 RIPK1 in other PRR signalling pathways 
In addition to TLRs, viral nucleic acids sensing retinoic acid inducible gene I 
(RIG-I) and DNA-dependent activator of IFN-regulatory factors (DAI) also 
utilized RIPK1/RIPK3 for downstream signalling (Chan et al., 2015; 
Christofferson, Li, & Yuan, 2014).  
Upon detection of viral RNA with its DExD/H-box RNA helicase domain, RIG-I 
recruits mitochondrial antiviral signalling (MAVS) via its caspase recruitment 
domains (CARD) domains. Subsequently, a mitochondrial complex containing 
RIPK1, FADD, TRADD, caspase-8 among other proteins is assembled to 
activate the downstream IKK complex for NF-κB and IRF activation 
(Christofferson et al., 2014). The activity of the signaling complex is 
modulated indirectly by RIPK1 and its posttranslational modifications. 
Ubiquitination of RIPK1 at K377 is required for efficient virus-induced 
activation of IRF3 and NF-κB. Caspase-8 negatively regulates the RIG-I 
response by cleaving RIPK1 at Asp324 to generate a 38 kDA fragment that 
mitigates IRF activation. The recruitment of caspase-8 to the RIG-I complex 
depends on the presence of RIPK1 and for its cleavage RIPK1 needs to be 
modified with polyubiquitin chains (Rajput et al., 2011).  
 
DAI induces type I IFNs, NF-κB activation and necroptotic cell death in 
response to double stranded viral DNA via RHIM interactions with RIPK1 and 
RIPK3. Both, RIPK1 and RIPK3, are required for full activation of NF-κB, 
whereas necroptosis induced by DAI is independent of RIPK1 but requires 
RIPK3 (Rebsamen et al., 2009; Upton, Kaiser, & Mocarski, 2010, 2012).  
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1.5 Interferons and necrosome formation 
Type I (predominantly α/β) and type II (γ) interferons (IFN) are pleiotropic 
cytokines with antiviral and immune-modulatory functions. While IFN α and β 
bind to IFN-I receptor, a heterodimer of two IFN-α receptor proteins (IFNAR1 
and IFNAR2), IFN-γ signals through its heterodimeric receptor composed of 
IFN-γ receptor 1 (IFNGR1) and 2 (IFNGR2). Ligand binding activates several 
signaling pathways including NF-κB, Phosphatidylinositol-4,5-biphosphate 3-
kinases (PI3Ks) and Janus-kinase (JAK)-signal transducers and activators of 
transcription (STAT)-pathway to induce the expression of target genes (Stark, 
Kerr, Williams, Silverman, & Schreiber, 1998). Type I and II IFNs activated 
protein kinase R (PKR) was proposed to induce necrosome formation in the 
absence of FADD or caspase activity (Robinson et al., 2012; Thapa et al., 
2011; Thapa et al., 2013). PKR mediates the phosphorylation of RIPK1 and 
thereby induces RIPK1-RIPK3-dependent necroptosis, which under steady 
state conditions is licensed by binding of phosphorylated FADD to RIPK1 
(Thapa et al., 2013). However, a recent study demonstrated no defects in 
IFN-γ induced necroptosis in PKR deficient macrophages (McComb et al., 
2014). Moreover, TNF, LPS and poly(I:C) triggered necroptosis in 
macrophages depends on IFNAR1-IFN-stimulated gene factor 3 (ISGF3) 
signaling, indicating the requirement of an autocrine loop of IFN α and β for 
the execution of RIPK1-RIPK3 dependent necroptosis (McComb et al., 2014).  
 
1.6 Anatomy of the intestinal tract 
The intestinal tract is divided into the small intestine and the large intestine, 
also called colon. The small intestine stretches from the pylorus to the 
ileocaecal valve, and is subdivided (from cranial to caudal) into the 
duodenum, jejunum and the ileum. The colon starts at the caecum, followed 
by the ascending colon, descending colon, and the rectum. The primary 
function of the intestinal tract is the digestion of food, absorption of nutrients, 
reabsorption of water, whereas the latter mainly occurring in the colon.  
 
The gastrointestinal wall is composed of the serosa/adventitia, muscularis 
externa, submucosa and the mucosa (from the outside to the inside), 
separating the intestinal lumen from the abdominal and pelvic cavity. The 
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serosa or adventitia consists of connective tissue and squamous epithelium to 
reduce frictional forces for surrounding organs during peristaltic movements. 
Within the serosa/adventitia lies the muscularis externa, which is formed by 
two smooth muscle layers, the outer longitudinal and inner circular muscle, 
both responsible for peristalsis, the unidirectional transport of luminal content 
towards the anus. The underlying submucosa is a layer of connective tissue 
containing blood vessels, lymphatic vessels and nerves branching into the 
muscularis externa and mucosa. The mucosa is the innermost layer and can 
be divided into three different parts: First, the muscularis mucosa, a smooth 
muscle layer separating the mucosa and the submucosa, second, the lamina 
propria, a layer of connective tissue containing nerve endings, capillaries, 
lymph nodes and vast numbers of immune cells, and third, the intestinal 
epithelium.  
 
1.7 Structure and function of the intestinal epithelium 
The intestinal epithelium is a monolayer of polarized epithelial cells that 
provide a physical and biochemical border separating the mucosal immune 
cells from the contents of the lumen. Instead of being a passive nutrient-
absorbing barrier, intestinal epithelial cells (IECs) perform diverse functions 
crucial for homeostasis, such as mediating selective transport, regulating 
barrier integrity, influencing microbial colonization, sampling the luminal 
microenvironment for antigens as well as beneficial and pathogenic microbes 
and fulfilling immunomodulatory functions. Moreover, IECs do not only 
function in an intrinsic fashion, but are part of a coordinated relationship 
between subepithelial immune cells and the intestinal microbiota (Maloy & 
Powrie, 2011).  
To keep this delicate system at balance, different regions of the intestinal 
epithelium evolved different anatomical architectures and highly specialized 
epithelial cells types, adapted to the distinct physiological functions. The small 
intestine is organized into the crypts of Lieberkühn, epithelial invasions into 
the underlying connective tissue that harbor pluripotent intestinal stem cells as 
well as transient amplifying (TA) cells, and epithelial protrusions into the 
lumen, called villi, which drastically increase the surface area for nutrient 
absorption. In contrast, the colon lacks villi and has a flat surface epithelium 
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but shares the organisation into stem cell and TA cell compartments (Figure 
3) (van der Flier & Clevers, 2009). The intestinal epithelium has the highest 
turnover rate of all tissues in adult mammals with IECs being renewed every 4 
to 5 days (van der Flier & Clevers, 2009). Self-renewal is orchestrated by Lgr5 
expressing stem cells, also called crypt base columnar cells (CBC), residing 
at the bottom of the crypts, which divide asymmetrically once per 24 h (Barker 
et al., 2007; Cheng & Leblond, 1974). They give rise to one stem cell residing 
in the crypt and a transient amplifying (TA) cell that migrates upwards to the 
crypt/villus border while it undergoes 4 to 5 rounds of cell division. During this 
time, IEC progenitors start to differentiate and reach the villus border after 2 
days as mature epithelial cells, whereas they continue to migrate upwards the 
crypt-villus axis. The cell fate and proliferative capacity of differentiating 
progenitor cells is determined by the activity or repression of various signaling 
pathways, such as Wnt-, Notch-, bonemorphogenetic protein (BMP)- and 
Hedgehog signaling (Barker, Bartfeld, & Clevers, 2010; Crosnier, Stamataki, 
& Lewis, 2006; van der Flier & Clevers, 2009). In general, differentiated 
intestinal epithelial cells can be divided into two groups, absorptive and 
secretory cell lineages. Absorptive enterocytes are the most prevalent cell 
type in the intestinal epithelium and account for more than 80% of all IECs. 
They have an apical brush border and are responsible for uptake and 
transport of nutrients across the epithelium (van der Flier & Clevers, 2009). 
Enteroendocrine cells belong to the secretory lineages, make up less than 1% 
of IECs and are scattered throughout the epithelium. They coordinate and 
modulate gut function by secreting hormones, such as gastrin, motilin or 
cholecystokinin. Goblet cells are the most prominent secretory cell lineage in 
the intestinal epithelium and their occurrence increases from the duodenum 
(4%) to the descending colon (16%) (van der Flier & Clevers, 2009). They 
produce secretory mucus glycoproteins (mucins), trefoil factor peptides (TFF) 
and other proteins that are the major components of the upper and lower 
mucus layer. The mucus layer provides protection against mechanical forces 
that emerge during movement of luminal content and importantly, limit or 
completely prevent microbial colonization in the outer and inner mucus layer 
respectively (Y. S. Kim & Ho, 2010). Paneth cells secrete antimicrobial 
peptides (AMP), for instance lysozyme P and α-defensins, into the lumen of 
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the small intestinal crypts to keep them free of microbes. As these AMPs 
diffuse into the mucus layer, they help to shape the composition of the 
residential microbiota and prevent infections by pathogens (Bevins & 
Salzman, 2011; Brandl, Plitas, Schnabl, DeMatteo, & Pamer, 2007; Cash, 
Whitham, Behrendt, & Hooper, 2006; Mukherjee, Vaishnava, & Hooper, 2008; 
Salzman, Ghosh, Huttner, Paterson, & Bevins, 2003). During differentiation, 
Paneth cells escape upward migration and instead, move to the bottom of the 
crypt where they reside. With a life expectancy of 6 to 8 weeks, they are the 
most long-lived differentiated cell lineage within the intestinal epithelium 
(Barker et al., 2010).  
Except for Paneth cells, differentiated cells continuously migrate upwards 
along the crypt-villus axis until they reach the tip of the villus after 3-5 days 
(Barker et al., 2010; van der Flier & Clevers, 2009). Here they detach and are 
exfoilated into the lumen. Although shedding cells show morphological 
features of apoptosis, it was shown that IEC death induced by loss of cell 
contacts, called anoikis, is a caspase independent process (Eisenhoffer et al., 
2012; Hall, Coates, Ansari, & Hopwood, 1994; Shibahara et al., 1995). 
However, the precise mechanisms regulating anoikis are unknown (Vereecke, 
Beyaert, & van Loo, 2011).  
Figure 3 Structure of the small intestinal and colonic epithelium. 
The intestinal epithelium forms a monolayer of polarized epithelial cells covered with mucus and separates 
luminal contents and immune cells in the lamina propria. In the small intestine (SI) (left) and colon (right) 
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epithelial invaginations called crypts contain rapidly proliferating stem cells and progenitor cells. Small 
intestinal crypts are additionally populated by Paneth cells, which secrete anti-microbial peptides (AMP) 
and contribute to the maintainance of the stem cell niche. Epithelial protrusions in the SI called villi, 
harbour differentiated intestinal epithelial cell lineages, which include nutrient absorbing enterocytes, 
hormone secreting enteroendocrine cells and mucus secreting goblet cells. Mucus enriched in AMPs and 
secretory IgA (SIgA) prevents close contact between commensals or pathogens with intestinal epithelial 
cells. Abbreviations: DC, dendritic cell; IEL, intraepithelial lymphocyte. Modified from (Mowat & Agace, 
2014).   
 
1.8 Cell death and immunity in the intestinal epithelium 
The ratio between proliferation, differentiation and cell death within the 
intestinal epithelium has to be tightly regulated. Increased proliferation or 
defects in the execution of cell death are associated with the development of 
colorectal cancer (CRC) (Grivennikov, Greten, & Karin, 2010). On the other 
hand, excessive or uncontrolled cell death might result in compromised barrier 
integrity. This would allow an uncontrolled translocation of immunoreactive 
luminal antigens into the lamina propria and a direct contact with mucosal 
immune cells triggering an inflammatory response. Indeed, increased cell 
dearth and dysregulated barrier function has been implicated in the aetiology 
and pathology of inflammatory bowel disease (IBD) and its two major clinical 
forms, Crohn’s Disease (CD) and Ulcerative Colitis (UC) (Maloy & Powrie, 
2011; Peterson & Artis, 2014; Roda et al., 2010). However, signaling 
pathways that regulate epithelial cell death are also involved in the 
maintenance of intestinal homeostasis and consequently need to be tightly 
balanced.  
 
IECs express various PPR such as TLRs, NLRs, RIG-I like receptors, on their 
basolateral and apical membranes (Takeuchi & Akira, 2010). Therefore, IECs 
show basal levels of NF-κB activation with protective effects including 
epithelial cell proliferation, IgA production, barrier stability and antimicrobial 
responses, but without inducing an inflammatory response (Abreu, 2010; 
Rakoff-Nahoum, Hao, & Medzhitov, 2006; Rakoff-Nahoum, Paglino, Eslami-
Varzaneh, Edberg, & Medzhitov, 2004).  
The importance of TLR- and MyD88 dependent signaling is demonstrated by 
studies with knockout mice in experimental colitis. For instance, Myd88-/-, Tlr2-
/- as well as Tlr4-/- mice showed more severe intestinal pathology and 
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increased mortality in response to DSS induced colitis (Rakoff-Nahoum et al., 
2004).  
During homeostatic conditions, TLR4 is expressed at low levels in IECs and 
located at the apical side (Abreu et al., 2001; Fukata et al., 2007; Lavelle et 
al., 2010). However, patients with IBD showed increased Tlr4 mRNA levels, 
which are suspected to cause increased sensitivity towards the microbiota 
and induce epithelial cell death (Abreu et al., 2001; Cario, 2013; Cario & 
Podolsky, 2000; Frolova, Drastich, Rossmann, Klimesova, & Tlaskalova-
Hogenova, 2008; Hausmann et al., 2002). In line with this, TLR4 was shown 
to contribute to necrotizing enterocolitis (NEC) by inducing enterocyte 
apoptosis as well as inhibiting enterocyte migration and proliferation. 
Accordingly, TLR4 deficiency protected newborn mice from NEC, although the 
molecular mechanisms of TLR4 mediated IEC death remain elusive (Hackam, 
Afrazi, Good, & Sodhi, 2013; Leaphart et al., 2007; Sodhi et al., 2010). In the 
context of intestinal infection models, full body TLR4 deficiency is associated 
with impaired clearance after infection with Salmonella typhimurium or 
Escherichia Coli, although both studies focused on the importance of TLR4 
induced cytokine production by subepithelial immune cells to fight the 
infection (Vazquez-Torres et al., 2004; Weiss, Raupach, Takeda, Akira, & 
Zychlinsky, 2004).  
 
TLR3 is expressed at low levels in IECs of lactating mice and expression 
levels increase strongly during postnatal development (Pott & Hornef, 2012). 
Infection of mice with rotavirus or injection of its synthetic analog polyinosinic-
polycytidylic acid (poly(I:C)) induced TLR3-TRIF dependent IEC apoptosis, 
villus shortening and antiviral gene response (McAllister et al., 2013; Pott & 
Hornef, 2012; A. Sato et al., 2006; R. Zhou, Wei, Sun, & Tian, 2007). 
However, a different study reported that IFN-β production in response to 
rotavirus infection is mediated by RIG-I-MAVS signaling and independent of 
TLR3 and TRIF (Broquet, Hirata, McAllister, & Kagnoff, 2011).  
Beside its protective effect, aberrant TLR3 and TLR4 mediated signaling can 
induce IEC death and thereby contribute to intestinal pathology, although the 
molecular mechanisms of IEC death in the different models remain unknown.  
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Death receptor ligands, in particular TNF, are potent regulators of cell death 
and inflammatory responses. In the intestinal tract the main sources of TNF 
are macrophages, Th17 cells and IECs (Nazli et al., 2010; Sanchez-Munoz, 
Dominguez-Lopez, & Yamamoto-Furusho, 2008; Taylor, Dzus, & Colgan, 
1998; Zachrisson, Neopikhanov, Samali, & Uribe, 2001). IECs express 
TNFR1 and therefore can respond to TNF by promoting inflammation and cell 
survival or undergo cell death (Lau et al., 2011; Strater & Moller, 2000). 
Intraperitoneal injection of TNF into wildtype mice caused villi shortening due 
to exfoliation of dying epithelial cells. However, TNF injection did not cause 
intestinal inflammation, presumably because of TNF-induced rearrangements 
of cell junctions (Marchiando et al., 2011; Marchiando et al., 2010; McAllister 
et al., 2013; Piguet, Vesin, Guo, Donati, & Barazzone, 1998; Williams et al., 
2013). On the other hand, overexpression of TNF induces transmural 
intestinal inflammation primarily mediated by TNF responsiveness of bone 
marrow and parenchymal cells (Armaka et al., 2008; Kontoyiannis, 
Pasparakis, Pizarro, Cominelli, & Kollias, 1999). Moreover, intestinal epithelial 
specific overexpression of TNF induces a similar intestinal pathology, 
however IECs are not the initiating responders to TNF causing intestinal 
inflammation (Roulis, Armaka, Manoloukos, Apostolaki, & Kollias, 2011). TNF 
is considered as a major driver of pathogenesis in IBD, since patients show 
increased levels of TNF in areas with disease manifestation (Arijs et al., 2009; 
Braegger, Nicholls, Murch, Stephens, & MacDonald, 1992; Breese et al., 
1994; Komatsu et al., 2001; MacDonald, Hutchings, Choy, Murch, & Cooke, 
1990; Reimund et al., 1996). Furthermore, anti-TNF treatment is used as an 
effective therapy for IBD (Hanauer et al., 2002; Hanauer et al., 2006; 
Sandborn et al., 2007; Sandborn et al., 2001). Finally, an IBD susceptibility 
locus encompassing the Tnf gene has been identified in genome wide 
association studies (GWAS) (Dechairo et al., 2001; Hampe et al., 1999; Rioux 
et al., 2000).  
Many genes known for their contribution to intestinal homeostasis, such as 
Nod2, Tlr4, Atg16l and Tnfaip3, have been identified as susceptibility loci for 
IBD development (Kaser, Zeissig, & Blumberg, 2010; Pott & Hornef, 2012). 
Some of these susceptibility genes exert their function at least partially via 
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NF-κB signaling. Genetic studies in mice demonstrated the importance of 
intestinal epithelial NF-κB signaling for the maintenance of homeostasis.  
For instance, mice with intestinal epithelial specific ablation of TAK1, NEMO 
or both, IKK1 and IKK2 show excessive IEC apoptosis and develop 
spontaneous colitis (Kajino-Sakamoto et al., 2008; Nenci et al., 2007). NEMO-
deficient IECs died by TNF-induced apoptosis that result in compromised 
barrier integrity. Subsequently, bacteria are able to translocate into the 
mucosa where they activate immune cells. Activated immune cells in turn 
trigger colitis. Consequently, blocking TNF- or MyD88-dependent signaling 
protected NEMOIEC-KO mice from developing colitis (Nenci et al., 2007). The 
death of NEMO-deficient IECs can only partially be attributed to canonical 
(p65-dependent) NF-κB activation, since mice with IEC-specific deletion of 
p65 do not phenocopy NEMOIEC-KO mice. These mice show slightly elevated 
levels of IEC death and intestinal disease with low penetrance but increased 
susceptibility to DSS induced colitis (Steinbrecher, Harmel-Laws, Sitcheran, & 
Baldwin, 2008). In addition, interference with the cell death machinery 
regulating extrinsic apoptosis can cause intestinal pathology as well. Intestinal 
epithelial cell specific deletion of cFLIP results in embryonic lethality, 
suggesting an important role for cFLIP during gut development (Wittkopf et 
al., 2013). Induced deletion of cFLIP in IECs of adult mice resulted in rapid 
mortality as a consequence of massive epithelial cell apoptosis and intestinal 
inflammation. cFLIP-deficient IECs were highly susceptible to TNF- and FAS-
induced RIPK3-independent apoptosis, supporting a role of cFLIP as negative 
regulator of caspase-8 activity (Wittkopf et al., 2013). Inhibition of extrinsic 
apoptosis by intestinal epithelial specific caspase-8 or FADD ablation caused 
spontaneous caspase-independent death of IECs. Interestingly, although 
functionally dependent on each other, FADD deficiency triggers colitis, 
enteritis and Paneth cell death, whereas mice lacking caspase-8 develop 
enteritis accompanied by Paneth cell loss, but no colitis (Gunther et al., 2011; 
Welz et al., 2011). The reason for this phenotypic difference is unknown, but 
could be attributed to additional functions of FADD in controlling intestinal 
homeostasis. Development of colitis but not enteritis and Paneth cell death in 
FADDIEC-KO mice depends on TNF, the microbiota and was ameliorated by 
additional deletion of CYLD (Welz et al., 2011). Caspase-8 deficiency 
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sensitized IECs to TNF, poly(I:C) and LPS induced death resulting in death of 
mice (Gunther et al., 2015). Interestingly, LPS induced death by triggering 
TNF production in non-epithelial cells rather than directly acting on IECs to 
induce TLR4 mediated signaling in IECs (Gunther et al., 2015). Both, FADD 
and caspase-8 deficient IECs died by RIPK3 dependent necroptosis, 
indicating an important role of FADD and caspase-8 as negative regulators of 
necroptosis in vivo.  
As described in the previous chapters, RIPK1 is a constituent of the same 
death-inducing complexes. Nevertheless, its role in the intestinal epithelium is 
remains unknown.  
 
In summary, signaling pathways controlling intestinal homeostasis require a 
tight regulation and dysfunction is associated with intestinal pathology. 
Although extrinsic apoptosis or necroptosis per se are not required for gut 
development and epithelial renewal, a functional cell death machinery is 
necessary to prevent excessive epithelial death and inflammatory disorders. 
However, the detailed mechanisms regulating cell death or survival require 
further investigation.  
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1.9 Cre/LoxP conditional gene targeting 
Cell type specific analysis of gene function in mice can be achieved using 
Cre/LoxP mediated recombination for conditional genes. Furthermore, 
Cre/LoxP mediated recombination allows the study the function of genes 
essential for embryonic development. In order to generate a conditional 
knockout allele, two specific 34 bp DNA sequences, called “LoxP” sites, are 
inserted in the same orientation to flank the desired gene locus or particular 
exons of interests. An allele carrying LoxP sites is called ‘floxed’ (FL) and 
mice carrying conditional alleles referred to as “floxed” mice. These floxed 
mice are crossed to mice expressing a bacteriophage P1-derived Cre 
recombinase under the control of a tissue specific promoter. Only in Cre 
expressing cells, LoxP sites are recognized and recombined by Cre, resulting 
in the excision of the floxed DNA fragment and an inactivation of the gene of 
interest.  
 
1.10 Project description 
The intestinal epithelium is a monolayer of cells with an exceptional high 
homeostatic cell turnover in highly balanced and complex processes to 
ensure barrier integrity. Several signaling pathways, such as NF-κB, are 
implicated in maintaining homeostasis. Excessive IEC death, for instance 
caused by disturbance of these pathways, can result in compromised barrier 
integrity, allowing a direct interaction between luminal antigens and sub-
epithelial immune cells resulting in intestinal inflammation.  
RIPK1 serves as a central signaling node in cytokine and PPR signaling 
pathways at the crossroad to induce pro-survival signaling or apoptosis as 
well as necroptosis. However, the function of RIPK1 in vivo in epithelial 
tissues remains largely unknown. In this study, Cre/LoxP conditional gene 
targeting was employed to generate mice with intestinal epithelial cell specific 
ablation of RIPK1, enabling to investigate the function of RIPK1 specifically in 
intestinal epithelial cells in vivo.  
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2. Material and Methods  
2.1 Material 
2.1.1 Chemicals 
Chemicals and compounds were purchased from AppliChem (Darmstadt, 
Germany), Corning (Corning, NY, United States), DAKO (Santa Clara, CA, 
United States), GE Healthcare (Chalfont St Giles, Great Britain), Merck 
(Darmstadt, Germany), Qiagen (Hilden, Germany), Roche (Basel, 
Switzerland), Roth (Karlsruhe, Germany), Sigma Aldrich (München, 
Germany), ThermoFisher Scientific (Waltham, MA, United States), VWR 
(Radnor, PA, United States).  
 
2.1.2 Material for mouse work 
Syringes, Braun 
Injection needles, Braun 
Ampicillin, ICN Biomedicals 
Ciprofloxacin, Fluka 
Meronem, AstraZeneca 
Neomycin, Sigma 
Vancomycin, Eberth 
Tamoxifen, Sigma  
Dimethylsulfoxid, PAN Biotech GmbH  
Cornoil, Sigma 
 
2.1.3 Material for histology 
Tissue retriever 2100, PickCell 
Tissue processor, Leica TP1020 
Rotary Microtome, Leica RM2255 
Modular tissue embeding center, Leica EG1150 and Leica EG1150C 
Microscope, Leica DM5500B 
ABC Kit Vectastain Elite (Vector, PK 6100) 
Avidin/Biotin Blocking Kit (Vector, SP-2001) 
Liquid DAB Substrate Chromogen System (DakoCytomation, Code K3466 
and Vector, ImPACT™ DAB SK-4105) 
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Normal goat serum, Vector Laboratories 
Entellan, Merck 
Glass slides, Menzel 
Cover slides, Menzel 
 
2.1.4 Material for biochemistry 
Homogenizer Precellys 24, PeqLab 
2 ml tubes for homogenisation, PeqLab 
1,4 mm Zirconium oxide beads for tissue homogenisation, PeqLab 
Gel casting system and SDS-Page system, Biorad 
Power supply, Biorad 
Protease Inhibitor Cocktail complete mini EDTA free, Roche 
Phosphatase inhibitor, PhosphoStop, Roche 
Bradford reagent, Biorad 
Protein Marker PeqGold Protein Marker V, PeqLab 
PVDF membranes Immobilon-P, Millipore 
Films Hyperfilm ECL, Amersham 
Super RX, Fujifilm 
 
2.1.5 Molecular biology reagents and equipment 
Trizol reagent, Invitrogen 
RNA extraction RNeasy mini kit, Qiagen 
RNase-free DNase set Qiagen 
Super scriptIII cDNA synthesis Kit, Invitrogen 
RT Cycler ABI HT 7900 Cycler, Applied Biosystems 
Power SYBR® Green PCR Master Mix, Applied Biosystems 
TaqMan® Gene Expression Master Mix, Applied Biosystems 
MicroAmp® Optical Adhesive Film, Applied Biosystems 
MicroAmp™ Optical 384-Well Reaction Plate, Applied Biosystems 
 
2.1.6 Laboratory equipment 
Centrifuges, Eppendorf and Haereus 
Thermomixer, Eppendorf 
PCR-cyclers, Biorad DNA Engine, Biometra and Eppendorf 
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DNA ladder, PeqLab 
Primers, Invitrogen and Metabion 
Bio Photometer, Eppendorf 
NanoDrop ND8100, PeqLab 
 
2.1.7 Cell culture 
Plastic ware for cell culture from BD Falcon, Millipore, TPP, Corning Tubes 
Eppendorf 1,5 ml and 2 ml reaction tubes 
Advanced DMEM/F12, Gibco 
DPBS, Gibco 
Fetal Calf Serum, PAN 
100x Penicillin (10000 U/ml)/Streptomycin (10000 µg/ml), Gibco 
100x L-Glutamine (200 mM), Gibco 
HEPES (1 M), Invitrogen 
B27, Invitrogen 
N2, Invitrogen 
N-Acetylcysteine, Sigma-Aldrich 
R-Spondin, RandD Systems 
Noggin, Peprotech 
mEGF, Invitrogen Biosource 
Matrigel, Corning 
4-Hydroxytamoxifen, Sigma 
Ethanol, VWR 
TNF, University of Ghent 
Poly(I:C), Amersham 
hIFN-β, peprotech 
mIFN-γ, Immunotools  
zVAD-fmk, Enzo 
 
2.1.8 Software 
Photoshop CS3, Leica microscopy Software Leica application suite, Prism 
Graph, Microsoft Office., FACSDiva, FlowJo 
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2.1.9 Buffers and solutions 
2.1.9.1 Washing buffers 
PBS (1x) pH 7,3 
NaCl    137 mM 
KCl    2.7 mM 
Na2HPO4-7H2O  4.3 mM 
KH2PO4   1.4 mM 
 
TBS (1x) pH 7,5 
Tris-Base    24.2 g 
NaCl    80g 
 
2.1.9.2 Buffers and solutions for immunostainings 
Endogenous peroxidase blocking buffer (for IHC) 
NaCitrate   0.04 M 
Na2HPO4   0.121 M 
NaN3    0.03 M 
H2O2    3% (v/v) 
 
Antigen retrieval buffer, Citrate buffer, pH 6.0 
NaCitrate   10 mM 
Tween-20   0.05% (v/v) 
 
Antigen retrieval bufferm, TEX Protease K buffer, pH 8.0 (for protease 
mediated antigen retrieval) 
Tris-Base   50 mM 
EDTA    1 mM 
Triton X-100   0.5% (v/v) 
 
2.1.9.3 Preparation of protein extracts 
 
High salt RIPA lysis buffer 
HEPES (pH 7.6)  20 mM 
NaCl    350 mM 
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MgCl2    1 mM 
EDTA    0.5 mM 
EGTA    0.1 mM 
Glycerol   20% (v/v) 
1% Nonident P-40, Protease inhibitor and Phosphatase inhibitors were added 
prior to use.   
Cytoplasmic and nuclear protein extraction buffers 
Buffer A (hypotonic lysis buffer) 
HEPES (pH 7.6)  10 mM 
KCl    10 mM 
MgCl2    2 mM 
EDTA    0.1 mM 
Protease inhibitor and Phosphatase inhibitors were added prior to use. 
After swelling 0.8% (v/v) Nonident P-40 was added.  
 
Buffer C (high salt nuclear lysis buffer) 
HEPES (pH 7.8)  50 mM 
KCl    50 mM 
NaCl    300 mM 
EDTA    0.1 mM 
Glycerol   10% (v/v) 
Protease inhibitor and Phosphatase inhibitors were added prior to use. 
 
2.1.9.4 Buffers and solutions for Western Blot analysis  
Tris-glycine electrophoresis buffer 
Tris-Base   25 mM 
Glycine   250 mM 
SDS    0.1% (w/v) 
SDS-polyacrylamide gel 
10% resolving gel (for 20 ml) 
H2O    7.9 ml 
30% acrylamide mix 6.7 ml 
1.5 M Tris (pH 8.8)  5.0 ml 
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10% (w/v) SDS  0.2 ml 
10% (w/v) APS  0.2 ml 
TEMED   0.012 ml 
 
5% stacking gel (for 10 ml) 
H2O    6.8 ml 
30% acrylamide mix 1.7 ml 
1 M Tris (pH 6.8)  1.25 ml 
10% (w/v) SDS  0.1 ml 
10% (w/v) APS  0.1 ml 
TEMED   0.01 ml 
 
Transfer buffer (for semidry and wet transfer) 
Tris-Base   25 mM 
Glycine   192 mM 
Methanol, pH 8.3  20% (v/v) 
 
Blocking buffer 
Tween-20   0.1% (v/v) 
nonfat dry milk  5% (w/v) 
in PBS 
 
Primary and secondary antibody dilution buffer  
Tween-20   0.1% (v/v) 
Nonfat dry milk or BSA 5% (w/v) 
in TBS 
 
5x Laemmli loading buffer 
Tris-HCl (pH 6.8)  250 mM 
SDS    10% (w/v) 
Glycerol   50% (v/v) 
Bromphenolblue  0.01% 
β-Mercaptoethanol  10% 
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2.1.9.5 Buffers for DNA extraction and genotyping PCRs 
Tail lysis buffer 
Tris-HCl (pH 8.5)  100 mM 
EDTA    5 mM 
NaCl    200 mM 
SDS    0.2% (w/v) 
0.1 mg Proteinase K (10 mg/ml in 50 mM Tris, pH 8.0) per 100 µl lysis buffer 
was added prior to use.  
 
TE buffer 
Tris-HCl (pH 8)  10 mM 
EDTA (pH 8)   1 mM 
 
10x TAG buffer 
Tris-Base (pH 8.5)  200 mM 
KCl    500 mM 
 
TAE buffer (25x) for 10 l 
Tris-Base (pH 8.5)  1210 g 
EDTA (pH 8.0)  500 ml of 0.5 M solution 
Acetic acid   285.5 ml 
 
2.1.9.6 Buffers for 3D intestinal epithelial cell culture 
Complete medium without growth factors (CM-GF) 
Advanced DMEM/F12 500 ml 
Glutamax 100x  5 ml 
HEPES (1M)   5 ml 
Pen/Strep   5 ml 
 
Complete medium with growth factors (CM+GF) 
CM-GF   50 ml 
B27 (50x)   1 ml 
N2 (100x)   0.5 ml 
n-Acetylcysteine  0.125 ml (of 500 mM stock) 
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ENR (EGF, Noggin, R-Spondin) 
CM+GF   78 µl 
EGF    2 µl (of 500 µg/ml stock) 
Noggin   10 µl (of 100 µg/ml stock) 
R-Spondin   10 µl (of 100 µg/ml stock) 
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2.2 Methods 
2.2.1 Animal handling and mouse experiments 
2.2.1.1 Mouse maintenance 
Mice were maintained in a conventional animal facility in individually ventilated 
cages (IVC) in a specific pathogen free (SPF) mouse facility in the Institute for 
Genetics and the CECAD Research Center at the University of Cologne. Mice 
were kept under a 12 hours light/dark cycle, given acidified water and a 
regular chow diet (Teklad Global Rodent 2018, Harlan) ad libitum.  
For breeding, male and female mice were placed together into one cage at a 
minimum age of eight weeks. Litters marked with an eartag at 2-weeks of age 
and tail biopsies were taken at the same age for isolation of genomic DNA 
and genotyping. Litters were weaned with an age of three weeks.  
Care of all mice was within institutional animal care committee guidelines. 
Animal procedures were conducted in accordance with European, national 
and institutional guidelines. All protocols were approved by local government 
authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen, Germany). Animals requiring medical attention were provided with 
appropriate care and excluded from the experiments described. No other 
exclusion criteria existed.  
 
Germ-free mice were produced by embryonic transfer into the gnotobiotic 
facilities at the University of Ulm and of the Hannover Medical School.  
 
2.2.1.2 Generation of conditional and full body knockout mice 
To generate mice with a deletion of RIPK1 specifically in the intestinal 
epithelium (RIPK1IEC-KO mice), Ripk1fl/fl mice were crossed with villin Cre 
transgenic mice (Madison et al., 2002). Ripk1fl/fl mice were generated as 
described in 3.1 and backcrossed in a C57BL/6 background for 10 
generations. RIPK1IEC-KO mice were crossed to Faddfl/fl mice (Mc Guire et al., 
2010), Myd88-/- mice (Adachi et al., 1998), Tnfr1-/- mice (Pfeffer et al., 1993), 
Triffl/fl mice (Dannappel et al., 2014), R26IKK2casfl/sfl (Sasaki et al., 2006) or 
Ripk3-/- mice (Newton, Sun, & Dixit, 2004) to generate double or triple 
deficient mice. All mice were analysed at 3 weeks of age unless otherwise 
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indicated. For all experiments littermates not carrying the villin Cre transgene 
were used as control mice.   
2.2.1.3 Generation of inducible conditional knock-out mice 
To generate mice with a tamoxifen-inducible conditional RIPK1 allele in the 
intestinal epithelium, Ripk1fl/fl mice were bred with VillinCreERT2 transgenics 
(el Marjou et al., 2004). VillinCreERT2 recombinase activity was induced by 
three daily intraperitoneal injections of 1 mg tamoxifen dissolved in 
DMSO/cornoil in 100 µl total volume. Vehicle-treated control mice received 
three daily intraperitoneal injections of DMSO in cornoil. Littermates only 
carrying loxP flanked Ripk1 alleles served as control mice for all experiments.   
 
2.2.1.4 Antibiotic treatment and germ-free mice 
For depletion of the intestinal microbiota, RIPK1IEC-KO mice were treated with 
two different mixtures of broad spectrum antibiotics supplied through the 
drinking water starting from embryonic day (E)17.5. To achieve efficient 
microbiota depletion, two different antibiotic mixtures were applied. One 
antibiotics regimen consisted of a mixture containing 1g/l ampicillin, 1 g/l 
neomycin, 0.5 g/l ciprofloxacin and 0.5 g/l meronem and was administered 
until weaning. After weaning, ciprofloxacin was replaced by 0.5 g/l 
vancomycin. The second antibiotic cocktail consisted of 1 g/l ampicillin, 1 g/l 
metronidazole, 0.2 g/l cirpofloxacin and 0.5 g/l vancomycin. As neither the 
overall physiological response nor the tissue pathology differed between the 
two regimens, mouse groups receiving either antibiotic mixture were analyzed 
together and data from individual experiments were pooled.  
For antibiotic treatment of VillinCreERT2/Ripk1fl/fl mice, 1g/l ampicillin, 1 g/l 
neomycin, 0.5 g/l meronem and 0.5 g/l vancomyin was given for 4 weeks prior 
administration of tamoxifen (see 2.2.1.3). 
In all cases, drinking water with antibiotics was exchanged every second day 
and mice were transferred into a new cage. In order to check the efficiency of 
microbiota depletion, homogenized feces (10 mg feces in 100 µl in LB 
medium) were plated on agar plates in serial dilutions.  
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Germ-free mice were generated by embryonic transfer into the gnotobiotic 
facilities at the University of Ulm and of the Hannover Medical School. 
Survival of germ-free RIPK1IEC-KO mice was monitored at the Hannover 
Medical School by daily inspection. Mice were sacrificed and dissected when 
medical attention was required.  
 
2.2.1.5 Preparation of tissue biopsies 
Mice were euthanized by cervical dislocation or decapitation.  
 
2.2.1.6 Tissue preparation 
After euthanasia, the abdominal cavity was opened by a longitudinal incision. 
The colon and small intestine were removed by one cut near the anus and a 
second cut after the pylorus. The intestine was washed in PBS, mesentery, fat 
and luminal content were removed. A small piece of about 5 mm length from 
the distal colon and ileum was collected for RNA extraction. For histological 
examination, the remaining colon and ileum were cut open longitudinally and 
rolled up lengthwise with the help of injection needles to form a so called 
“swiss-rolls”.  
 
2.2.1.7 Isolation and FACS analysis of lamina propria immune cells 
Immune cells of the colon and lamina propria were isolated as described 
previously (Klose et al., 2013). In brief, the mice were euthanized and the 
colon and/or small intestine were collected as described in sections 2.2.1.5 
and 2.2.1.6. The intestines were washed in ice-cold PBS, remaining fat and 
Peyer’s Patches were removed, and the intestines were opened 
longitudinally. To remove epithelial cells, intestines were incubated in 1xHBSS 
containing 5 mM EDTA and 10 mM HEPES at 37°C for 15 min under 
agitation. The supernatant was removed and this procedure was repeated 
twice. Afterwards, the tissue was chopped into pieces and incubated in HBSS 
supplemented with 4% FCS, DispaseII (0.15 mg ml-1; Roche), Collagenase D 
(0.4 mg ml-1; Roche) and DNaseI (0.5 mg ml-1; Sigma Aldrich) in order to 
digest the tissue. Isolated immune cells were purified by Percoll gradient 
centrifugation (GE Healthcare LifeScience). Isolated immune cells were 
incubated with CD16/CD132 antibody (BD Biosciences) for 15 min to block Fc 
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receptors. In order to so stain for the individual immune cell subpopulations, 
the cells were incubated with the following antibodies for 30 min on ice: CD3e 
(145-2C11), CD11b (M1/70), CD45.2 (104), Ly6G (1A8), B220 (RA3-6B2), 
F4/80 (BM8) (BD Biosciences). Afterwards, stained immune cells were 
analyzed with a BD FACS Canto I (BD Biosciences) using FACSDiva 
software. Experiments were analyzed with FlowJo software (Tristar). Isolation 
of lamina propria immune cells was performed by/under supervision of Dr. 
Christina Eftychi.  
 
2.2.2 Histology 
2.2.2.1 Preparation of intestinal tissue for histological analysis 
For histological examination the tissue was transferred into histology 
cassettes and fixed in 4% paraformaldehyde overnight at 4°C. For 
dehydration the samples were passed through increasing concentrations of 
ethanol (2 h for each in 30% (v/v), 50% (v/v), 70% (v/v), 96% (v/v) and 2 times 
in 100% (v/v) ethanol). Subsequently, samples were incubated twice for 2 h in 
xylol and then transferred to liquid paraffin for embedding in paraffin blocks. 
The tissue was sectioned at 3-4 µm thickness, mounted on glass slides and 
dried overnight at 37°C.  
 
2.2.2.2 Hematoxylin and Eosin staining  
For deparaffinisation tissue sections were placed in xylol for 20 min. 
Rehydration was performed by placing the slides in descending series of 
ethanol solutions for 2 min each (100% (v/v), 96% (v/v), 75% (v/v) ethanol) 
and washed or 5 min in tap water. The sections were stained in Meyer’s 
Hematoxylin for 1 min, differentiated in tepid water for 10 sec, incubated in tap 
water for 15 min to develop blue staining and washed for 1 min in deionised 
water. The slides were placed in Eosin staining solution for 1 min. To remove 
excessive staining the slides were washed in tap water for 7 times. The 
samples were placed for 1 min each in 75% (v/v), 96% (v/v) and 100% (v/v) 
ethanol and then cleared in xylol for dehydration and preservation. Finally, 
coverslips were mounted with Entellan.  
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2.2.2.3 Periodic acid-Schiff staining of intestinal tissue sections 
For periodic acid-Schiff (PAS) staining, slides were deparaffinized, rehydrated 
and washed as described in section 2.2.2.2 (H&E staining procedure). Tissue 
sections were treated with periodic acid for 5 min and washed two times for 5 
min in tap water, followed by incubation in Schiff’s reagent for 5 to 10 min. 
Chromogen formation was monitored under the microscope and the reaction 
was stopped by washing the slides in running tap water for 10 min. Nuclei 
were counterstained with Meyer’s Hematoxylin for 1 min. Samples were 
washed, dehydrated and mounted as described above (see 2.2.2.2).  
 
2.2.2.4 Alkaline phosphatase staining 
Staining for alkaline phosphatase was performed with Vector® Red Alkaline 
Phosphatase Substrate Kit I (Cat. No. SK-5100) according to manufacturer’s 
instructions. Tissue sections were deparaffinised and rehydrated as described 
under H&E staining procedure (see 2.2.2.2). Samples were rinsed with 20x 
TBS. To visualize the presence of alkaline phosphates, 1 drop of Vulcan Fast 
Red Chromogen was added to 2.5 ml Vulcan Red buffer, mixed well, added to 
the slides and incubated for 15 min. Formation of the reaction product was 
followed under the microscope and reaction was stopped after a sufficient 
staining intensity was observed by washing the slides for 1 min in deionised 
water. Nuclei were counterstained with Meyer’s Hematoxylin for 1 min. 
Samples were washed, dehydrated and mounted as described above (see 
2.2.2.2). 
 
2.2.2.5 Immunohistochemistry 
For immunohistochemical (IHC) stainings, tissue sections were deparaffinised 
and rehydrated in ascending concentrations of ethanol as described in section 
2.2.2.2. Endogenous peroxidase activity was blocked by incubation of 
samples for 15 min at room temperature with endogenous peroxidase 
blocking buffer. Thereafter slides were washed 3 times for 5 min in tap water. 
Antigen unmasking was performed either by heat induced antigen retrieval in 
citrate buffer for 20 min at 120°C in a pressure steam cooking device or by 
Proteinase K digestion with 10 µg/ml Proteinase K in TEX buffer for 10 min at 
room temperature. Afterwards the samples were washed three times for 5 min 
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in PBS. In order to block unspecific background, sections were incubated 
either in PBS with 10% (v/v) normal goat serum (NGS), 0.3% (v/v) Triton X-
100 and Avidin or in PBS supplemented with 1% (w/v) bovine serum albumin 
(BSA), 10% NGS, 0.2% (v/v) cold fish skin gelatine, 0.3% (v/v) Triton X-100 
and Avidin for 1 h at room temperature. Primary antibodies were diluted in 
PBS with 0.2% (v/v) cold fish skin gelatine and Biotin and incubated on the 
sections overnight at 4°C. Samples were washed three times for 5 min in PBS 
with 0.5% (v/v) Tween-20. Thereafter secondary antibodies were incubated 
on the slides for 1 h at room temperature diluted in PBS with 10% (v/v) NGS 
or 1% (w/v) BSA, 10% (v/v) NGS, 0.2% (v/v) cold fish skin gelatine and 0.3% 
(v/v) Triton X-100. After washing three times for 5 min with PBS, 0.5% (v/v) 
Tween-20 an Avidin-Biotin-HRP complex (ABC Kit) was applied to the slides 
for 30 min at room temperature. After washing in PBS, 0.5% Tween-20 the 
staining was developed by exposing the sections to DAB chromogen. 
Formation of precipitate was followed under the microscope and when a 
sufficient signal intensity was reached, the reaction was stopped by washing 
the slides in PBS. To ensure equal staining conditions incubation times with 
DAB were equal for all corresponding samples. Nuclei were counterstained 
with Hematoxylin for 1 min and subsequently dehydrated in descending 
concentrations of ethanol, cleared in xylol and mounted in Entellan. 
 
 
 
Table 1: Primary antibodies and conditions for immunohistochemistry 
Antigen Company Clone Host Dilution 
B220 homemade RA3 6B2 rat 1:1000 
cleaved caspase-3 Cell signalling 9661 rabbit 1:1000 
CD3 Abcam ab5690 rabbit 1:200 
CD45 BD Bioscience 30-F11 rat 1:500 
F4/80 homemade BM8 rat 1:200 
Gr1 BD Pharmingen 1A8 rat 1:500 
Ki67 DAKO TEC-3 rat 1:1000 
Lysozyme DAKO EC 3.2.1.17 rabbit 1:2000 
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Table 2: Secondary antibodies and conditions for immunohistochemistry 
Antigen Company Clone Host Dilution 
biotinylated rat IgG DAKO E0468 rabbit 1:1000 
Biotinylated rabbit IgG Perkin Elmer NEF813 goat 1:1000 
 
 
2.2.3 Biochemical analysis 
 
2.2.3.1 Isolation of intestinal epithelial cells (IECs) 
In order to isolate IECs mice were euthanized, the colon and the small 
intestine were removed and transferred into ice-cold PBS as described above 
(see section 2.2.1.6). The isolation procedure for IECs was described 
previously in (Ukena et al., 2007). Briefly, colon and small intestine were 
opened longitudinally and luminal content was removed by washing in cold 
PBS. Intestinal tissue was incubated in a 50 ml Falcon tube with 10 mM DTT 
in PBS for 10 min at 37°C and 180 rpm to remove mucus and debris. After 
washing in PBS, the colon/small intestines were transferred into new Falcon 
tubes and incubated in 1x HANK’s salt solution (HBSS) supplemented for 15 
min at 37°C and 180 rpm. To efficiently detach IECs and crypts from the 
underlying tissue, the tubes were vortexed at full speed for 1 min. Afterwards 
the remaining colon/ small intestines was removed with a forceps and IECs 
were harvested by centrifugation for 10 min at 1200 rpm. The supernatant 
was removed, the pellets were resuspended in 1-3 ml PBS and transferred 
into Eppendorf tubes. IECs were centrifuged for 1 min at 13000 rpm, the 
supernatant was discarded and isolated IECs were frozen in liquid nitrogen or 
directly processed for extraction of proteins or RNA.  
 
2.2.3.2 Preparation of protein extracts 
For total protein extraction from colonic or small intestinal IECs, cells were 
lysed for 30 min on ice in high salt RIPA buffer supplemented with protease- 
and phosphatase inhibitors. During incubation on ice cells were inverted 
repetitively. Afterwards protein samples were centrifuged for 20 min at 13000 
rpm and 4°C to pellet cell debris. The supernatant was collected and protein 
concentration was determined.  
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2.2.3.3 Preparation of cytoplasmic and nuclear protein extracts 
To prepare cytoplasmic and nuclear protein fractions, pelleted IECs were 
resuspended in an appropriate amount of hypotonic buffer A and incubated on 
ice for 10 min. Afterwards NP-40 was added to a final concentration of 0.8% 
(v/v) and incubated for 5 min on ice to lyse the plasma membrane. The 
cytoplasmic protein fraction was separated from nuclei by centrifugation at 
13000 rpm for 1 min at 4°C. The supernatant containing cytoplasmic proteins 
was transferred into a new Eppendorf tube and frozen away. The pellet 
containing nuclei was washed twice in buffer A without NP-40 to remove 
remaining cytoplasmic extracts and detergent. In order to lyse the nuclei, the 
pellet was resuspended in an appropriate volume of buffer C and incubated 
on ice for 30 min. Afterwards, samples were centrifuged for 10 min at 13000 
rpm at 4°C and the supernatant with nuclear proteins was collected into a new 
tube and frozen away. The protein concentration of cytoplasmic and nuclear 
fractions was determined. 
 
2.2.3.4 Western Blot analysis 
Protein extracts were boiled for 10 min in 1x Laemmli buffer to denature 
proteins and reduce disulfide bonds. Proteins were separated according to 
size on 10% SDS-polyacrylamid gels (SDS-PAGE). Electrophoresis was 
performed under denaturing conditions in Tris-Gylcine electrophoresis buffer. 
After sufficient separation was achieved, proteins were transferred to PVDF 
membranes by semidry or wet transfer. PVDF membranes were activated by 
incubation in 100% (v/v) methanol for 5 min and subsequently placed in 
transfer buffer. Two Whatman papers (3 mm) were soaked in transfer buffer 
and SDS gels were equilibrated in transfer buffer for 5 to 15 min. The 
following bottom to top assembly was used for both semidry and wet transfer: 
A sheet of Whatman paper was covered by the SDS gel, followed by the 
PVDF membrane and another piece of Whatman paper on the top. For 
efficient semidry transfer of proteins to the PVDF membrane 1 mA current 
was applied per cm2 membrane for 2 h. Wet transfer was performed with 120 
mA current per membrane for 2 h or with 30 mA current per membrane for 
overnight transfer.  After protein transfer the membranes were washed in PBS 
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for 5 min on a shaker. Equal loading, efficiency and quality of protein transfer 
were checked by Ponceau S staining. In order to de-stain membranes, they 
were washed in PBS with 0.5% (v/v) Tween-20 until Ponceau S staining 
disappeared. To reduce unspecific binding of antibodies, membranes were 
incubated with PBS supplemented with 5% (w/v) non-fat dry milk, 0.5% (v/v) 
Tween-20 for 1 h under agitation. Primary antibodies were diluted in PBS with 
5% (w/v) BSA, 0.1% (v/v) Tween-20, 0.001% NaN3 and incubated on the 
membrane overnight at 4°C under constant agitation. Membranes were 
washed three times for 5 min in PBS with 0.1% (v/v) Tween-20 and incubated 
with HRP-conjugated secondary antibody diluted in PBS with 5% (w/v) non-fat 
dry milk and 0.1% (v/v) Tween-20 for 1 h at room temperature under agitation. 
Afterwards membranes were washed three times for 5 min in PBS with 0.1% 
(w/v) Tween-20. Protein bands were visualized using commercial ECL, ECL 
Pico or ECL Femto with varying exposure times to chemiluminescent films 
depending on the individual band intensities. Exposed films were developed 
and fixed in AGFA developer solution and AGFA fixation solution respectively.  
MATERIAL and METHODS 
 47 
Table 3: Primary antibodies used for WB analysis 
Antigen Company Clone Host Dilution 
β-Actin Santa Cruz I19 goat 1:5000 
cFLIP Alexis ADI-AAP-440-E rabbit 1:1000 
cIAP1 Enzo ALX-803-335-C100 rat 1:1000 
Cre     
c-Rel Santa Cruz sc-71 rabbit 1:1000 
HDAC1 HDAC1 sc-7872 rabbit 1:1000 
p50/p105 NCI BRB NR1157 rabbit 1:20000 
p65 Santa Cruz sc-372 rabbit 1:1000 
p100/52 NCI BRB NR1495 rabbit 1:20000 
RelB Cell Signaling 4922 rabbit 1:1000 
RIPK1 BD Bioscience 610459 mouse 1:1000 
RIPK3 Enzo ADI-905-242-100 rabbit 1:1000 
TRAF2 Santa Cruz sc-876 rabbit 1:1000 
α-Tubulin Sigma B-5-1-2 mouse monoclonal 1:5000 
 
 
Table 4: Secondary antibodies used for WB analysis 
Antigen Company Clone Host Dilution 
Rabbit IgG-HRP GE Healthcare NA934V goat 
1:5000/ 
1:10000 
Mouse IgG-
HRP 
GE 
Healthcare NA9310V sheep 
1:5000/ 
1:10000 
Goat IgG HRP Jackson Lab 705-035-003 donkey 1:5000 
Rat IgG-HRP Jackson Lab 112-035-003 goat 1:5000 
 
2.2.4 Molecular Biology 
 
2.2.4.1 Preparation of genomic DNA 
Tail biopsies were digested in 200 µl tail lysis buffer supplemented with 10 
mg/ml Proteinase K for a least 2 h at 56°C. For precipitation of DNA 200 µl 
isopropanol were added and the tube was inverted several times. The tube 
was centrifuged for 2 min at 13000 rpm, the supernatant discarded and 200 µl 
70% (v/v) ethanol were added to wash the DNA. The sample was centrifuged 
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again for 2 min at 13000 rpm, the supernatant discarded and the pellet air-
dried for 20 min. Finally, the DNA pellet was resuspended in 200 µl Tris-EDTA 
buffer and used for genotyping PCRs.  
 
2.2.4.2 Genotyping PCRs 
Genotyping was performed by using 2 µl genomic tail DNA for Polymerase-
chain-reaction (PCR) based genotyping per reaction. For one reaction 2 µl 
genomic tail DNA were mixed with 12.5 µl ready-to-use Mastermix (VWR), 2 
µl of 3 µM primer mix and 10.5 µl H2O. Annealing and elongation 
temperatures depend on the primer sets used for individual PCRs (see Table 
5 and Table 6). 10 µl of the PCR reaction products were separated on 2% 
(w/v) agarose gels.  
 
Table 5: Primer-sequences for genotyping PCRs and PCR-amplified fragment sizes.  
WT: wildtype; Tg: transgene; FL: floxed; KO: knock-out; DEL: deleted 
Typing for Primer sequence (5’ 3’) Band size 
villin Cre 
ACA GGC ACT AAG GGA GCC AAT G 
WT: 900 bp 
Tg: 350 bp 
AT TGCA GGT CAG AAA GAG GTC ACA G 
GTT CTT GCG AAC CTC ATC ACT C 
villin CreERT2 
CAA GCC TGG CTC GAC GGC C 
Tg: 300 bp 
CGC GAA CAT CTT CAG GTT CT 
Ripk1 floxed 
CAT GGC TGC AAA CAC CTA AAC WT: 320 bp 
FL: 380 bp GTT ACA ACA TGC AAA TCA AC 
Ripk1 deleted 
GAGGAAGACATCACTGAAGA 
KO: 230 bp 
CAGAGGGCTGGATCTGGTGG 
Myd88 
GAG CAG GCT GAG TGC AAA CTT GGT CTG WT: 1000 bp 
KO: 1000 bp 
(2 PCRs) 
AGC CTC TAC ACC CTT CTC TTC TCC ACA 
ATC GCC TTC TAT CGC CTT CTT GAC GAG 
Tnfr1 
AGA AAT GTC CCA GGT GGA GAT CTC 
WT: 120 bp 
KO: 300 bp 
GGC TGC AGT CCA CGC ACT GG 
ATT CGC CAA TGA CAA GAC GCT GG 
Fadd 
TCA CCG TTG CTC TTT GTC TAC WT: 208 bp 
FL: 280 bp 
DEL: 331 bp 
GTA ATC TCT GTA GGG AGC CCT 
CTA GCG CAT AGG ATG ATC AGA 
Ripk3 
CGC TTT AGA AGC CTT CAG GTT GAC 
WT: 320 bp 
KO: 485 bp 
GCC TGC CCA TCA GCA ACT C 
CCA GAG GCC ACT TGT GTA GCG 
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Table 6: PCR programes for genotyping PCRs 
Typing for 
PCR program 
Cycles 
Temperature Time 
villin Cre 
94°C 3 min  
94°C 
1min 35 67°C 
72°C 
72°C 5 min  
 
Ripk1 floxed 
94°C 2 min  
94°C 30 sec 
35 60°C 30 sec 
72°C 30 sec 
72°C 5 min  
 
Ripk1 deleted 
94°C 2 min  
94°C 30 sec 
35 60°C 30 sec 
72°C 30 sec 
72°C 5 min  
 
Myd88 
94°C 3 min  
94°C 30 sec 
35 67°C 1 min 
72°C 1 min 
72°C 5 min  
 
Tnfr1 
94°C 2 min  
94°C 1 min 
30 61°C 30 sec 
72°C 30 sec 
72°C 2 min  
 
Fadd 
94°C 3 min  
94°C 30 sec 
34 55°C 30 sec 
72°C 30 sec 
72°C 3 min  
 
MATERIAL and METHODS 
 50 
Table 6 continued 
Ripk3 
94°C 4 min  
94°C 1 min 
30 60°C 30 sec 
72°C 1 min 
72°C 10 min    
2.2.4.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed to separate PCR-amplified DNA 
fragments according to size. 2% (w/v) agarose was dissolved by boiling in 1x 
TAE buffer and 0.5 mg/ml Ethidiumbromide were added. Gels were run in 1x 
TAE buffer for 20 to 40 min at 120 to 140 mV.  
 
2.2.4.4 RNA extraction 
For RNA extraction from whole colon/small intestinal tissue or IECs, samples 
were homogenized in 1 ml Trizol reagent (Invitrogen) and incubated for 20 
min at room temperature for complete cell lysis. Samples were centrifuged for 
10 min at 13000 rpm to pellet cell debris. The supernatant was transferred 
into a new tube and incubated for 5 min at room temperature. To extract 
nucleic acids 200 µl chloroform per 1 ml Trizol were added and samples were 
mixed vigorously for 15 sec followed by 5 min incubation at room temperature. 
The samples were centrifuged for 15 min at 13000 rpm to separate aqueous 
and organic phase. Afterwards the upper aqueous phase was transferred into 
a new tube containing an equal volume of 70% (v/v) ethanol and mixed 
gently. The samples were loaded on Quiagen RNeasy columns. For binding 
of nucleic acids to the filter of the column, the columns were centrifuged for 1 
min at 9000 rpm. For washing 500 µl washing buffer (provided by 
manufacturer) was added and the column was subsequently centrifuged at 
9000 rpm for 30 sec. In order to digest genomic DNA RNase-free DNase 
diluted in RDD buffer (provided by manufacturer) was added to the column 
and incubated for 30 min at room temperature. Afterwards the column was 
washed twice as described and RNA was eluted in nuclease free H2O by 
centrifugation for 2 min at 13000 rpm. To check for possible genomic DNA 
contamination, equal volumes of RNA were subjected to β-Actin PCR (see 
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section 2.2.4.3). Finally, the concentration and purity of extracted RNA were 
assessed by photometric analysis using NanoDrop. 
 
2.2.4.5 cDNA synthesis 
In order to synthesize cDNA, the Superscript III kit (Invitrogen) was used 
according to manufacturer’s instructions. For 10 µl final reaction volume, 1 µg 
RNA was mixed with 1 µl of 50 ng/µL random hexamer primers and 1 µl of 10 
mM dNTPs. The reaction mixture was first incubated at 65°C for 5 min to 
allow primers to anneal to mRNA and subsequently cooled on ice for a few 
minutes. Meanwhile, 10 µl cDNA reaction mix containing 2 µl 10x RT-reaction 
buffer, 4 µl 25 mM MgCl2, 2 µl 0.1 M DTT, 1µl RNase OUT (40 U/µl) and 1 µl 
of SuperScript III polymerase (200 U/µL) were prepared and added to the 
samples. Reverse transcription was performed in a PCR cycler using the 
following program: 10 min at 25°C, 50 min at 50°C for cDNA synthesis and 5 
min at 85°C heat-inactivation. To digest the RNA 1 µl RNaseH was added to 
the reaction and the samples were incubated for 20 min at 37°C. The cDNA 
reaction mix was diluted 10-fold in nuclease-free water and 1 µl of cDNA was 
used for an actin-PCR to check successful cDNA synthesis.  
 
2.2.4.6 Quantitative real time PCR 
Gene expression was quantified by performing probe-based Taqman 
quantitative real time PCR (qRT-PCR). All samples were run in two technical 
replciates. qRT-PCR was performed in a final volume of 10 µl, consisting of 2 
µl cDNA, 5 µl Mastermix (Applied Biosystems), 0.5 µl primer-probe mix 
(Applied Biosystems) and 2.5 µl nuclease-free water. All reactions were 
carried out in 384-well plates. The following PCR program was performed: 10 
min at 95°C for the activation of the polymerase, followed by 40 amplification 
cycles each with 10 sec at 95°C and 1 min at 60°C each.  
The comparative ΔΔCT or ΔCT was used to determine RNA expression levels 
of the genes of interest. For the ΔΔCT method, the CT value of the 
endogenouse reference gene (TATA box binding protein) was substracted 
from the CT values of the target gene to obtain the ΔCT value for each 
duplicate. Relative quantification was performed by calculation of the ΔΔCT 
value.  
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Table 7: Taqman probes used for qRT-PCR 
Gene Taqman probe 
Ccl2 Mm00441242_m1 
Ccl5 Mm01302428_m1  
Cxcl1 Mm00433859_m1 
Il-1b Mm00434228_m1  
Il-12a, p35 Mm00434165_m1  
Tnf Mm00443258_m1  
Tbp Mm00446973_m1  
 
 
2.2.5 Cell culture 
 
2.2.5.1 Isolation and culture of small intestinal organoids 
Small intestinal crypts were isolated and grown to organoids as previously 
described (T. Sato et al., 2009). Mice were sacrificed and the small intestine 
isolated as described in sections 2.2.1.5 and 2.2.1.6 respectively. To remove 
luminal content the small intestine was cut open longitudinally and was 
washed in PBS. The intestine was placed on a petri dish and cut opened up 
with tweezers making sure the mucosal side was facing upwards. A smoothed 
coverslip was used to carefully scrape off the villi. After a short washing in 
PBS the intestine was chopped into 2 to 4 mm pieces and transferred into a 
50 ml Falcon tube. To wash the intestinal tissue 10 ml PBS were added, 
pieces were pipetted up and down, were allowed to settle down and the 
supernatant aspirated. Washing was repeated 15 to 20 times until the 
supernatant was clear. Afterwards the pieces of intestine were incbuated in 
PBS containing 2 mM EDTA for 30 min at 4°C under agitation to release the 
crypts from the underlying tissue. Intestinal fragments were allowed to settle 
and the supernatant was aspirated. To isolate and collect intestinal crypts, 10 
ml PBS supplemented with 10 (w/v) FCS were added to the intestinal tissue 
and mixed vigorously. The supernatant was aspirated and passed through a 
70 µM cell strainer. The flow through containing small intestinal crypts was 
collected and this procedure was repeated three more times. Crypt fractions 3 
and 4 were centrifuged for 5 min at 800 rpm. The supernatant was removed, 
the pellets were resuspended in 5 ml CM-GF and centrifuged for 5 min at 600 
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rpm to remove single cells. The culture of the isolated crypt fractions was 
performed in a lamin-rich Matrigel, shown to support small intestinal growth. 
An adequate amount of crypts was resuspended in 200 µl matrigel and 50 µl 
matrigel drops with crypts were seeded out per well in a 24-well plate. 
Matrigel was allowed to polymerize for 10 min at 37°C and 500 µl CM+GF 
with 5 µl ENR were added to the crypts. In order to prevent anoikis, 1 µl of 10 
mM ROCK inhibitor (Y27632) (Sigma) was added to the crypt culture for the 
first 3 days.  
For the passage of crypt cultures the matrigel was gently detached from the 
the well with a 1000 µl pipet tip and transferred into a 15 ml Falcon tube. IN 
order to mechanically rupture the crypts, the medium containing the crypts 
and the matrigel was passed through a 23 gauche syringe several times. The 
crypt fragments were centrifuged for 5 min at 600 rpm at 4°C, the supernatant 
was aspirated and crypts were resuspended in an appropriate volume of 
matrigel. For culturing in 24-well plates, 50 µl matrigel was seeded per well, 
20 µl matrigel were used per well in a 48-well plate and 10 µl matrigel per well 
for culturing organoids in a 96-well plate. After incubation for a few minutes at 
37°C, 500 µl, 200 µl or 100 µl CM+GF supplemented with 1 µl ENR per 100 µl 
medium was added to the corresponding wells.  
 
2.2.5.2 Tamoxifen-induced deletion of RIPK1 in organoid cultures 
For tamoxifen-induced in vitro deletion of RIPK1 in crypt cultures organoids 
from VillinCreERT2/Ripk1fl/fl mice were isolated as described in 2.2.5.1. 
Organoids were maintained in culture for at least 4 passages before the 
deletion of RIPK1 was induced. The cultures were seeded and grown in 
DMEM/F12 without phenol red for 24 to 36 h. In order to delete RIPK1, 100 
nM 4-hydroxytamoxifen (4-OHT) dissolved in ethanol or for mock treatment, 
an equal amount of ethanol was added to the culture medium. After 20 to 24 h 
the 4-OHT containing medium was replaced by fresh culture medium and 
organoids were kept in culture for further analysis as indicated.  
 
2.2.5.3 Assessment of cell death in organoids 
In order to quantify cell death in organoids by propidium iodide (PI) uptake, 
organoids were cultured and RIPK1 was deleted by addition of 4-OHT as 
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described above (2.2.5.1 and 2.2.5.2). To harvest the crypts for analysis, the 
medium was removed from the wells and 300 µl TrypLE™ solution (Life 
Technologies) per well were added. Organoids were carefully detached with a 
1000 µl pipet tip and transferred into an Eppendorf tube. For mechanic break 
up, the organoids were passed 2 times through a syringe with a 23 G injection 
needle and incubated for 5 min at 37 °C. 800 µl PBS with 2% FCS were 
added to the culturesto stop further digestion and the samples were 
centrifuged for 5 min at 500 rpm. Subsequently, organoids were resuspended 
in 200 µl PBS supplemented with 2% FCS and propidium iodide was added to 
a final concentration of 1 µg/ml immediately before FACS analysis. Cell death 
was determined by quantification of PI-positive cells as aquired with a 
FACSCalibur FACS analyser.  
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3. Results 
3.1 RIPK1 deficiency in IECs induces intestinal pathology 
and epithelial cell death 
3.1.1 Generation of mice with intestinal epithelial specific RIPK1 
deficiency 
To investigate the role of RIPK1 in the murine intestinal epithelium, mice 
lacking RIPK1 specifically in the cells of the intestinal epithelium were 
generated. Therefore Ripk1fl/fl mice (Dannappel et al., 2014) were crossed to 
mice that express Cre recombinase under control of the intestinal epithelial 
cell (IEC) specific villin promoter (el Marjou et al., 2004). In these mice, the 
third exon of the Ripk1 alleles is excised by Cre recombinase only in IECs. 
The resulting mice (from here on called ‘RIPK1IEC-KO mice’) are deficient for 
RIPK1 specifically in IECs. 
Successful deletion of RIPK1 in colonic and small intestinal IECs was 
confirmed by Western Blot (Figure 4).  
 
 
Figure 4. Conditional deletion of RIPK1 in IECs. 
Whole cell protein extracts from primary (a) small intestinal and (b) colonic IECs from 
Ripk1fl/fl mice (FL/FL) and RIPK1IEC-KO mice (IEC-KO) were analysed by immunoblot 
with the indicated antibodies.  
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3.1.2 Increased IEC apoptosis and mild inflammation in the ileum 
of RIPK1IEC-KO mice  
RIPK1IEC-KO mice were born at expected Mendelian ratios (Figure 5a), 
however grew slower and had significantly reduced body weight at 3 weeks of 
age compared to their Ripk1fl/fl littermates (Figure 5b). These mice showed 
signs of cachexia, which became apparent at 2 weeks of age (data not 
shown). All RIPK1IEC-KO mice died prematurely before reaching an age of 28 
days (Figure 5c), showing that RIPK1IEC-KO mice develop a severe 
spontaneous phenotype and that intestinal RIPK1 has an important role in 
maintaining intestinal homeostasis.  
 
Figure 5. RIPK1IEC-KO mice develop spontaneous phenotype resulting in 
premature death. 
(a) Table showing expected and observed absolute number and possibilities of 
offspring with the indicated genotype resulting from breeding villin Cre tg/wt; Ripk1wt/fl 
mice with villinCre wt/wt; Ripk1fl/fl mice. (b) Body weight of Ripk1fl/fl (FL/FL) and 
RIPK1IEC-KO mice (IEC-KO) mice at 3 weeks of age. (c) Kaplan-Meier survival curve 
for Ripk1fl/fl and RIPK1IEC-KO mice. *P≤0.05, **P≤0.01, ***P≤0.005  
 
Histological analysis of Hematoxylin and Eosin (H&E) stained ileal sections 
from 3 week-old RIPK1IEC-KO mice revealed an almost complete loss of villus 
structures throughout the ileum (Figure 6 red line). Numerous cells with 
morphological features of dying cells such as fragmented nucleus were 
identified in the lumen of the crypts and within the epithelium, indicating that 
Ripk1-/- IECs undergo cell death (Figure 6 black arrows). Crypts were 
a 
b c 
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elongated compared to Ripk1fl/fl mice suggesting hyperproliferation in 
intestines of RIPK1IEC-KO mice (Figure 6 black line). Staining against Ki67, a 
marker for proliferative cells, confirmed increased numbers of proliferating 
IECs in RIPK1IEC-KO mice and expansion of the transient amplifying (TA) cell 
compartment (Figure 7). PAS staining against glycosylated mucus-proteins 
secreted by goblet cells and staining against alkaline phosphatase (AP) 
expressed by mature enterocytes on small intestinal sections of RIPK1IEC-KO 
mice showed reduced numbers of goblet cells and mature enterocytes 
respectively (Figure 7). In addition, lysozyme staining revealed reduced 
numbers of Paneth cells in RIPK1IEC-KO mice compared to Ripk1fl/fl mice 
(Figure 7).  
 
Figure 6. Intestinal pathology and IEC death in RIPK1IEC-KO mice.  
Representative images of haematoxylin and eosin stained ileal sections from 3-week 
old Ripk1fl/fl mice and RIPK1IEC-KO mice. Red line depicts villus length. Black line 
represents crypt length. Black arrows indicate dead epithelial cells. Scale bars: 100 
µm. 
 
As described above, ileal H&E sections of 3-week old RIPK1IEC-KO mice 
showed increased incidence of dying intestinal epithelial cells. In order to 
determine the type of epithelial death, IHC against cleaved caspase-3 (CC3)  
was done. 
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Figure 7. Hyperproliferation and reduced numbers of differentiated epithelial 
cells in RIPK1IEC-KO mice. 
Representative images of small intestinal swiss rolls from 3-week old Ripk1fl/fl and 
RIPK1IEC-KO mice stained for alkaline phosphatase (AP), Periodic acid-Schiff (PAS), 
immunostained for Ki67 and lysozyme and counterstaind with haematoxylin. Scale 
bars: 100 µm.  
 
As shown in Figure 8, RIPK1IEC-KO mice showed high numbers of dying 
epithelial cells that were positive for cleaved caspase-3, indicating that RIPK1 
deficiency sensitized IECs to apoptosis. Apoptosis of Ripk1-/- IECs occurred 
mainly in the crypts and the TA cell compartment of the intestinal epithelium, 
indicating that primarily undifferentiated progenitor cells underwent apoptosis. 
Quantification of cell death revealed that 50% of all crypts in the ileum of 
RIPK1IEC-KO mice harboured apoptotic IECs (Figure 8). In average, every crypt 
in RIPK1IEC-KO harbored two apoptotic cells, emphasizing the massive extent 
of cell death observed in this phenotype (Figure 8). Taken together, these 
results show that RIPK1IEC-KO mice develop a severe spontaneous phenotype 
characterised by extensive apoptosis of IECs, villus atrophy, reduced 
numbers of differentiated cells, epithelial hyperproliferation and premature 
lethality.  
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Figure 8 Increased numbers of apoptotic IECs in RIPK1IEC-KO mice.  
(a) Immunohistochemical staining for CC3 and haematoxylin counterstaining of small 
intestinal sections from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice. Scale bars: 100 
µm. (b) Quantification of crypts containing CC3-positive cells and the number of 
CC3-positive cells per crypt in the ileum of 3-week old Ripk1fl/fl and RIPK1IEC-KO mice. 
*P≤0.05, **P≤0.01, ***P≤0.005 
 
To check if increased epithelial death triggers an inflammatory response, 
quantitative real time PCR (qRT-PCR) was employed to monitor expression 
levels of inflammatory cytokines and chemokines in whole small intestinal 
tissue isolated from RIPK1IEC-KO mice and their Ripk1fl/fl littermates. 
Messenger RNA (mRNA) levels of Tnf, an important pro inflammatory 
cytokine, and Cxcl1, a chemoattractant for neutrophils were statistically 
significantly increased in RIPK1IEC-KO compared to their floxed littermates 
(Figure 9). Other cytokines, Il1b and Il12a, showed no difference in 
expression levels between RIPK1IEC-KO mice and Ripk1fl/fl mice. Furthermore, 
expression of chemokines Ccl2 and Ccl5 was not different between RIPK1IEC-
KO and Ripk1fl/fl mice (Figure 9). To further elucidate the immune response in 
the intestines of 3-week old RIPK1IEC-KO mice, immunostainings allowing 
identification of different immune cell lineages were performed on tissue 
sections. Furthermore, immune cells were isolated from the small intestinal 
lamina propria, immunostained for different immune cell lineages and 
subsequently analysed with FACS. Immunostaining for CD45+ cells, a marker 
for immune cells with hematopoietic origin, revealed that the overall number of 
immune cells is slightly increased in RIPK1IEC-KO mice (Figure 10). 
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Figure 9 Elevated expression of Tnf and Cxcl1 in intestines of 3-week old 
RIPK1IEC-KO mice.  
qRT-PCR analysis of inflammatory cytokine and chemokine mRNA expression levels 
in whole small intestinal tissue from 3-week old Ripkfl/fl and RIPK1IEC-KO mice.  
n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
 
In more detail, a few Gr1 positive granulocytes scattered throughout the 
lamina propria of RIPK1IEC-KO mice were detected, and the number of F4/80 
positive macrophages did not differ between RIPK1IEC-KO and control mice 
(Figure 10). IHC for cells of the adaptive immune response revealed no 
visually detectable changes in B220 positive B-cell and CD3 positive T-cell 
numbers in RIPK1IEC-KO mice and compared to their floxed littermates (Figure 
10). FACS analysis of immune cells isolated from the lamina propria allowed a 
more quantitative comparison of immune cell numbers in RIPK1IEC-KO and 
Ripk1fl/fl mice. The total number of CD45+ leucocytes was slightly increased in 
RIPK1IEC-KO mice compared to Ripk1fl/fl mice, although this change was not 
statistically significant (Figure 10). Analysis of the composition of the CD45+ 
leucocyte population revealed significantly increased numbers of Gr1+ 
granulocytes in the small intestine of RIPK1IEC-KO mice compared to control 
mice (Figure 10). The numbers of CD11bhi F4/80+ Ly6G- macrophages and 
CD3+ T-cells did not differ between RIPK1IEC-KO and Ripk1fl/fl mice (Figure 10). 
Finally, the total numbers of B220 positive B-cells were significantly reduced 
in RIPK1IEC-KO mice compared to littermate controls. Taken together, these 
results show that ablation of RIPK1 in the small intestine causes a severe 
spontaneous phenotype, characterized by extensive intestinal epithelial cell 
apoptosis, hyperproliferation and a mild inflammatory response.  
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Figure 10 Slightly increased leucocyte numbers in the mucosa of 3-week old 
RIPK1IEC-KO mice. 
(a) Ileal swiss rolls from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice were 
immunostained for CD45, Gr1, F4/80, CD3, B220 and counterstained with 
haematoxylin. Scale bars: 100 µm (b) Lamina propria immune cells were isolated 
from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice, immunostained for CD45 and 
analysed by FACS. (c) Lamina propria immune cells were isolated from 3-week old 
Ripk1fl/fl and RIPK1IEC-KO mice, immunostained for CD11b Ly6G (neutrophils), CD11b 
F4/80 Ly6G (macrophages), CD3 (T-cells) and B220 (B-cells) and analysed by flow 
cytometry. Isolation and immunostaining of lamina propria immune cells in (b) and (c) 
was done by Dr. Christina Eftchi. n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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3.1.3 Increased IEC apoptosis and mild inflammation in the colon 
of RIPK1IEC-KO mice 
To investigate the colon pathology of RIPK1IEC-KO mice, H&E sections of 
colons from 3-week-old RIPK1IEC-KO mice were examined. In the proximal 
colon, RIPK1IEC-KO mice showed increased cellularity in the lamina propria, 
elongated crypts and high numbers of cells with morphological features of 
dying cells within the epithelium and the lumen of the crypts (Figure 11). 
 
Figure 11 Intestinal pathology and IEC apoptosis in the colon of RIPK1IEC-KO 
mice.  
(a) Histological analysis of colonic swiss rolls from 3-week old RIPK1IEC-KO mice 
stained with H&E or immunostained for CC3. Scale bars: 100 µm. (b) Quantification 
of CC3-staining for the distal and proximal colon of 3-week old Ripk1fl/fl and RIPK1IEC-
KO mice. n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
 
IHC against CC3 indicated that death of IECs was apoptototic (Figure 11). 
Extensive IEC apoptosis was affecting 50% of the crypts in the proximal colon 
with each crypt harbouring one apoptotic epithelial cell in average (Figure 11). 
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Ki-67 staining revealed increased numbers of proliferating cells, suggesting a 
hyperproliferating epithelium in the proximal colon. RIPK1IEC-KO mice had 
reduced numbers of goblet cells and mature enterocytes compared to control 
mice as shown by staining for PAS and AP respectively (Figure 12).  
In the distal colon the phenotype was less severe compared to the proximal 
colon. Crypts were only slightly elongated compared to Ripk1fl/fl mice and few 
scattered dying IECs were detected within the epithelium and (Figure 11). 
Staining against CC3 showed that these cells died by apoptosis, although the 
extent of cell death was less pronounced compared to the proximal colon and 
the ileum (Figure 11). As already indicated by H&E sections, Ki-67 staining 
confirmed that the number of proliferating cells was only slightly increased in 
RIPK1IEC-KO mice compared to Ripk1fl/fl mice (Figure 12). Similar to the ileum 
and the proximal colon, goblet cell numbers were reduced in the distal colon 
of RIPK1IEC-KO mice compared to their floxed littermates (Figure 12).  
 
Figure 12 Hyperproliferation and reduced numbers of differentiated epithelial 
cells in the colon of RIPK1IEC-KO mice.  
Representative images of colon swiss rolls from 3-week old RIPK1IEC-KO mice stained 
stained for AP, PAS, immunostained for Ki67 and counterstained with haematoxylin. 
Scale bars: 100 µm.      
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To assess whether RIPK1IEC-KO mice suffered from colitis, qRT-PCR was 
performed using whole colon tissue isolated from 3-week old RIPK1IEC-KO and 
control mice. Messenger RNA levels for Tnf, Ccl5, Cxcl1 and Il1b were 
significantly increased in RIPK1IEC-KO mice compared to Ripk1fl/fl mice (Figure 
13). Expression levels of cytokine Il12a and chemokine Ccl2 did not differ 
between 3-week old RIPK1IEC-KO and Ripk1fl/fl mice (Figure 13).  
Figure 13 Differential expression of inflammatory cytokines and chemokines in 
the colon of 3-week old RIPK1IEC-KO mice.  
qRT-PCR analysis of inflammatory cytokine and chemokine expression levels in 
whole colonic tissue from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice.  
n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
 
 
In order to assess the composition of immune cells in the colon of RIPK1IEC-KO 
mice, IHC against the different immune cell lineages was performed. Staining 
against CD45 showed that the overall number of immune cells was increased 
in the proximal but not in the distal colon (Figure 14). Gr1 positive 
granulocytes were only rarely detected in the lamina propria of RIPK1IEC-KO 
mice (Figure 14). IHC indicated that the number of B220 positive B-cells did 
not differ between RIPK1IEC-KO and Ripk1fl/fl mice, however an increase in CD3 
positive T-cells was detected in the proximal colon, but not the distal colon of 
RIPK1IEC-KO mice when compared to control mice (Figure 14). For a direct 
quantitative comparison of leucocyte numbers, immune cells of the lamina 
propria were isolated from 3-week old RIPK1IEC-KO mice and their Ripk1fl/fl 
littermates, immunostained and subsequently analysed with FACS. The total 
number of CD45+ leucocytes in the lamina propria was significantly increased 
in RIPK1IEC-KO mice compared to control mice (Figure 14). This increase was 
mainly due to significantly increased numbers of CD11bhi Ly6Ghi neutrophils 
and CD3+ T-cells in RIPK1IEC-KO mice. No differences in the numbers of 
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CD11bhi F4/80+ Ly6G- macrophages and B220+ B-cells were detected 
between RIPK1IEC-KO mice and Ripk1fl/fl mice (Figure 14). Taken together, 
these data show that RIPK1IEC-KO mice develop a severe spontaneous 
phenotype in the proximal colon associated with extensive IEC apoptosis, 
hyperproliferation and mild inflammation characterized by moderately 
increased mRNA levels of a number of cytokines and chemokines as well as 
mild leucocyte infiltrations. In contrast to this, a comparable mild phenotype 
was observed in the distal part of the colon.  
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Figure 14 Increased infiltration of immune cells in the mucosa of RIPK1IEC-KO 
mice.  
(a) Colon swiss rolls from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice were 
immunostained for CD45, Gr1, F4/80, CD3, B220 and counterstained with 
haematoxylin. Scale bars: 100 µm (b) Colonic lamina propria immune cells were 
isolated from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice, immunostained for CD45 
and analysed by FACS. (c) Colonic lamina propria immune cells were isolated from 
3-week old Ripk1fl/fl and RIPK1IEC-KO mice, immunostained for CD11b Ly6G 
(neutrophils), CD11b F4/80 Ly6G (macrophages), CD3 (T-cells) and B220 (B-cells) 
and analysed by flow cytometry. Isolation, immunostaining and FACS of lamina 
propria immune cells in (b) and (c) was done by Dr. Christina Eftychi. n.s. not 
significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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3.1.4 Progressive phenotype in RIPK1IEC-KO mice 
To investigate the development of the intestinal phenotype in RIPK1IEC-KO 
mice, newborn and 7-day old RIPK1IEC-KO mice were analysed. Newborn 
RIPK1IEC-KO mice were macroscopically indistinguishable from their floxed 
littermates and exhibited a largely normal histopathology (data not shown and 
Figure 15a). Few apoptotic epithelial cells were found in the small intestine 
and the colon of newborn RIPK1IEC-KO mice (Figure 15a). No difference in 
numbers of proliferating epithelial cells were detected, and numbers of CD45+ 
leucocytes did not differ between RIPK1IEC-KO and Ripk1fl/fl mice in both the 
ileum and colon (Figure 15a). qRT-PCR revealed that mRNA levels of the 
tested cytokines and chemokines, except for Ccl5, were not significantly up- 
or downregulated in RIPK1IEC-KO mice compared to control mice (Figure 15).  
Figure 15. No intestinal pathology in newborn RIPK1IEC-KO mice.  
(a) Respresentatitve images of intestinal sections from newborn Ripk1fl/fl and 
RIPK1IEC-KO mice stained with H&E or immunostained for CC3, Ki67 and CD45. Scale 
bars: 100 µm. (b,c) qRT-PCR analysis of ileal (b) and colonic (c) whole tissue for 
mRNA expression levels of cytokines and chemokines in RIPK1IEC-KO mice compared 
to Ripk1fl/fl mice. n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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At 7 days of age, H&E stained sections of RIPK1IEC-KO mice showed local loss 
of villus structures in the small intestine, elongated crypts and dying epithelial 
cells in both colon and small intestine (Figure 16a). IHC against CC3 revealed 
increased numbers of apoptotic cells in colon and small intestine of RIPK1IEC-
KO mice compared to floxed littermates (Figure 16a).  
Figure 16. Intestinal pathology in 1-week old RIPK1IEC-KO mice.  
(a) Representative images of intestinal sections from 1-week old Ripk1fl/fl and 
RIPK1IEC-KO mice stained with H&E or immunostained for CC3, Ki67 or CD45. Scale 
bars: 100 µm (b) Quantification of crypts containing CC3+ cells and the number of 
CC3+ cells per crypts in 1-week-old Ripk1fl/fl and RIPK1IEC-KO mice. (c, d) b,c) qRT-
PCR for mRNA expression levels of inflammatory cytokines and chemokines in ileal 
(b) and colonic (c) tissue from 1-week old Ripk1fl/fl and RIPK1IEC-KO mice. n.s. not 
significant. *P≤0.05, **P≤0.01, ***P≤0.005 
  
Tissue section stainings as well as quantification of cell death revealed an 
intermediate stage between the extent of apoptosis observed in RIPK1IEC-KO 
mice at 1 day and 3 weeks of age (Figure 16a, b). This indicates a 
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progressive exacerbation of the phenotype with age. Increased numbers of 
proliferating epithelial cells, a moderate increase in CD45+ leucocytes in the 
lamina propria accompanied by a moderate increase in Tnf and Il1b mRNA 
levels was observed in 1-week old RIPK1IEC-KO mice (Figure 16a, c, d). These 
results suggest that the phenotype caused by RIPK1 ablation develops 
progressively after birth and hyperproliferation as well as mild inflammation in 
the colon and the small intestine occur in response to IEC apoptosis.  
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3.1.5 Inducible postnatal deletion of RIPK1 leads to intestinal 
pathology and lethality 
To exclude potential developmental defects caused by IEC specific deletion of 
RIPK1 during embryogenesis, a tamoxifen-inducible mouse model was used 
(Marjou et al., 2004). In this transgenic mouse line, called villin-CreERT2, Cre 
recombinase is fused to a mutated ligand-binding domain of the human 
estrogen receptor and expressed under the control of the IEC specific villin 
promoter (el Marjou et al., 2004).  
Deletion of RIPK1 was achieved by three daily intraperitoneal (i.p.) injections 
of 1 mg tamoxifen and mice were sacrificed 24 h after the last tamoxifen 
injection (from here on referred to as ‘RIPK1tamIEC-KO’) (Figure 17a). Efficient 
deletion of RIPK1 upon tamoxifen injections was confirmed by Western Blot 
analysis (Figure 17b). Acute depletion of RIPK1 caused a severe 
spontaneous intestinal pathology accompanied by 20% body weight loss and 
death of RIPK1tamIEC-KO mice (Figure 17c, d). Histological analysis revealed 
that RIPK1tamIEC-KO mice but not tamoxifen treated Ripk1fl/fl littermates showed 
massive epithelial erosion, goblet cell loss and IEC apoptosis in the colon and 
the small intestine (Figure 18).  
Figure 17. Acute deletion of RIPK1 results in body weight loss and lethality. 
(a) Mice received three daily i.p. injections of 1 mg tamoxifen and were sacrificed 24h 
after the last injection. (b) Immunoblot analysis of small intestinal IEC protein extracts 
isolated from Ripk1fl/fl mice and RIPK1tamIEC-KO mice 24 h after the last tamoxifen 
injection. (c,d) Body weight (c) and Kaplan-Meier survival curve (d) of tamoxifen-
injected Ripk1fl/fl and RIPK1tamIEC-KO mice receiving normal drinking water or 
antibiotics. 0h marks the timepoint of the first tamoxifen injection. h, hours AB, 
antibiotics. n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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Figure 18. Epithelial erosion and IEC apoptosis upon acute deletion of RIPK1. 
Representative H&E stained or CC3 immunostained histological images from colonic 
and ileal swiss rolls of tamoxifen-treated Ripk1fl/fl and RIPK1tamIEC-KO mice receiving 
antibiotics (AB) or normal drinking water. Scale bars: 100 µm 
 
Importantly, vehicle treated RIPK1tamIEC-KO mice as well as tamoxifen injected 
villin-CreERT2 mice did not develop intestinal pathology and increased IEC 
apoptosis, indicating that IEC apoptosis was specifically induced after deletion 
of RIPK1 (Figure 19a-d). These results demonstrate an important epithelial 
cell-intrinsic role of RIPK1 in preventing IEC apoptosis and maintaining 
intestinal homeostasis. 
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Figure 19. No intestinal pathology in vehicle treated RIPK1tamIEC-KO mice and 
tamoxifen injected VillinCreERT2 mice  
(a) Body weight of vehicle-treated Ripk1fl/fl and RIPK1tamIEC-KO mice. (b) 
Representative H&E stained colonic and ileal swiss rolls from vehicle-treated Ripk1fl/fl 
and RIPK1tamIEC-KO mice. Scale bars: 100 µm. (c) Body weight of tamoxifen-injected 
VillinCreERT2 mice. (d) H&E stained colonic ileal swiss rolls from tamoxifen-injected 
VillinCreERT2 mice. Scale bars: 100 µm.  
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3.2 Intestinal pathology in RIPK1IEC-KO mice develops 
independent of the microbiota 
3.2.1 Antibiotic treatment does not prevent development of 
intestinal disease in RIPK1IEC-KO mice  
The microbiota regulates intestinal homeostasis and contributes to intestinal 
inflammation in IBD patients as well as in genetic mouse models of IBD 
(Maloy & Powrie, 2011). In order to check if microbial derived signaling 
contributes to the phenotype observed in the RIPK1IEC-KO mice, mice were 
treated with broad-spectrum antibiotics in the drinking water from E17.5 until 
21 days of age to diminish microbial colonization of the gastrointestinal tract. 
At 3 weeks of age, antibiotic treated RIPK1IEC-KO mice showed signs of 
wasting syndrome and had significantly reduced body weight compared to 
antibiotics receiving floxed littermates (Figure 20a). Although wasting occured, 
the survival of AB treated SPF-housed RIPKIEC-KO mice was slightly prolonged 
compared to conventional SPF-housed RIPK1IEC-KO mice (Figure 20b). 
Histological examination of H&E stained sections and immunostaining against 
CC3 showed that antibiotic treated RIPK1IEC-KO mice developed intestinal 
pathology and showed extensive IEC apoptosis similar to conventional 
housed RIPK1IEC-KO mice, suggesting that the microbiota does not contribute 
to the intestinal pathology observed in RIPK1IEC-KO mice (Figure 20c).  
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Figure 20. Antibiotic treatment does not prevent intestinal pathology in 
RIPK1IEC-KO mice 
(a) Body weight of 3-week old Ripk1fl/fl and RIPK1IEC-KO mice receiving antibiotics in 
the drinking water. (b) Kaplan-Meier survival curve of Ripk1fl/fl and RIPK1IEC-KO mice 
with normal water and antibiotics in the drinking water (data for conventional Ripk1fl/fl 
and RIPK1IEC-KO mice taken from Fig5c). (c) Representative images of intestinal 
sections from 3-week old antibiotic treated Ripk1fl/fl and RIPK1IEC-KO mice stained with 
H&E or immunostained against CC3. Scale bars: 100 µm. n.s. not significant. 
*P≤0.05, **P≤0.01, ***P≤0.005  
3.2.2 Antibiotic treatment does not prevent intestinal pathology in 
RIPK1tamIEC-KO mice 
In order to investigate if the microbiota contributes to intestinal pathology 
induced upon acute deletion of RIPK1 (RIPK1tamIEC-KO mice), cohorts of mice 
were treated with antibiotics in the drinking water for 4 weeks prior to deletion 
of RIPK1. Microbiota depletion significantly reduced body weight loss in 
RIPK1tamIEC-KO mice and prolonged survival compared to conventional housed 
RIPK1tamIEC-KO mice (Figure 17c, d). However, neither intestinal pathology nor 
the extent of cell death was ameliorated but rather delayed in antibiotic 
treated RIPK1tamIEC-KO mice (Figure 18). In line with the results from the 
antibiotic treated conditional RIPK1 knockout mice, diminishing the microbiota 
had a mild effect on the macroscopic appearance of the mice but had no 
effect on the intestinal pathology.  
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3.2.3 RIPK1IEC-KO mice develop intestinal disease independent of 
the microbiota 
To unequivocally address the role of microbial induced signaling in RIPK1IEC-
KO mice, germfree RIPK1IEC-KO mice were generated in the gnotobiotic 
facilities of the Universities of Ulm and Hannover. At 3-weeks of age, 
germfree RIPK1IEC-KO mice had significantly reduced body weight compared 
to germfree Ripk1fl/fl littermates (Figure 21a). Despite wasting, some germfree 
RIPK1IEC-KO mice showed prolonged survival compared to SPF housed 
RIPK1IEC-KO mice survived up to 16 weeks of age (Figure 21b).  
Histological examination of H&E stained sections from colon and ileum of 3-
week old mice revealed that germfree RIPK1IEC-KO mice developed intestinal 
pathology (Figure 21c). To directly compare tissue damage between SPF 
housed and germfree RIPK1IEC-KO mice, H&E stained sections were subjected 
to a blindfolded semi-quantitative composite scoring system addressing 
intestinal pathology (Adolph et al., 2013). In the colon, germfree RIPK1IEC-KO 
mice exhibit tissue damage to the same extent as SPF housed RIPK1IEC-KO 
mice, whereas in the ileum pathology is slightly but significantly ameliorated in 
germfree RIPK1IEC-KO mice (Figure 21d). IHC for CC3 showed that germfree 
RIPK1IEC-KO mice were not protected against apoptosis of IECs in the colon 
and the ileum. Quantification of cell death revealed that numbers of apoptotic 
IECs were significantly increased in the distal colon of germfree RIPK1IEC-KO 
mice but did not differ in the proximal colon and the ileum compared to SPF 
RIPK1IEC-KO mice (Figure 21e).  
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Figure 21. Microbiota independent intestinal disease in RIPK1IEC-KO mice 
(a) Body weight of germ-free Ripk1fl/fl and RIPK1IEC-KO mice at different ages. (b) 
Kaplan-Meier survival curve of SPF-housed germ-free Ripk1fl/fl and RIPK1IEC-KO mice. 
Survival data of SPF-housed Ripk1fl/fl and RIPK1IEC-KO mice taken from Fig.5c) (c) 
Representative images of intestinal sections from 3-week old germ-free Ripk1fl/fl and 
RIPK1IEC-KO mice stained with H&E or immunostained for CC3. Scale bars: 100 µm. 
(d) Quantification of intestinal pathology observed in SPF-housed and germ-free 
RIPK1IEC-KO mice at 3-week of age. Histology scoring was performed by Dr. Katerina 
Vlantis. (e) Quantification of crypts containing CC3-positive cells and the number of 
CC3-positive cells per crypt in the colon and small intestine of 3-week old SPF-
housed and germ-free Ripk1fl/fl and RIPK1IEC-KO mice. Data for SPF-housed Ripk1fl/fl 
and RIPK1IEC-KO mice were taken from Figure 8b and 11b. n.s. not significant. 
*P≤0.05, **P≤0.01, ***P≤0.005 
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3.2.4 Phenotype in RIPK1IEC-KO mice develops independently of 
Myd88-mediated signaling  
RIPK1 is a signaling adapter protein involved in bacterial induced toll-like 
receptor (TLR) signaling. To investigate a potential contribution of TLR-
signaling to Ripk1-/- IEC apoptosis and intestinal disease of RIPK1IEC-KO mice, 
RIPK1IEC-KO mice were crossed with Myd88 full body knockout mice, to 
generate mice, with ablation of RIPK1 specifically in the intestinal epithelium 
and MYD88 in all cells of the mice (Adachi et al., 1998). Full body MYD88 
deficiency did not prevent severe wasting and premature death of RIPK1IEC-KO 
mice (Figure 22a and data not shown). Analysis of H&E stained sections 
revealed that 3 week old RIPK1IEC-KO/Myd88-/- mice developed intestinal 
pathology in the colon and the ileum (Figure 22b). CC3 staining showed high 
numbers of apoptotic IECs in the colon and ileum. Except for the distal colon, 
where more apoptotic cells were found, IEC apoptosis occured to the same 
extent as observed in RIPK1IEC-KO mice (Figure 22b, c). These results 
suggest, that microbiota induced TLR signaling does not trigger cell death in 
Ripk1-/- IECs and does not contribute to the pathology observed in RIPK1IEC-
KO mice.  
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Figure 22. Myd88 independent pathology in RIPK1IEC-KO mice 
(a) Body weight of 3-week old Ripk1fl/fl/Myd88-/- and RIPKIEC-KO/Myd88-/- mice. (b) 
Representative images from intestinal sections from 3-week old Ripk1fl/fl/Myd88-/- and 
RIPKIEC-KO/Myd88-/- mice stained with H&E or immunostained for CC3. Scale bars: 
100 µm (c) Quantification of crypts containing CC3-positive cells and the number of 
CC3-positive cells per crypt in the colon and small intestine of 3-week old 
Ripk1fl/fl/Myd88-/- and RIPKIEC-KO/Myd88-/- mice. n.s. not significant. *P≤0.05, **P≤0.01, 
***P≤0.005 
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3.3 Intestinal pathology in RIPK1IEC-KO mice partially 
depends on TNF signaling 
RIPK1 is an important signaling node downstream of TNFR1, which can 
induce cell death as well as cell survival. To address whether TNFR1 
mediated signaling is involved in the development of the intestinal pathology 
and apoptosis observed in RIPK1IEC-KO mice, RIPK1IEC-KO mice were crossed 
with Tnfr1 (Tnfrsf1a) full body knockout mice (Pfeffer et al., 1993). Resulting 
RIPK1IEC-KO/Tnfr1-/- mice were deficient for RIPK1 specifically in IECs and 
lacked TNFR1 in all cells of the mice. RIPK1IEC-KO/Tnfr1-/- mice were partially 
protected from cachexia and 50% of the mice survived until 3 months of age 
(Figure 23a, b), indicating that severe wasting and premature death of 
RIPK1IEC-KO mice depends on TNFR1 mediated signaling. Histological 
examination of H&E stained sections from 3-week old RIPK1IEC-KO/Tnfr1-/- 
mice revealed partial protection from villus atrophy in the ileum, a less severe 
reduction of goblet cells in colon and small intestine as well as reduced 
numbers of epithelial cells in the epithelium with morphological features of 
dying cells (Figure 23c). Immunohistochemistry for CC3 and quantification of 
cell death revealed reduced numbers of apoptotic IECs in the ileum as well as 
proximal colon of RIPK1IEC-KO/Tnfr1-/- mice and increased IEC apoptosis in the 
distal colon compared to RIPK1IEC-KO mice (Figure 23c, d). These results 
suggest that TNFR1 mediated signaling contributes to intestinal pathology 
and cell death in RIPK1IEC-KO mice, but also TNFR1-independent signaling 
appears to be involved.  
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Figure 23. Premature lethality and IEC apoptosis in RIPK1IEC-KO mice partially 
depend on TNFR1-mediated signaling.  
(a) Body weight of 3-week old RIPK1IEC-KO mice, Ripk1fl/fl/Tnfr1-/- and RIPK1IEC-
KO/Tnfr1-/- mice. Data for RIPK1IEC-KO mice were taken from Figure 5b. (b) Kaplan-
Meier survival curve for RIPK1IEC-KO, Ripk1fl/fl/Tnfr1-/- and RIPK1IEC-KO/Tnfr1-/- mice. 
Survival data of RIPK1IEC-KO mice was taken from Figure 5c. (c) Representative 
images from intestinal sections from 3-week old Ripk1fl/fl/Tnfr1-/- and RIPK1IEC-
KO/Tnfr1-/- mice were stained with H&E or immunostained for CC3. Scale bars: 100 
µm (d) Quantification of crypts containing CC3-positive cells and the number of CC3-
positive cells per crypt in the colon and ileum of 3-week old Ripk1fl/fl/Tnfr1-/- and 
RIPK1IEC-KO/Tnfr1-/- mice. n.s. not significant. *P≤0.05, **P≤0.01, ***P 
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3.4 Death of Ripk1-/- IECs depends on FADD and RIPK3 
mediated signaling 
3.4.1 Apoptosis in RIPK1IEC-KO mice depends on FADD 
Execution of extrinsic apoptosis is mediated by FADD and caspase-8 (Boldin, 
Goncharov, Goltsev, & Wallach, 1996; Chinnaiyan, O'Rourke, Tewari, & Dixit, 
1995; Muzio et al., 1996). FADD integrates upstream signals with its DD and 
binds to caspase-8 via its DED, inducing caspase-8 dimerization that triggers 
its autocatalytic activity resulting in the execution of apoptosis (Muzio et al., 
1996; Muzio, Stockwell, Stennicke, Salvesen, & Dixit, 1998). To assess if 
Ripk1-/- IECs die by FADD-caspase-8 dependent apoptosis, RIPK1IEC-KO mice 
were crossed to Faddfl/fl mice (Mc Guire et al., 2010). Resulting RIPK1IEC-
KO/FADDIEC-KO mice, that were deficient for RIPK1 and FADD specifically in 
IECs, had only slightly reduced body weight at 3 weeks of age and a normal 
life span (Figure 24a, b). In contrast to this, RIPK1IEC-KO/FADDhetIEC-KO 
littermate mice had reduced body weight and died prematurely similar to 
RIPK1IEC-KO mice, indicating that wasting and premature death of RIPK1IEC-KO 
mice is caused by FADD mediated processes (Figure 24a, b). Analysis of 
H&E stained ileal sections revealed that 3-week old RIPK1IEC-KO/FADDIEC-KO 
mice did not develop similar intestinal pathology as observed in RIPK1IEC-KO 
mice, whereas their RIPK1IEC-KO/FADDhetIEC-KO littermates did (Figure 24c). 
Staining for lysozyme indicated that Paneth cell loss in RIPK1IEC-KO/FADDIEC-
KO mice persisted (Figure 24c). Furthermore, RIPK1IEC-KO/FADDIEC-KO mice 
had slightly increased numbers of immune cells in the ileal lamina propria as 
shown by immunohistochemical staining for CD45 (Figure 24c). Importantly, 
CC3 staining showed significantly reduced numbers of apoptotic IECs in the 
ileum of RIPK1IEC-KO/FADDIEC-KO mice (Figure 24c, d), indicating that Ripk1-/- 
IECs died by FADD dependent apoptosis. However, many dying CC3 
negative IECs were detected, suggesting that these died a caspase-
independent death (Figure 24c inset, arrow). In conclusion, these results 
show that small intestinal pathology in RIPK1IEC-KO mice is caused by FADD-
dependent IEC apoptosis. The additional epithelial specific ablation of FADD 
prevents IECs apoptosis, but triggers non-apoptotic death of IECs and a 
pathology reminiscent of the phenotype described for FADDIEC-KO mice (Welz 
et al., 2011).  
RESULTS 
 82 
Figure 24. FADD-dependent IEC apoptosis in the ileum of RIPK1IEC-KO mice.  
(a) Body weight of 3-week old Ripk1fl/fl/Faddfl/fl, RIPK1IEC-KO/FADDhetIEC-KO and 
RIPK1IEC-KO/FADDIEC-KO mice. (b) Kaplan-Meier survival curve of mice with the 
indicated genotypes. (c) Representative images of ileal sections from mice with the 
indicated genotypes stained with H&E or immunostained for Lysozyme, CC3 and 
CD45. Scale bars: 100 µm (d) Quantification of crypts containing CC3-positive cells 
and the number of CC3-positive cells per crypt in the ileum of 3-week old 
Ripk1fl/fl/Faddfl/fl, RIPK1IEC-KO/FADDhetIEC-KO and RIPK1IEC-KO/FADDIEC-KO mice. n.s. not 
significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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To understand the role of FADD in the context of the colonic RIPK1IEC-KO 
phenotype, 3-week old RIPK1IEC-KO/FADDIEC-KO mice were analysed. Similar 
to the ileum, ablation of FADD in RIPK1-deficient IECs significantly reduced 
the extent of pathology and the number of CC3 positive cells in the proximal 
colon when compared to RIPK1IEC-KO/FADDhetIEC-KO or RIPK1IEC-KO mice 
(Figure 25). In stark contrast to RIPK1IEC-KO mice, where the distal colon was 
only mildly affected, 3-week old RIPK1IEC-KO/FADDIEC-KO mice showed an 
aggravated pathology in this region (Figure 25). Examination of H&E stained 
colon sections revealed that 8 out of 14 RIPK1IEC-KO/FADDIEC-KO mice showed 
areas with epithelial erosion and elevated numbers of infiltrating immune cells 
at 3 weeks of age in the distal to medial colon, which have never been 
observed in RIPK1IEC-KO mice (n=18) (Figure 25). This was further supported 
by staining for CD45, which revealed increased numbers of immune cells in 
the distal colon of RIPK1IEC-KO/FADDIEC-KO mice (Figure 25). As described for 
the ileum and proximal colon, few CC3 positive dying cells were detected but 
high numbers of dying CC3 negative cells were found in the epithelium and 
lumen of the crypts of RIPK1IEC-KO/FADDIEC-KO mice (Figure 25a magnified 
inset with arrow, b).  
 
Adult RIPK1IEC-KO/FADDIEC-KO mice had similar body weight like their floxed 
littermates (data not shown). Analysis of H&E stained ileal sections from 13-
week old RIPK1IEC-KO/FADDIEC-KO mice revealed villus shortening, loss of 
goblet and Paneth cells and crypt elongation, which were not observed in 
Ripk1fl/fl/Faddfl/fl mice. Few dying cells but no gross aberrant morpholoigcal 
changes were observed in the proximal colon of 13-week old RIPK1IEC-
KO/FADDIEC-KO mice (Figure 26). In the distal colon many dying IECs were 
found in the epithelium and the presence of ulcers were detected in adult 
RIPK1IEC-KO/FADDIEC-KO mice (Figure 26).  
Taken together, these data show that IECs in RIPK1IEC-KO mice die by FADD 
dependent apoptosis and additional IEC specific deletion of FADD protects 
Ripk1-/- IECs from undergoing apoptosis, however sensitizes IECs to a 
caspase-independent death.  
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Figure 25. Caspase-independent IEC death and ulcerating colitis in RIPK1IEC-
KO/FADDIEC-KO mice.  
(a) Representative images from H&E stained and CC3 or CD45 immunostained 
colon swiss rolls from 3-week old mice with the indicated genotypes. Scale bars: 100 
µm (d) Quantification of crypts containing CC3-positive cells and the number of CC3-
positive cells per crypt in the distal and proximal colon from 3-week old 
Ripk1fl/fl/Faddfl/fl, RIPK1IEC-KO/FADDhetIEC-KO and RIPK1IEC-KO/FADDIEC-KO mice. n.s. not 
significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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Figure 26. Colitis and small intestinal pathology in adult RIPK1IEC-KO/FADDIEC-KO 
mice.  
Histological analysis of H&E stained colonic and ileal sections from adult 
Ripk1fl/fl/Faddfl/fl and RIPK1IEC-KO/FADDIEC-KO mice. Scale bars: 100 µm.  
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3.4.2 Death of IECs in RIPK1IEC-KO/FADDIEC-KO mice depends on 
RIPK3 mediated necroptosis 
RIPK3 and its kinase activity have been shown to be crucial for the execution 
of TNF-induced necroptosis (Cho et al., 2009; He et al., 2009; D. W. Zhang et 
al., 2009). Murine RIPK3 deficiency does not result in a significant phenotypic 
effect, enabling to study the role of RIPK3 and necroptosis in various infection 
and disease models (Newton et al., 2004; Vanden Berghe, Linkermann, 
Jouan-Lanhouet, Walczak, & Vandenabeele, 2014). In the context of intestinal 
epithelial specific FADD deficiency, RIPK3 was reported to be an essential 
mediator non-apoptotic death of IECs (Welz et al., 2011). Given the striking 
phenotypic similarities between FADDIEC-KO and RIPK1IEC-KO/FADDIEC-KO mice, 
it could be possible that pathology in RIPK1IEC-KO/FADDIEC-KO mice depends 
on RIPK3 dependent death. To investigate the role of RIPK3 in RIPK1- and 
FADD-double deficiet IECs, RIPK1IEC-KO/FADDIEC-KO mice were crossed to 
Ripk3-/- mice (Newton et al., 2004).  
Figure 27. Intestinal pathology in RIPK1IEC-KO/FADDIEC-KO depends on RIPK3.  
(a) Body weight of 3-week old RIPKIEC-KO/FADDIEC-KO/Ripk3-/- and 
Ripk1fl/fl/Faddfl/fl/Ripk3-/- mice. (b) Representative histological images from H&E 
stained ileal and colonic sections from 3-week old RIPKIEC-KO/FADDIEC-KO/Ripk3-/- and 
Ripk1fl/fl/Faddfl/fl/Ripk3-/- mice. Scale bars: 100 µm. n.s. not significant.  
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Figure 28. No increased cell death in RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice.  
(a) Representative images from CC3 and CD45 immunostained colonic and ileal 
swiss rolls from 3-week old Ripk1fl/fl/Faddfl/fl/Ripk3-/- and RIPK1IEC-KO/FADDIEC-
KO/Ripk3-/- mice. Scale bars: 100 µm. (b) Immunostaining of ileal sections from 3-
week old Ripk1fl/fl/Faddfl/fl/Ripk3-/- and RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice for 
lysozyme. Scale bars: 100 µm. (c) Quantification of crypts containing CC3-positive 
cells and the number of CC3-positive cells per crypt in the ileum, distal and proximal 
colon of 3-week old Ripk1fl/fl/Faddfl/fl/Ripk3-/- and RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice. 
n.s. not significant. *P≤0.05, **P≤0.01, ***P≤0.005 
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RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice were born at expected mendelian ratios, 
RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice had normal body weight and a normal 
life span (Figure 27a). Histological examination of H&E stained swiss rolls of 
ileal and colonic sections from 3-week old triple knockout mice did not show 
signs of any pathology and were indistinguishable from their littermate 
controls (Figure 27b). Intestinal epithelial apoptosis was not increased in the 
colon and only slightly increased in the small intestine of RIPK1IEC-
KO/FADDIEC-KO/Ripk3-/- mice compared to control Ripk1fl/fl/Faddfl/fl/Ripk3-/- mice, 
although in the ileum it reached statistical significance (Figure 28a, c). 
Furthermore, no CC3 negative dying cells were detected in the colon and the 
ileum (Figure 28a), indicating that caspase-independent cell death in 
RIPK1IEC-KO/FADDIEC-KO mice is RIPK3-dependent. The numbers of CD45 
positive immune cells in the lamina propria of triple knockout mice was similar 
to control mice, suggesting that colitis and enteritis in RIPK1IEC-KO/FADDIEC-KO 
mice was a consequence of RIPK3 dependent death of IECs (Figure 28a).  
Figure 29. No intestinal pathology in adult RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice.  
Histological analysis of H&E stained colonic and ileal sections from 13-week old 
RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice and Ripk1fl/fl/Faddfl/fl/Ripk3-/- mice. Scale bars: 
100 µm. 
 
Colonic and ileal H&E stained sections from 13-week old RIPK1IEC-
KO/FADDIEC-KO/Ripk3-/- mice were indistinguishable from 
Ripk1fl/fl/Faddfl/fl/Ripk3-/- littermates (Figure 29). Despite the lack of intestinal 
pathology in RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice, 3-week old triple knockout 
mice displayed slightly increased levels of Tnf, Il1b, Ccl5 and Il10 as shown 
by qRT-PCR analysis of whole small intestinal tissue (Figure 30).  
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Figure 30. Increased TNF mRNA levels in the ileum of RIPK1IEC-KO/FADDIEC-
KO/Ripk3-/- mice. 
qRT-PCR analysis of mRNA expression levels for inflammatory cytokines and 
chemokines of whole ileal tissue from 3-week old Ripk1fl/fl/Faddfl/fl/Ripk3-/- and 
RIPK1IEC-KO/FADDIEC-KO/Ripk3-/- mice. n.s. not significant. *P≤0.05, **P≤0.01, 
***P≤0.005 
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3.4.3 Death of Ripk1-/- IECs is independent of RIPK3 
As described previously, Ripk1-/- IECs died by FADD dependent apoptosis, 
and in IECs with additional deletion of FADD the mode of death switched to 
RIPK3-dependent necroptosis. These results suggest that RIPK3 alone might 
not be a major driver of apoptosis and pathology in RIPK1IEC-KO mice. To 
investigate a potential role of RIPK3 in the apoptosis observed in IECs of 
RIPK1IEC-KO mice, RIPK1IEC-KO mice were crossed to Ripk3-/- mice (Newton et 
al., 2004). RIPK1IEC-KO/Ripk3-/- mice showed significant reduction of body 
weight compared to their Ripk1fl/fl/Ripk3-/- littermates and died prematurely 
(Figure 31a, b). Histological examination of H&E stained ileal and colonic 
sections revealed that RIPK1IEC-KO/Ripk3-/- mice developed intestinal 
pathology reminiscent of RIPK1IEC-KO mice (Figure 31c). Furthermore, 
RIPK1IEC-KO/Ripk3-/- mice exhibited Paneth cell loss and IEC apoptosis to the 
same extent as RIPK1IEC-KO mice did, indicating that apoptosis in Ripk1-/- IECs 
is independent of RIPK3 and RIPK3-mediated necroptosis is not a primary 
pathway triggering death of IECs and pathology in RIPK1IEC-KO mice (Figure 
32).  
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Figure 31. Premature death, cachexia and intestinal pathology in RIPK1IEC-KO 
mice is independent of RIPK3.  
(a) Body weight of 3-week old Ripk1fl/fl/Ripk3-/- and RIPK1IEC-KO/Ripk3-/- mice. (b) 
Kaplan-Meier survival curve of Ripk1fl/fl/Ripk3-/- and RIPK1IEC-KO/Ripk3-/- mice. (c) 
Histological analysis of H&E stained colonic and ileal sections from 3-week old 
Ripk1fl/fl/Ripk3-/- and RIPK1IEC-KO/Ripk3-/- mice. Scale bars: 100 µm. *P≤0.05, 
**P≤0.01, ***P≤0.005  
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Figure 32. Apoptosis and Paneth cell loss in RIPK1IEC-KO mice is independent of 
RIPK3.  
(a, b) Representative images from (a) CC3, CD45 and (b) lysozyme immunostained 
colonic and ileal swiss rolls from 3-week old Ripk1fl/fl/Ripk3-/- and RIPK1IEC-KO/Ripk3-/- 
mice. Scale bars: 100 µm. (c) Quantification of crypts containing CC3-positive cells 
and the number of CC3-positive cells per crypt in the ileum, distal and proximal colon 
of 3-week old Ripk1fl/fl/Ripk3-/- and RIPK1IEC-KO/Ripk3-/- mice. *P≤0.05, **P≤0.01, 
***P≤0.005 
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3.5 Scaffolding function of RIPK1 prevents the degradation 
of pro-survival proteins 
3.5.1 Pathology in RIPK1IEC-KO mice is independent of NF-κB 
activity 
The in vivo results presented above revealed an important cell intrinsic 
function of RIPK1 to protect IECs from apoptosis. The role of RIPK1 in NF-κB 
activation is controversial and possibly cell type specific (Gentle et al., 2011; 
Kelliher et al., 1998; Wong et al., 2010). Given the fact that RIPK1 deficiency, 
but not loss of RIPK1 kinase activity, triggered IEC apoptosis, it could be 
possible that Ripk1-/- IECs are sensitized to apoptosis due to the loss of 
RIPK1 scaffolding function for NF-κB activation (Polykratis et al., 2014). On 
the other hand, mice lacking p65 or IKK2 specifically in IECs do not develop 
spontaneous pathology (Egan et al., 2004; Steinbrecher et al., 2008). 
Furthermore, mice deficient for NEMO in IECs develop spontaneous colitis 
but survive to adulthood (Nenci et al., 2007). To address if impaired NF-κB 
activation caused apoptosis of Ripk1-/- IECs, RIPK1IEC-KO mice were crossed 
to mice carrying a stop floxed constitutively active IKK2 transgene (IKK2ca) 
(Sasaki et al., 2006). Heterozygous IEC specific expression of the IKK2ca 
transgene was reported to show sustained NF-κB activation in intestinal 
epithelial cells (Vlantis et al., 2011). RIPK1IEC-KO/IKK2caIEChet mice were born 
at expected mendelian ratios, but had slightly reduced body weight compared 
to their floxed littermates and died prematurely (Figure 33a and data not 
shown). In line with this, RIPK1IEC-KO/IKK2caIEChet mice were not protected 
from IEC apoptosis and intestinal pathology (Figure 33b). Compared to 
RIPK1IEC-KO mice, the pathology was aggravated in colons of RIPK1IEC-
KO/IKK2caIEChet mice. Colonic crypts were showing more severe 
hyperproliferation than in RIPK1IEC-KO mice and local accumulations of 
immune cells were present, which were not observed in RIPK1IEC-KO mice 
(Figure 33b). These results suggest that Ripk1-/- IECs are not sensitized to 
apoptosis by reduced NF-κB activity.  
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Figure 33. Pathology in RIPK1IEC-KO is independent of canonical NF-κB 
activation.  
(a) Body weight of 3-week old RIPK1IEC-KO/IKK2caIEChet and Ripk1fl/fl/Ikk2cawt/fl mice. 
(b) Representative histological images of H&E stained, CC3 and CD45 
immunostained colonic and ileal sections from 3-week old Ripk1fl/fl/Ikk2cawt/f and 
RIPK1IEC-KO/IKK2caIEChet mice. Scale bars: 100 µm. n.s. not significant. *P≤0.05, 
**P≤0.01, ***P≤0.005 
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3.5.2 RIPK1 prevents degradation of pro-survival proteins 
Previous studies showed that TNF stimulation of Ripk1-/- MEFs induced 
degradation of TRAF2 as well as cIAP1 and subsequent stabilization of NIK 
resulting in non-canonical NF-κB activation as shown by p110 processing to 
p52 (Gentle et al., 2011; J. Y. Kim et al., 2011). Furthermore the authors 
showed cleavage of cFLIP and caspase-8 activation in RIPK1 deficient MEFs 
upon TNF stimulation culminating in death of Ripk1-/- MEFs (Gentle et al., 
2011; J. Y. Kim et al., 2011). Therefore it could be possible that RIPK1 
deficiency sensitizes IECs to apoptosis by impaired stability of pro-survival 
proteins. Indeed, western blot analysis of IECs showed that protein levels of 
cIAP1 and TRAF2 were reduced in RIPK1IEC-KO mice compared to Ripk1fl/fl 
mice (Figure 34b), suggesting that RIPK1 might control their stability thereby 
promoting IEC survival. Since the mRNA levels of Birc2 (cIAP1) and Cflip 
(cFLIP) were not reduced Ripk1-/- IECs compared to Ripk1fl/fl IECs (Figure 
34a), it is likely that posttranslational mechanisms induced the degradation of 
cIAP1 and TRAF2 in Ripk1-/- IECs. Consistent with previous studies, TNF 
stimulation of Ripk1-/- MEFs induced rapid degradation of cIAP1, TRAF2 and 
TRADD (data not shown).  
To assess whether degradation of proteins involved in TNFR1 signaling 
complex 1 could be occur in the absence of RIPK1 in inestinal epithelial cells 
in vitro, the intestinal organoid culture system was employed (T. Sato et al., 
2009). Intestinal crypts isolated from RIPK1IEC-KO mice did not form organoids 
and died within 48 hours after isolation, whereas organoids from Ripk1fl/fl mice 
could be maintained in culture (data not shown). This shows that RIPK1 
deficiency also caused IEC death in vitro. In order to obtain RIPK1 deficient 
organoids, intestinal organoids from RIPK1tamIEC-KO mice were cultured and 
deletion of RIPK1 was induced by adding 4-hydroxytamoxifen (4-OHT) to the 
culture medium for 24 hours (see 2.2.5.1 and 2.2.5.2). This treamtment was 
sufficient to induce efficient deletion of RIPK1 Figure 34c). 48 h after adding 
4-OHT, RIPK1tamIEC-KO organoids showed reduced proteins levels of cIAP1, 
TRAF2 and cFLIP, whereas Cre negative Ripk1fl/fl organoids did not (Figure 
34c). In addition, RIPK1tamIEC-KO organoids died 48 h after administration of 4-
OHTas shown by photography and FACS analysis of the change of PI 
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positive organoids (Figure 34d, e). These results suggest that the degradation 
of pro-survival protein might contribute to the death of Ripk1-/- IECs.  
Figure 34. Degradation of cIAP1 and TRAF2 in Ripk1-/- IECs and RIPK1tamIEC-KO 
organoids. 
(a) qRT-PCR analysis for mRNA expression levles of pro-survival and pro-apoptotic 
genes in intestinal epithelial cells isolated from 3-week Ripk1fl/fl and RIPK1IEC-KO mice. 
(b) Immunoblot analysis of small intestinal IECs from 3-week old Ripk1fl/fl and 
RIPK1IEC-KO mice for the indicated antibodies. Animals were sacrificed and IEC were 
isolated by Marius Dannappel. Dr. Chun Kim performed immunoblot analysis of IEC 
extracts. (c) Immunoblot analysis of Ripk1fl/fl (FL) and RIPK1tamIEC-KO (iKO) organoids 
after 48 h treatment with 4-hydroxytamoxifen (4-OHT) with the indicated antibodies. 
Organoid culture was performed by Marius Dannappel and Dr. Chun Kim performed 
immunoblot analysis of organoid lysates. (d) Representative images depicting 
Ripk1fl/fl and RIPK1tamIEC-KO organoids 48 h after treatmemt with 4-OHT for 20 h. 
Original magnification, x400. (e) FACS analysis of PI-stained cells from Ripk1fl/fl and 
RIPK1tamIEC-KO organoids 43 h after 4-OHT treatment in the presence or absence of 
zVAD. Organoid cell culture was done by Marius Dannappel and PI-staining and 
FACS analysis was performed by Dr. Katerina Vlantis. *P≤0.05, **P≤0.01, ***P≤0.005 
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3.5.3 Increased TNF production as an autocrine amplification loop 
causing IEC apoptosis 
Previous studies have shown that deletion of cIAP1/2 using SMAC (also 
known as DIABLO) mimetics induced the activation of canonical and non-
canonical NF-κB signalling resulting in the expression of TNF and other 
cytokines (E. Varfolomeev et al., 2007). Since Ripk1-/- IECs and organoids 
showed degradation of cIAP1 (Figure 34b, c), it might be possible that cIAP1 
degradation results in NF-κB activation and subsequent TNF expression 
which induces death of IECs or organoids in an autocrine manner. In order to 
test this hypothesis, IECs from RIPK1IEC-KO and Ripk1fl/fl mice were isolated, 
cytoplasmic and nuclear fractions prepared and analyzed by immunoblot. The  
Figure 35. Increased NF-κB activation and Tnf expression in Ripk1-/- IECs.  
(a) Immunoblot analysis of nuclear- and cytoplasmic fractions prepared form IECs 
isolated from 3-week old Ripk1fl/fl and RIPK1IEC-KO mice probed with the indicated 
antibodies. Mice were sacrificed and IEC isolated by Marius Dannappel. Dr. Chun 
Kim prepared nuclear and cytoplasmic fractions and performed immunoblot analysis. 
(b, c) qRT-PCR analysis of mRNA expression levels of Tnf, Il1b and Cxcl1 in IECs 
from small intestine (b) and colon (c) of 3-week old Ripk1fl/fl and RIPK1IEC-KO mice. 
qRT-PCR in (c) was pipetted by Dr. Teresa Corona. (d) qRT-PCR analysis for Tnf 
expression levels in Ripk1fl/fl and RIPK1tamIEC-KO mice 30 h after 4-OHT or EtOH 
removal. N, nuclear, C, cytoplasmic, EtOH, ethanol, 4-OHT, 4-hydroxytamoxifen 
*P≤0.05, **P≤0.01, ***P≤0.005 
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nuclear fraction of RIPK1-deficient IECs showed p65, RelB and c-Rel as well 
as processed p50 and p52, indicating increased NF-κB activity compared to 
Ripk1fl/fl mice, where only p50 was detected in the nuclear fraction (Figure 
35a).  
Consistent with this hypothesis, qPCR analysis using IECs from RIPK1IEC-KO 
and Ripk1fl/fl mice revealed significantly increased expression levels of TNF in 
the colon and small intestine of RIPK1IEC-KO mice and elevated Il1b mRNA 
levels in the colon (Figure 35b, c). Furthermore, deletion of RIPK1 by 4-OHT 
treatment in RIPK1tamIEC-KO organoids led to increased expression levels of 
TNF within 30h after the removal of 4-OHT that was not observed in vehicle- 
treated control organoids (Figure 35d).  
Figure 36. Increased sensitivity of Ripk1-/-/Tnfr1-/- organoids to poly(I:C) and 
IFN-induced death.  
Representative images of organoids isolated from RIPK1IEC-KO/Tnfr1-/- and 
Ripk1fl/fl/Tnfr1-/- mice taken 16 h after stimulation with poly(I:C), IFN-β and IFN-γ. 
Experiments were performed by Marius Dannappel and Dr. Katerina Vlantis. Ctrl, 
control, IFN, interferon. Original magnification, x400.  
 
As described above, intestinal crypts isolated from RIPK1IEC-KO mice failed to 
form organoids in vitro. Interestingly, intestinal crypts from RIPK1IEC-KO/Tnfr1-/- 
mice could be grown to organoids and maintained in culture for a few weeks, 
although they did not grow as well as control organoids from Ripk1fl/fl/Tnfr1-/- 
mice (Figure 36). This is in line with the idea that TNF produced by Ripk1-/- 
IECs induced death in autocrine manner. Nevertheless, organoids from 
RIPK1IEC-KO/Tnfr1-/- mice were highly sensitive to polyinosinic:polycytidylic 
acid (poly(I:C)), interferon-β (IFN-β) and IFN-γ induced death (Figure 36). 
Therefore, it is possible that TIR-domain-containing adaptor-inducing 
interferon- β (TRIF)- and IFN-dependent signaling pathways also contribute to 
the death of Ripk1-/- IECs and to the pathology in RIPK1IEC-KO mice. To assess 
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the effect of TRIF-mediated signaling pathways in the context of pathology 
and IEC death in RIPK1IEC-KO mice, RIPK1IEC-KO mice were crossed to Triffl/fl 
mice (Dannappel et al., 2014). RIPK1IEC-KO/TRIFIEC-KO mice showed similar 
body weight reduction and premature lethality like RIPK1IEC-KO mice did 
(Figure 37a and data not shown). In line with this, intestinal pathology and cell 
death was not ameliorated compared to RIPK1IEC-KO mice, indicating that, if at 
all, TRIF-mediated signaling plays, if at all, only a minor role in the 
development of the in vivo pathology exhibited by RIPK1IEC-KO mice (Figure 
37b).  
Taken together, these result show that RIPK1 controls stability of TNFR1 
complex 1 proteins, thereby promoting survival of IECs. Furthermore, RIPK1 
deficiency is associated with increased canonical and non-canonical NF-κB 
activity, resulting in increased TNF expression that triggers death of Ripk1-/- 
IECs in an autocrine manner.  
Figure 37. Intestinal pathology is independent of TRIF-mediated signaling.  
(a) Body weight of 3-week old Ripk1fl/fl/Triff/fl and RIPK1IEC-KO/TRIFIEC-KO mice. (b) 
Representative histological images of H&E stained, CC3 and CD45 immunostained 
colonic and ileal sections from 3-week old Ripk1fl/fl/Triffl/fl and RIPK1IEC-KO/TRIFIEC-KO 
mice. Scale bars: 100 µm. *P≤0.05, **P≤0.01, ***P≤0.005 
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4. Discussion 
4.1 RIPK1 as a master regulator of cell death. 
Cell death and inflammation are crucial processes to control viability and 
homeostasis of an organism, and dysfunction of either may be of pathological 
outcome. RIPK1 serves as an essential signaling node regulating 
inflammation, apoptosis and necroptosis in response to various stimuli such 
as TNF and some TLR-ligands, and thus, must be tightly controlled for the 
maintenance of tissue homeostasis. Indeed, mice with homozygous deletion 
of RIPK1 show excessive cell death and inflammation in several tissues and 
die shortly after birth (Kelliher et al., 1998).  
Here we set to investigate the role of RIPK1 specifically in IECs and to 
circumvent early postnatal lethality of Ripk1-/- mice, we generated conditional 
RIPK1 knockout mice lacking RIPK1 specifically in IECs. RIPK1IEC-KO mice 
have a cachectic appearance, die prematurely and show massive IEC 
apoptosis (Figure 5-Figure 12). Additional deletion of FADD protected IECs 
from succumbing to apoptosis but sensitized RIPK1 and FADD double-
deficient IECs to caspase-3 independent RIPK3-driven cell death (Figure 
24,Figure 25). RIPK3 deficiency did not protect RIPK1IEC-KO mice from 
developing intestinal pathology (Figure 31, Figure 32), but rescued IEC death 
and inflammation in RIPK1IEC-KO/FADDIEC-KO mice (Figure 24, Figure 25). 
Therefore, similar to FADDIEC-KO mice (Welz et al., 2011), IECs of RIPK1IEC-
KO/FADDIEC-KO mice die by necroptosis, whereas RIPK3-driven necroptosis is 
no major contributor to the pathology in RIPK1IEC-KO mice. Thus, in this work, 
we could demonstrate an important cell-intrinsic role of RIPK1 for the 
maintenance of intestinal epithelial homeostasis by inhibiting FADD-
dependent apoptosis of IECs. Furthermore, this work provides evidence for 
the in vivo relevance of RIPK1-independent RIPK3-dependent necroptosis, 
which drives the phenotype in RIPK1IEC-KO/FADDIEC-KO mice and most likely in 
FADDIEC-KO mice (Welz et al., 2011). Similarily, intestinal pathology in 
FADDIEC-KO mice could not be prevented by expressing kinase-dead RIPK1 in 
IECs, providing further evidence for the in vivo importance of RIPK1-kinase 
activity independent RIPK3-dependent necroptosis (Dannappel et al., 2014).  
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The role of RIPK1 in IECs as an inhibitor of apoptosis is distinct to the role of 
RIPK1 in other tissues. For instance in the skin, RIPK1-deficiency caused skin 
inflammation and sensitized keratinocytes to FADD-dependent apoptosis as 
well as RIPK3-MLKL-dependent necroptosis (Dannappel et al., 2014). FADD 
deficiency did not protect against but delayed skin inflammation in RIPK1E-KO 
mice. In turn, these results suggest that the early postnatal skin inflammation 
and death observed in FADDE-KO mice depend on RIPK1 (Bonnet et al., 2011; 
Dannappel et al., 2014). Thus, RIPK1 has a tissue specific function to 
maintain homeostasis in epithelial tissues. Similar to the skin, hematopoietic 
specific deletion of RIPK1 in mice caused apoptosis and RIPK3-dependent 
necroptosis in hematopoietic cells resulting in death of the mice (Roderick et 
al., 2014). In addition, two recent publications demonstrated a contribution of 
both concurrent pathways, FADD-caspase-8-mediated apoptosis and RIPK3-
MLKL-dependent necroptosis to the early postnatal death of Ripk1-/- mice, as 
neither ablation of FADD/caspase-8 nor RIPK3/MLKL alone could prevent 
lethality of RIPK1-null mice (Dillon et al., 2014; Kaiser et al., 2014; Rickard et 
al., 2014; H. Zhang et al., 2011). However, Ripk1-/-/Caspase-8-/-/Ripk3-/- and 
Ripk1-/-/Fadd-/-/Ripk3-/- mice, in which extrinsic apoptosis and necroptosis are 
blocked, survive until adulthood without an aberrant gross morphology, 
although while aging, they develop acute lymphoproliferative syndrome 
(ALPS) (Dillon et al., 2014; Rickard et al., 2014). Taken together, these 
genetic studies suggest that RIPK1 ensures the maintenance of health in an 
organism in a cell-type specific manner, by inhibiting both apoptotic and 
necroptotic cell death.  
 
One important remaining question is, why RIPK1-deficiency sensitizes IECs to 
apoptosis, whereas in other tissues such as skin, thymus or liver, both 
apoptosis and necroptosis occur (Dannappel et al., 2014; Rickard et al., 
2014). It was proposed that RIPK3 expression levels correlate with a cell’s 
ability to undergo necroptosis (He et al., 2009). However, primary RIPK1-
deficient IECs have comparably higher RIPK3 protein levels as epidermal 
extracts from RIPK1E-KO mice (Dannappel et al., 2014), thus, the sensitivity 
towards necroptosis is probably independent of RIPK3 protein levels. Maybe 
the reason for sensitization to the type of cell death in the context of RIPK1-
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deficiency lies, first, in the nature of the cell death trigger (discussed below), 
and/or second, in a yet to be identified cell-intrinsic characteristic(s) of IECs. 
Future work is required to address this question.  
 
In addition to its pro-survival function, RIPK1 has death-inducing capacities. 
Full body deletion of caspase-8 or FADD results in embryonic lethality at 
E10.5 due to failed vascularization of the yolk sac, which is fully rescued by 
additional ablation of RIPK3 (Dillon et al., 2012; Kaiser et al., 2011; Oberst et 
al., 2011; Sakamaki et al., 2002; E. E. Varfolomeev et al., 1998; Yeh et al., 
1998). Interestingly, ablation of RIPK1 rescues the embryonic lethality of 
FADD and caspase-8 deficient mice, however these mice succumb 
postnatally as RIPK1-deficient mice do (Dillon et al., 2014; Kaiser et al., 2014; 
H. Zhang et al., 2011). The embryonic lethality of fadd-/- and caspase-8-/- mice 
is TNFR1-dependent, thus RIPK1 promotes lethality in FADD and caspase-8 
deficient mice by mediating TNF-induced RIPK3-dependent necroptosis 
(Dillon et al., 2014).  
 
In summary, RIPK1 is a key regulator of cell death and inflammation ednowed 
with anti-apoptotic and anti-necroptotic as well as pro-necroptotic functions, 
which are most likely dependent on the cellular context and on the cell type 
specific manner.  
 
4.2 How are RIPK1-deficient IECs sensitized to FADD-
mediated apoptosis?  
It is well known that RIPK1 deficient lymphocytes and MEFs are sensitized to 
TNF-induced caspase-8 mediated apoptosis (Feoktistova et al., 2011; Kelliher 
et al., 1998; Lee, Shank, Cusson, & Kelliher, 2004; Oberst et al., 2011; Tenev 
et al., 2011; H. Zhang et al., 2011). Since RIPK1 kinase dead MEFs or 
BMDMs are not sensitized to TNF-induced apoptosis and mice expressing a 
kinase-inactive RIPK1 (Ripk1D138N mice) do not show a spontaneous 
phenotype, the increased sensitivity to cell death and the survival promoting 
function of RIPK1 in IECs is independent of its kinase activity (Lee et al., 
2004; Newton et al., 2014; Polykratis et al., 2014). RIPK1-deficient IECs do 
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not show impaired, but rather increased nuclear translocation of the active 
NF-κB subunits. In addition, heterozygous IEC-specific expression of a 
constitutively active IKK2 did not ameliorate the extent of apoptosis in RIPK1-
deficient IECs. Instead, intestinal pathology was rather aggravated compared 
to RIPK1IEC-KO mice, which might be partially attributed to the very mild 
inflammation observed in IKK2caIEChet mice (Vlantis et al., 2011). Finally, 
mRNA levels of pro-survival genes, some of them NF-KB target genes, were 
not reduced in RIPK1-deficient IECs. All together, these results suggest that 
the role of RIPK1 in prevention of FADD-dependent apoptosis in IECs is 
independent of its role in NF-κB signaling and that RIPK1 is not required for 
NF-κB activation in IECs. In line with this result, another recent publication 
demonstrated unaffected IkBa phosphorylation and NF-κB target gene 
expression in response to TNF in organoids with induced deletion of RIPK1 
(Takahashi et al., 2014).  
RIPK1 has been shown to be important for the stability of cIAP1 and TRAF2 
within the TNFR1-associated signaling complex (Gentle et al., 2011; J. Y. Kim 
et al., 2011). TNF stimulation of Ripk1-/- MEFs induced the degradation of 
cIAP1, TRAF2 and cFLIPL, resulting in NIK stabilization and subsequent non-
canonical NF-κB activation as well as caspase-8 dependent apoptosis (Gentle 
et al., 2011; J. Y. Kim et al., 2011). Furthermore, loss of IAPs alone (by 
treatment with compound A or BV6) was sufficient for the stabilization of NIK 
and to activate canonical and non-canonical NF-κB pathways resulting in de 
novo TNF production inducing a positive feedback amplification and cell death 
in various cancer cell lines (E. Varfolomeev et al., 2007; Vince et al., 2007). 
Degradation of cIAP1, cFLIPL and TRAF2, NIK stabilization, canonical as well 
as non-canonical NF-KB activation and increased TNF production was 
observed in IECs isolated from RIPK1IEC-KO mice and RIPK1-deficient 
organoids (Figure 34, Figure 35) (Takahashi et al., 2014). However, if the 
non-canonical NF-KB pathway contributes to the phenotype observed in 
RIPK1IEC-KO mice is not known and needs to be addressed. In the case of 
RIPK1-null mice, additional ablation of NIK did not rescue the early postnatal 
lethality, arguing against a physiological relevance of non-canonical NF-κB 
activation in the context of RIPK1-deficiency (Dillon et al., 2014). Therefore, in 
accordance with the inhibitory function of RIPK1 in FADD-caspase-8 
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mediated apoptosis, the degradation of pro-survival proteins cIAP1, TRAF2 
and cFLIPL might be directly connected to caspase-8 dependent cell death.  
Except mammalian XIAP, cellular inhibitors of apoptosis family members are 
not able to directly inhibit the catalytic activity of caspases (Eckelman & 
Salvesen, 2006; Eckelman, Salvesen, & Scott, 2006). In case of cIAP1 and 
cIAP2, it was proposed that they modify caspase-3 and -7 with K48-linked 
ubiquitination chains to promote their proteosomal degradation (Choi et al., 
2009). Aside from regulating effector-caspases, an important pro-survival 
function of cIAP1 and cIAP2 is attributed to their ability to promote NF-κB 
pathway mediated pro-survival protein expression and to inhibit RIPK1 kinase 
activity (complex IIb-) dependent apoptosis (Bertrand et al., 2008; Mahoney et 
al., 2008; Petersen et al., 2007; E. Varfolomeev et al., 2007; Vince et al., 
2007; L. Wang et al., 2008). Both, impaired NF-κB activation and prevention 
of complex IIb-formation, cannot be attributed to Ripk1-/- IECs. Thus it is 
possible that death of RIPK1-deficient cells is not caused by loss of cIAP1, or 
second, cIAP1 has another, so far unappreciated pro-survival.  
Another possibility is that death of RIPK1-deficient IECs is caused by the loss 
of TRAF2. Interestingly, Traf2-/- MEFs exhibit a very similar response upon 
TNF stimulation as Ripk1-/- MEFs do, however they do not show degradation 
of cIAP1, indirectly arguing against the loss of cIAP1 as cause of death in 
RIPK1-deficient MEFs (Gentle et al., 2011). In the same study the authors 
could demonstrate that the degradation of TRAF2 is responsible for the 
increased sensitivity of Ripk1-/- MEFs to TNF (Gentle et al., 2011). In both, 
RIPK1- and TRAF2-deficient MEFs, TNF stimulation induced proteasome 
dependent cFLIPL destabilization, suggesting that, either TNF induces cFLIPL 
degradation or, cFLIPL is constantly degraded and reappears through a 
RIPK1- and TRAF2-dependent mechanism (Gentle et al., 2011). Reduced 
cFLIPL levels in turn, could change the stoichiometry within the TNFR1 DISC 
allowing uncontrolled caspase-8 dimerization and subsequent activation 
resulting in apoptotic cell death. Similar to MEFs and IECs, primary Ripk1-/- 
keratinocytes showed low levels of TRAF2 degradation in response to TNF 
stimulation, whereas cIAP1 protein levels were already very low in 
unstimulated cells (Dannappel et al., 2014). In response to TNF, Ripk1-/- 
keratinocytes died by apoptosis in vitro (Dannappel et al., 2014). Presumably, 
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degradation of TRAF2 and cIAP1 is a common mechanism explaining the 
increased sensitivity of RIPK1-deficient cells to TNF-induced apoptosis. 
These degradation processes may also attribute for the very similar 
phenotype of Traf2-/- mice in a C57BL/6 background and for Ripk1-/- mice and 
might be causative for the sensitization for cell death (Kelliher et al., 1998; 
Yeh et al., 1997). In a BALB/C background, Traf2-/- mice exhibited a 
phenotype reminiscent to RIPK1IEC-KO mice, characterized by premature 
lethality within 3 weeks after birth and TNF-dependent intestinal epithelial cell 
apoptosis (Piao et al., 2011). Therefore, it could be possible that RIPK1 acts 
upstream of TRAF2 to prevent IEC apoptosis. The really interesting new gene 
(RING) domain and cIAP1/2 interaction motif (CIM) of TRAF2 were shown to 
confer resistance to TNF-induced cell death (Vince et al., 2009; L. Zhang, 
Blackwell, Shi, & Habelhah, 2010). TRAF2 RING domain mutant cells 
exhibited normal NF-KB activation in response to TNF, therefore its pro-
survival function must be independent of NF-KB activation (Vince et al., 
2009). A potential mechanism, by which the RING domain of TRAF2 could 
promote survival, is by modifying the large catalytic domain of caspase-8 with 
K-48 linked ubiquitin chains upon caspase-8 autoprocessing and thereby 
triggering its proteasomal degradation (Gonzalvez et al., 2012). Like this, 
TRAF2 could increase the cell’s threshold to undergo extrinsic apoptosis 
(Gonzalvez et al., 2012). It is unknown how the CIM domain of TRAF2 
promotes survival, however, one possibility could be a role for cIAPs in the 
regulation of caspase-8 activity.  
The molecular mechanism, by which RIPK1 stabilizes TRAF2 remains elusive 
for the moment (Gentle et al., 2011). One possibility is that RIPK1 prevents 
the modification of TRAF2 and cIAP1 with ubiquitin chains in a direct or 
indirect kinase activity independent manner, which would target them for 
degradation. However supporting experimental evidence is pending at the 
moment. Overexpression systems in a RIPK1-deficient and RIPK1-mutant 
background would help to address these questions and to unravel the 
molecular mechanism TNF-induced apoptosis in the absence of RIPK1 and 
TRAF2.  
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4.3 Triggers of FADD-dependent apoptosis in RIPK1IEC-KO 
mice 
Ablation of RIPK1 in IECs disables RIPK1-dependent processes that are 
required to protect IECs from undergoing FADD-dependent apoptosis. IEC 
apoptosis still occurs in the intestines of germ-free RIPK1IEC-KO mice (Figure 
21), thus the signals triggering apoptosis in Ripk1-/- IECs are independent of 
the microbiota and are most likely host organism derived. In order to 
understand the function of RIPK1 in regulating cell death in different signalling 
pathways, it is necessary to identify triggers that cause death in RIPK1-
deficient IECs, but not in healthy IECs under physiological conditions.  
 
Signalling via RIPK1 can be stimulated by death receptor ligands TNF, Fas, 
TRAIL to induce apoptosis and, under particular conditions, also necroptosis 
(Weinlich & Green, 2014). Full body ablation of TNFR1 partly protected 
RIPK1IEC-KO mice from severe wasting, prevented premature lethality and 
significantly reduced the extent of IEC apoptosis in the colon and small 
intestine of RIPK1IEC-KO mice (Figure 23) (Takahashi et al., 2014). 
Interestingly, primary Ripk1-/- IECs expressed increased levels of TNF (Figure 
35). Similarly, tamoxifen-inducible deletion of RIPK1 in organoids resulted in 
increased TNF expression and subsequent death of organoids (Figure 35). 
Therefore, TNF is largely responsible for triggering IEC apoptosis and 
intestinal pathology and in RIPK1IEC-KO mice and, furthermore, RIPK1-
deficient IECs are one important source of TNF, which triggers apoptosis in 
an autocrine manner.  
In other models, RIPK1-deficiency caused pathologies that differentially 
depend on TNF-signalling. For instance, in RIPK1E-KO mice, TNFR1 deficiency 
reduced keratinocyte necroptosis and delayed the onset of skin inflammation, 
but could not completely prevent it (Dannappel et al., 2014). In RIPK1-null 
mice in a C57BL/6 background, TNFR1 deficiency did not protect against 
early postnatal lethality and systemic inflammation, however rescued the 
colonic and small intestinal phenotype of Ripk1-/- mice (Rickard et al., 2014). 
On a mixed C57BL/6 129/Sv caspase-11-deficient background, TNFR1 
deletion prolonged survival of Ripk1-/- mice up to 12 days (Cusson, Oikemus, 
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Kilpatrick, Cunningham, & Kelliher, 2002; Dillon et al., 2014). The reason for 
the phenotypic differences observed in RIPK1-null mice in the different 
genetic backgrounds is unknown.  
 
Beside the importance of TNF-induced signalling in the context of the 
RIPK1IEC-KO mice phenotype, apoptotic IECs were still observed in RIPK1IEC-
KO/Tnfr1-/- mice, suggesting that also TNFR1-independent signalling pathways 
contribute to cell death in RIPK1IEC-KO mice. Possibly, other death receptor 
ligands, such as Fas or TRAIL induce Ripk1-/- IEC apoptosis. However, 
combined deletion of TNF and FasL was not able to prevent postnatal death 
of RIPK1-deficient mice (Rickard et al., 2014). Binding of FasL or TRAIL to 
their cognate receptors, leads to direct recruitment of FADD via DD 
interactions, thereby triggering the assembly of a membrane-associated DISC 
for the induction of apoptosis. RIPK1 was shown to be dispensable for FasL-
induced apoptosis and only had a minor cytoprotective role in TRAIL-induced 
apoptosis (Geserick et al., 2009; Holler et al., 2000; E. Varfolomeev et al., 
2005). Therefore, it is unlikely that FasL or TRAIL contribute to the intestinal 
pathology in RIPK1IEC-KO mice.  
 
During bacterial or viral infections, PAMPs are detected by PPRs such as 
TLR3 and TLR4 and activate host-defence pathways to mount an adequate 
immune response. Dependent on the cellular context, TLR3/TLR4 stimulation 
can induce TRIF RHIM interaction-dependent apoptosis and necroptosis 
(Kaiser & Offermann, 2005). Therefore, it is conceivable, that TLR3/TLR4-
induced signalling triggers apoptosis of RIPK1-deficient IECs. However, IEC-
specific TRIF ablation did not ameliorate severe wasting, premature lethality 
and intestinal cell death of RIPK1IEC-KO mice, indicating that TRIF-mediated 
signalling is not involved in apoptosis of RIPK1-deficient IECs (Figure 37). 
Interestingly, in contrast to Ripk1-/- organoids, Ripk1-/-/Tnfr1-/- organoids grew 
in culture for a limited period of time, but were highly sensitive to Poly(I:C), 
IFN-β and IFN-γ induced cell death (Figure 36). Therefore, TRIF- and/or IFN-
mediated pathways might contribute to IEC death together with TNFR1 in a 
redundant fashion. This possibility is supported by the fact that the survival of 
Ripk1-/-/Tnfr1-/-/Trif-/- mice is significantly extended beyond those of Ripk1-/-
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/Tnfr1-/- and Ripk1-/-/Trif-/- mice (Dillon et al., 2014). In the skin, TRIF-
deficiency slightly ameliorated the extent of skin inflammation in RIPK1E-KO 
mice (Dannappel et al., 2014). Although the effect of TRIF-ablation on the 
extent of keratinocyte apoptosis and necroptosis was not evaluated in this 
work, TRIF and TNFR1 double deficiency might provide further protection 
from skin pathology in RIPK1E-KO mice. On the other hand, in both models 
RIPK3-mediated necroptosis is an important driver of the phenotype, and 
TRIF deletion maybe disables a TRIF-RIPK3 RHIM-mediated interaction that 
causes necroptosis in the absence of RIPK1. In this case, given the RIPK3-
independency of the intestinal phenotype, TNFR1-TRIF double deficiency 
would not give any further protection compared to TNFR1 deficiency. 
However, this needs to be addressed with a genetic approach requiring the 
generation of triple mutant animals.  
Similar to TNFR1 and TRIF-double deficiency, Ripk1-/-/Tnfr1-/-/Ifnar-/- mice had 
a survival advantage compared to Ripk1-/-/Tnfr1-/- and Ripk1-/-/Ifnar-/- mice 
(Dillon et al., 2014). In vitro studies revealed that Ripk1-/- MEFs are sensitized 
to type I IFN-induced death, that depends on RIPK3 and MLKL (Dillon et al., 
2014; Kaiser et al., 2014). As RIPK3-dependent necroptotic death plays no 
major role in RIPK1-deficient IECs, it is unlikely that deletion of IFNAR would 
ameliorate cell death in RIPK1IEC-KO mice, although experimental evidence is 
required to assess this possibility.  
 
Given the importance of RIPK1 in the described signalling pathways 
regulating cell death and cytokine production, it is not surprising that RIPK1 is 
linked to bacterial and viral infections. Several studies emphasized the 
importance of RIPK1 and/or RIPK3 mediated cell death pathways during 
infection scenarios. In order to successfully disseminate and infect another 
host, many viruses counteract host’s cell death machinery. For instance, 
vaccinia virus expresses B13R/Spi2, a potent inhibitor of caspase-1 and 
caspase-8. Infected cells are sensitized to RIPK1/RIPK3 dependent 
necroptosis induced by increased TNF expression after pathogen encounter 
in different tissues. In line with this, VV infected Ripk3-/- mice showed reduced 
cell death and inflammation and finally succumbed to the infection due to 
uncontrolled spreading of the pathogen (Chan et al., 2003; Cho et al., 2009). 
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Likewise Ripk1D138N mice showed impaired control of vaccinia virus 
replication, underlining the importance of RIPK1/RIPK3-mediated necroptosis 
for the host’s antiviral response (Polykratis et al., 2014). However, if infections 
with VV cause or prevent RIPK1/RIPK3-dependent necroptosis in healthy 
IECs is unknown.  
Murine cytomegalovirus (MCMV) encodes viral inhibitor of caspase-8 
activation (vICA) and viral inhibitor of RIP activation (vIRA) to block both, 
apoptotic and necroptotic cell death (Brune, Menard, Heesemann, & 
Koszinowski, 2001; Mack, Sickmann, Lembo, & Brune, 2008; Rebsamen et 
al., 2009; Upton et al., 2008). vIRA harbors two RHIM-domains and can 
prevent death of infected host cells by binding to RIPK1 and RIPK3 to prevent 
DAI induced necroptosis and NF-κB activation. Mutating the RHIM of vIRA 
abolished the virulence of MCMV due to increased host cell necroptosis, 
which was restored in Dai-/- and Ripk3-/- mice (Upton et al., 2012). In rare 
cases, cytomegalovirus infection can cause ilietis and colitis in 
immunocompetent patients, although it remains elusive if CMV interferes or 
hijacks the RIPK1/RIPK3-dependent cell death machinery in infected IECs 
(Tejedor Cerdena et al., 2011). In the described examples, the diverse roles 
of RIPK1 during infections were examined mainly in immune cells and the 
possibility of bacterial and viral induced apoptosis/necroptosis in IECs remain 
elusive. A recent publication demonstrated that poly(I:C) directly triggers a 
TLR3-TRIF-caspase-8 pathway to induce IEC apoptosis and IEC shedding 
(McAllister et al., 2013). Although not evaluated in this specific experimental 
setting, it is likely that RIPK1 is a mediator of TLR3-TRIF induced apoptosis in 
IECs, as reported for other cell types (Estornes et al., 2012). Upon blocking 
extrinsic apoptosis, as in Caspase-8IEC-KO mice, intraperitoneal injection of 
Poly(I:C), induced RIPK1 kinase-dependent RIPK3-dependent IEC 
necroptosis, providing further evidence for a physiological role of RIPK1 in the 
regulation of TLR3-induced cell death in IECs. However, the contribution of 
RIPK1 in IEC-specific viral infection models still needs to be addressed.  
 
Several recent studies revealed, that bacterial infections can induce RIPK1 
and/or RIPK3 dependent cell death. For instance, Salmonella enterica serovar 
Typhimurium can induce macrophage death by triggering type I IFN 
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production that culminates in autocrine RIPK1- and RIPK3-dependent 
macrophage necroptosis to evade host’s innate immune system (Robinson et 
al., 2012). In a similar way and in contrast to VV and MCMV infections, 
Mycobacterium tuberculosis uses TNF-induced host cell RIPK1/RIPK3-
dependent necroptosis for its own dissemination into the extracellular space 
(Chan et al., 2015). The primary etiological agent of periodontitis, 
Porphyromonas gingivalis, which is also associated with atherosclerosis, was 
shown to specifically cleave RIPK1 in infected human aortic endothelial cells 
with a lysine-specific Kgp protease to prevent activation of the host cell death 
machinery (Madrigal, Barth, Papadopoulos, & Genco, 2012). Finally, in 
specific infection scenarios, RIPK1 can have dual functions. First, 
macrophages infected with Yersinia pestis, the causative agent of “black 
death”, are removed by RIPK1 kinase-dependent caspase-8 mediated 
apoptosis and second, both, RIPK1 and caspase-8 are required for TNF, IL-6, 
IL-18 production and caspase-1 activation in Y. pestis infected macrophages 
(Grobner et al., 2007; Philip et al., 2014; Weng et al., 2014). Although these 
studies suggest differential roles for RIPK1 during bacterial infections, most of 
the studies focused on the role of immune cells during infections. Many 
pathogens, for instance Heliobacter pylori, Clostridium difficile, 
Cryptosporidium parvum, Shigella dysenteriae and enterohemorrhagic 
Escherichia coli (EHEC) were shown to induce IEC apoptosis in vitro and/or in 
vivo, however the molecular mechanism of cell death was investigated in 
these studies (Keenan, Sharpnack, Collins, Formal, & O'Brien, 1986; Wada, 
Mori, & Iwanaga, 1997; Wagner et al., 1997). Nevertheless, it has been 
reported that gastrointestinal attaching and effacing (A/E) pathogens, such as 
enteropathogenic Escherichia coli (EPEC), Shigella and Salmonella express a 
type III secretion system effector NleB1, which directly interacts with death 
domain proteins FADD, RIPK1 and TRADD to antagonize DR-induced 
apoptosis of in 293T cells (S. Li et al., 2013; Pearson et al., 2013). Therefore, 
although experimental evidence is missing so far, it is possible that RIPK1-
regulated cell death in IECs is involved in bacterial infections.  
 
Beside its role in RIPK1 in the described pathways, RIPK1 is suggested to be 
involved in other cell survival/proliferation pathways, such as insulin-like 
DISCUSSION 
 111 
growth factor 1 receptor (IGF-1R) or epidermal growth factor receptor 
(EGFR)-mediated signalling (Lin, Yang, Wang, & Liu, 2006; Ramnarain et al., 
2008). However, if RIPK1 has a role in regulating cell survival or cell death 
within these pathways and if this is relevant for RIPK1-deficient IECs is 
unknown and needs to be addressed.  
Upon DNA damage, a signalling platform called the PIDDosome forms, that 
among others, contains NEMO and RIPK1 and signals through either cell 
survival or caspase-2 mediated apoptosis. Within the PIDDosome, RIPK1 
negatively regulates DNA-damage induced apoptosis by promoting NF-κB 
activation (Tinel et al., 2007). During excessive DNA damage induced by 
etoposide, an inhibitor of topoisomerases, ATM stimulates two sequential NF-
κB activation pathways via NEMO and RIPK1 in cancer cells to induce 
feedforward autocrine TNF-signaling in order to eliminate affected cells and 
alert neighbouring cells (Biton & Ashkenazi, 2011). RIPK1 regulates genotoxic 
stress induced apoptosis in a kinase activity dependent and DR-independent 
manner within a cytosolic platform called “Ripoptosome” (Tenev et al., 2011). 
Within the Ripoptosome, the levels of cFLIPL and cFLIPS determine cell fate 
between apoptosis and RIPK3-dependent necroptosis by regulating caspase-
8 activity (Feoktistova et al., 2011). Although the mode of death may have 
different consequences relevant for some pathophysiological conditions, it is 
rather unlikely that genotoxic stress is a trigger of apoptosis in Ripk1-/- IECs.  
 
In summary, autocrine TNF is the major inducer of IEC apoptosis in the colon 
and ileum of RIPK1IEC-KO mice. However, beside TNF, other triggers of FADD-
dependent apoptosis in RIPK1-deficient IECs apoptosis exist, that still need to 
be identified to understand how RIPK1 regulates intestinal homeostasis. In 
addition, many studies revealed that RIPK1-regulated cell death pathways not 
only regulate homeostasis, but also are important during pathophysiological 
conditions such as infections and for executing appropriate host immune 
responses to protect the organism.  
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4.4 The role of RIPK1 in (intestinal) inflammation 
Except for Tnf and Cxcl1, expression of cytokines and chemokines was only 
slightly upregulated in the colon and ileum of RIPK1IEC-KO mice on mRNA 
levels (Figure 9, Figure 13). Although, the overall number of leucocytes and in 
particular CD11bhi Ly6Ghi neutrophils, which are usually the first cells 
recruited to a site of inflammation, were differentially increased in the lamina 
propria of RIPK1IEC-KO intestines, on histological sections they showed a 
dispersed staining pattern and were not found in focal spots (Figure 10,Figure 
14). Ulcers were not detectable in none of the examined H&E stained sections 
from colon and ileum derived from RIPK1IEC-KO mice (Figure 6). Thus, despite 
extensive epithelial cell apoptosis, RIPK1IEC-KO mice develop only very mild 
inflammation in the colon and the ileum. IEC apoptosis, intestinal pathology 
and premature death of RIPK1IEC-KO mice were independent of commensal 
bacteria and MyD88-mediated signalling (Figure 17, Figure 18, Figure 20-
Figure 22). Noteworthy, another publication reported a partial dependency of 
severe wasting, premature lethality and inflammation in RIPK1IEC-KO mice on 
the microbiota and MyD88-dependent signalling (Takahashi et al., 2014). 
However, in this study, a detailed characterization of colitis/ilietis in both has 
so far not been provided, and similar to our results, double-knockout mice still 
showed IEC apoptosis. The reason for the discrepancies in the macroscopic 
state and survival of RIPK1IEC-KO mice between both studies are unknown. 
Nevertheless, since antibiotic treatment ameliorated wasting and prolonged 
the survival of RIPK1IEC-KO (Figure 20) (Takahashi et al., 2014) as well as of 
RIPK1tamIEC-KO (Figure 17, Figure 18) and low numbers of germ-free RIPK1IEC-
KO mice survived up to 22 weeks (Figure 21a, b), it is possible that the 
depletion or absence of the microbiota has a beneficial effect for the overall 
constitution and survival of the mice without affecting IEC death and intestinal 
pathology.  
 
The phenotype of RIPK1IEC-KO mice is in stark contrast to other murine 
intestinal models of (extrinsically-induced) intestinal cell death such as 
NEMOIEC-KO mice or FADDIEC-KO mice, which have less dying IECs compared 
to RIPK1IEC-KO mice, but develop ulcerating colitis already at 3 weeks of age 
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(Nenci et al., 2007; Welz et al., 2011)(unpublished data). In both cases, colitis 
depends on commensals inducing MyD88-dependent signalling, however 
death of IECs is only reduced but not abrogated (Nenci et al., 2007; Welz et 
al., 2011)(unpublished data). In line with this, previous reports showed, that 
IECs express low levels of TLR4 and LPS-induced death of IECs in mice 
depends on TNF produced by non-epithelial cells in response to LPS sensing 
(Gunther et al., 2015; Williams et al., 2013). Thus, most likely commensal-
induced TLR4-MyD88-mediated signalling does not directly induce IEC death 
in RIPK1IEC-KO, FADDIEC-KO and NEMOIEC-KO mice. In the case of the latter two, 
according to the current model, a compromised barrier integrity, caused by 
IEC death, allows the translocation of bacterial antigens in to the bowel wall, 
where they activate mucosal immune cells and thereby induce cytokine 
production, which drives the inflammatory phenotype. Increased abundance 
of inflammatory cytokines such as TNF in turn, induces death of more IECs 
triggering a feedforward loop sustaining and promoting disease development.  
 
Within the intestinal epithelium, dead cells are removed mainly by cell 
shedding, whereas the contribution of phagocytosis is under debate, thus 
controlled proliferation and regulation of cell adhesion- and tight junction 
proteins is necessary for proper barrier integrity. As RIPK1IEC-KO mice do not 
show ulcerating colitis (and ilieits), one may speculate that despite extensive 
cell death, the intestinal epithelial barrier integrity remains intact. This would 
provide an explanation why MyD88 ablation, and thus sensing of bacteria in 
the lamina propria, does not have an impact on the pathology in these mice. 
However, if a compromised barrier is the cause or the consequence of 
intestinal inflammation remains a question at the moment. Recently, it was 
demonstrated that mice with IEC specific ablation of claudin-7, a constituent 
of epithelial tight junctions, primarily had a leaky intestinal barrier, which was 
followed by inflammation of the colon, suggesting that a compromised barrier 
might be sufficient to cause colitis (Tanaka et al., 2015). Similarly, Caspase-
8IEC-KO mice, an intestinal cell death model for RIPK3-dependent IEC 
necroptosis, showed breakdown of epithelial barrier upon poly(I:C) injection 
that most likely contributes to lethal systemic spreading of intestinal microbes 
(Gunther et al., 2015). It remains to be shown, if the expression of 
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constituents regulating proliferation, cell adhesion and epithelial tight- and gap 
junctions differs between RIPK1IEC-KO mice and other mouse models, or is 
regulated differentially by other means.  
 
Another possibility, which could account for the different pathology in the 
RIPK1IEC-KO-, NEMOIEC-KO-, FADDIEC-KO- and Caspase-8IEC-KO mice, is the 
mode of cell death of IECs. Historically, apoptosis is considered as an 
immunotolerogenic or “silent” mode of cell death during which the dying cells 
are orderly disassembled by phagocytes to limit the amount of released 
DAMPs. In contrast, unregulated necrosis/necroptosis are considered as 
immunogenic, due to the uncontrolled release of DAMPs into the 
neighbourhood. Accordingly, in RIPK1IEC-KO mice, with predominantly 
apoptotic IECs, no or only a mild inflammation would be expected. In contrast, 
in RIPK1IEC-KO/FADDIEC-KO the dominant mode of death switched to RIPK3-
dependent necroptosis, that is immunogenic, resulting in colitis with presence 
of ulcers in 50% of the analysed mice (Figure 25).  
In other intestinal cell death models, such as NEMOIEC-KO mice, IKK1/2IEC-KO 
mice and TAK1IEC-KO mice, apoptosis is the main driver of the phenotype, 
however, mice develop severe colitis (Kajino-Sakamoto et al., 2008; Nenci et 
al., 2007). However, it should be considered that in these models impaired 
NF-κB and MAPK activation may also contribute to the observed phenotypes. 
Although a possible a role of necroptosis needs to be adressed in these 
models, they demonstrate that apoptotic IEC death is able is to trigger 
intestinal inflammation. Since the molecular mechanisms initiating apoptosis 
differ in RIPK1IEC-KO mice on the one, and NEMOIEC-KO on the other hand, it 
could be possible that the mode of apoptosis has an influence on the 
immunogenicity itself or indirectly via the products that are exposed on the cell 
surface or secreted by dying cells. For instance it was shown that a small 
difference in the combination of molecules exposed during death of cells, can 
determine if the dying cell is recognised as immunogenic or not (Obeid et al., 
2007). As mentioned, the immunogenic potential of necrotic/necroptotic death 
is attributed to the release of DAMPs, subdivided further into molecules with 
non-inflammatory functions in living cells with immunomodulatory properties 
such as HMGB1, uric acid, ATP and second, alarmins and molecules with 
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cytokine-like functions, for instance IL-1a, IL-1ß or IL-33 (Kaczmarek, 
Vandenabeele, & Krysko, 2013). In the plasma of Ripk1-/- mice increased 
levels of IL-33 but not HMGB1 were detected, and this increase was 
independent of caspase-8 but dependent on RIPK3 and MLKL, thus seems to 
be specific for necroptosis (Rickard et al., 2014). IL-33 is of special interest, 
since it is a chromatin-associated protein constitutively expressed by epithelial 
cells and usually inactivated by effector caspases during apoptosis (Luthi et 
al., 2009; Palmer & Gabay, 2011). However, if levels of IL-33 or another yet to 
be identified DAMP differ before the onset of inflammation and may account 
for the phenotypic difference in RIPK1IEC-KO mice and RIPK1IEC-KO/FADDIEC-KO 
as well as other intestinal cell death models remains to be shown.  
 
In summary, it is not clear if a different mode of cell death and/or differences 
in the barrier regulation account for the phenotypic differences in regard to 
inflammation that are observed in RIPK1IEC-KO mice and other models.  
 
4.5 Concluding Remarks 
The data presented in this work unravels RIPK1 as an important regulator of 
intestinal homeostasis that prevents FADD-dependent apoptosis during 
homeostatic conditions. Further studies are required to decipher the molecular 
mechanisms of RIPK1-regulated cell death downstream of TNF and other 
signalling pathways. This might provide important insights to understand the 
pathogenesis of human diseases such as IBD. Although the pathogenic role 
of TNF in IBD is not fully understood, anti-TNF therapy is successfully used in 
IBD patients. There is increasing evidence that apoptosis and necroptosis 
contributes to the pathology in IBD and thus, specific targeting of components 
of cell death effectors may provide novel therapeutic opportunities.  
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